Announcements

10 April 2024
Meet Us at the 48th FEBS Congress, 29 June–3 July 2024, Milano, Italy

Conference: The 48th FEBS Congress
Date: 29 June–3 July 2024
Location: Milano, Italy

MDPI will be attending the 48th FEBS Congress at Booth #30, and we welcome researchers from different backgrounds to visit us and share their latest ideas.

The Italian Society of Biochemistry and Molecular Biology (SIB), founded in 1951, will host the event. The 48th FEBS Congress—“Mining biochemistry for human health and well-being”—welcomes scientists from Europe and other parts of the world.

The 48th FEBS Congress will present a broad-spectrum and ground-breaking scientific program in a fruitful collaboration with FEBS journals and representatives from FEBS Constituent Societies. The SIB and biochemical community are focusing on human health and well-being through molecular and cellular science approaches; this is a key social issue amid ongoing global transitions. Besides presenting the latest and emerging developments in biochemical sciences, the Congress will include dedicated education-oriented sessions, symposia organized by young biochemists, and biochemistry-related economic discussions. Industry representatives will also give presentations on the latest advances in commercial instrumentation.

The following MDPI journals will be represented:

If you plan to attend this conference, please start an online conversation with us. Our delegates look forward to meeting you in person and answering your questions. For more information about the conference, please visit the following website: https://2024.febscongress.org/.

8 April 2024
Meet Us at the 2024 ASCO Annual Meeting, 31 May–4 June 2024, Chicago, IL, USA


The 2024 ASCO Annual Meeting will take you to discover state-of-the-art research, groundbreaking treatments, and visionary insights, igniting your passion for oncology. This year's program will feature over 200 sessions, complementing Dr. Lynn Schuchter’s Presidential theme “The Art and Science of Cancer Care: From Comfort to Cure”.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth at the conference and answering any questions you may have. For more information regarding the conference, please visit the following link: https://conferences.asco.org/am/attend.

7 April 2024
Pharmaceutics Webinar | Where Are We Now and Where Is Antimicrobial Therapy Headed?, 24 April 2024


A welcome message from Dr. Fábio Fernandes, the webinar chair:

Dear Colleagues,

It is my pleasure to welcome each of you to this webinar! As Chair, I am pleased to see the convergence of research aimed at understanding “Where Are We Now and Where Is Antimicrobial Therapy Headed?”.

Antimicrobial resistance poses more of a concern today than ever before. Our collaborative efforts, insights, and inventions are critical in navigating this difficult world. This meeting provides an opportunity for us to exchange ideas, examine breakthroughs, and plot a course for a future in which effective antimicrobial therapy remains a cornerstone of modern medicine.

Our schedule for this webinar is packed with interesting talks, from antimicrobial dendrimer and lipid nanoparticles to the regulation of biofilms by RNA. I encourage all of you to actively engage in the sessions, contribute your views, and take advantage of the opportunity to network with our panel of experts and other researchers.

Again, welcome to this webinar!

Dr. Fábio Fernandes

Date: 24 April 2024 10.00 a.m. CEST | 4:00 a.m. EDT | 4:00 p.m. CST Asia
Webinar ID: 841 5162 0647
Webinar Secretariat: journal.webinar@mdpi.com
Webinar Announcement: https://sciforum.net/event/Pharmaceutics-3

Register for free:

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we will inform you when the recording is available.

Speaker/Presentation Time in CEST Time in EDT
Dr. Fábio Fernandes
Chair Introduction
10:00 a.m.–10:10 a.m. 4:00a.m.–4:10 p.m.
Dr. Sandra Pinto
Introducing the topic: “Where Are We Now and Where Is Antimicrobial Therapy Headed?”
10:10 a.m.–10:30 a.m. 4:10 a.m.–4:30 a.m.
Dr. Maria Manuela Gaspar
The Key Role of Liposomes as Delivery Systems for the Management of Infectious Diseases
10:30 a.m.–10:50 a.m. 4:30a.m.–4:50 a.m.
Dr. Vasco Bonifácio
Polyurea Pharmadendrimers: The Next Generation of Antimicrobials
10:50 a.m.–11:10 a.m. 4:50 a.m.–5:10 a.m.
Dr. Vânia Pobre
How RNA Regulators Influence Biofilm Formation
11:10 a.m.–11:30 a.m. 5:10 a.m.–5:30 a.m.
Q&A Session 11:30 a.m.–12:00 p.m. 5:30 a.m.–6:00 a.m.
Dr. Fábio Fernandes
Closing of Webinar
12:00 p.m.–12:05 p.m. 6:00 a.m.–6:05 a.m.

Webinar Chair and Keynote Speakers:

  • Fábio Fernandes (Chair), Institute for Bioengineering and Biosciences (IBB) and Associate Laboratory, Institute for Health and Bioeconomy (i4HB), Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal;
  • Sandra Pinto, Institute for Bioengineering and Biosciences (IBB) and Associate Laboratory, Institute for Health and Bioeconomy (i4HB), Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal;
  • Maria Manuela Gaspar, Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal;
  • Vasco Bonifácio, Institute for Bioengineering and Biosciences (IBB) and Associate Laboratory, Institute for Health and Bioeconomy (i4HB), Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal;
  • Vânia Pobre, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa (ITQB NOVA), Oeiras, Portugal.

Relevant Special Issue:

Where Are We Now and Where Is Antimicrobial Therapy Headed?
Guest Editor: Dr. Sandra N. Pinto
Deadline for manuscript submissions: 20 June 2024

2 April 2024
Pharmaceutics | Top 10 Cited Papers in 2022


We are pleased to invite you to read the top 10 cited papers of Pharmaceutics (ISSN: 1999-4923) in 2022. We hope this announcement will provide useful information for this field. The list of papers is as follows:

1. “Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives”
by Teresa Pardo-Moreno, Anabel González-Acedo, Antonio Rivas-Domínguez, Victoria García-Morales, Francisco Jose García-Cozar, Juan Jose Ramos-Rodríguez and Lucía Melguizo-Rodríguez
Pharmaceutics 2022, 14(6), 1117; https://doi.org/10.3390/Pharmaceutics14061117
Available online: https://www.mdpi.com/1999-4923/14/6/1117

2. “Recent Fabrication Methods to Produce Polymer-Based Drug Delivery Matrices (Experimental and In Silico Approaches)”
by Anna Procopio, Elena Lagreca, Rezvan Jamaledin, Sara La Manna, Brunella Corrado, Concetta Di Natale and Valentina Onesto
Pharmaceutics 2022, 14(4), 872; https://doi.org/10.3390/Pharmaceutics14040872
Available online: https://www.mdpi.com/1999-4923/14/4/872

3. “A Historical Review of Brain Drug Delivery”
by William M. Pardridge
Pharmaceutics 2022, 14(6), 1283; https://doi.org/10.3390/Pharmaceutics14061283
Available online: https://www.mdpi.com/1999-4923/14/6/1283

4. “Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation”
by Hanhee Cho, Seong Ik Jeon, Cheol-Hee Ahn, Man Kyu Shim and Kwangmeyung Kim
Pharmaceutics 2022, 14(4), 728; https://doi.org/10.3390/Pharmaceutics14040728
Available online: https://www.mdpi.com/1999-4923/14/4/728

5. “Hard, Soft, and Hard-and-Soft Drug Delivery Carriers Based on CaCO3 and Alginate Biomaterials: Synthesis, Properties, Pharmaceutical Applications”
by Yanqi Huang, Lin Cao, Bogdan V. Parakhonskiy and Andre G. Skirtach
Pharmaceutics 2022, 14(5), 909; https://doi.org/10.3390/Pharmaceutics14050909
Available online: https://www.mdpi.com/1999-4923/14/5/909

6. “Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials”
by Natalia Krasteva and Milena Georgieva
Pharmaceutics 2022, 14(6), 1213; https://doi.org/10.3390/Pharmaceutics14061213
Available online: https://www.mdpi.com/1999-4923/14/6/1213

7. “The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells”
by Yelee Kim, Hyosuk Kim, Eun Hye Kim, Hochung Jang, Yeongji Jang, Sung-Gil Chi, Yoosoo Yang  and Sun Hwa Kim
Pharmaceutics 2022, 14(6), 1271; https://doi.org/10.3390/Pharmaceutics14061271
Available online: https://www.mdpi.com/1999-4923/14/6/1271

8. “Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity”
by Aleen Khoury, Jennette A. Sakoff, Jayne Gilbert, Kieran F. Scott, Shawan Karan, Christopher P. Gordon and Janice R. Aldrich-Wright
Pharmaceutics 2022, 14(4), 787; https://doi.org/10.3390/Pharmaceutics14040787
Available online: https://www.mdpi.com/1999-4923/14/4/787

9. “3D Printed Mini-Floating-Polypill for Parkinson’s Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy”
by Hellen Windolf, Rebecca Chamberlain, Jörg Breitkreutz and Julian Quodbach
Pharmaceutics 2022, 14(5), 931; https://doi.org/10.3390/Pharmaceutics14050931
Available online: https://www.mdpi.com/1999-4923/14/5/931

10. “Chitosan-Hyaluronan Nanoparticles for Vinblastine Sulfate Delivery: Characterization and Internalization Studies on K-562 Cells”
by Carmela Cannavà, Federica De Gaetano, Rosanna Stancanelli, Valentina Venuti, Giuseppe Paladini, Francesco Caridi, Corneliu Ghica, Vincenza Crupi, Domenico Majolino, Guido Ferlazzo et al.
Pharmaceutics 2022, 14(5), 942; https://doi.org/10.3390/Pharmaceutics14050942
Available online: https://www.mdpi.com/1999-4923/14/5/942

You are invited to view and submit relevant papers to the journal Pharmaceutics via the following link: https://www.mdpi.com/journal/pharmaceutics.

Pharmaceutics Editorial Office

2 April 2024
MDPI Insights: The CEO's Letter #10 - South Korea, IWD, U2A, Japan

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Stefan Tochev (CEO, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), during media meetings at Prain Agency office in Seoul, South Korea.

Visit to Seoul, South Korea

During my recent visit to South Korea, I had the privilege of meeting various stakeholders, including representatives of government, research institutions, and academia, to understand their needs and communicate MDPI’s commitment to accessible science. Accompanied by my colleagues Dr. Giulia Stefenelli and Dr. Jisuk Kang, I engaged with the Korean scientific community, which is increasingly embracing open access (OA).

As the leading OA publisher in South Korea, MDPI is trusted by local authors and in 2023 enjoyed an approximately 30% share of the OA market. South Korea ranks sixth globally for MDPI in terms of research papers submitted and published.

MDPI and South Korea by Numbers

As at 30 March, over 76,000 MDPI articles have been authored by individuals affiliated with Korean institutions. We have over 1,800 active editorial board members (EBMs) from South Korea, with more than 880 EBMs having an H-index between 26 and 50, including 10 serving as Chief Editors.

“South Korea is the sixth-largest contributor to our total publications”

Over the past five years (2019–2023), nearly 120,000 authors affiliated with South Korean institutes have published with MDPI. Specifically in 2023, we received approximately 25,000 submissions from South Korean authors, publishing close to 13,000 articles, resulting in a rejection rate of 47.4%, which is not far below MDPI’s overall rejection rate of 56.4% in 2023.

Institutional Partnerships with South Korea

I am pleased to share that MDPI has more than 825 institutional partnerships worldwide, with 12 in South Korea, including Kyunghee University, Chung-Ang University, and Inha University, among others.


Left to right: Dr. Jisuk Kang (Scientific Officer, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), and Stefan Tochev (CEO, MDPI) fielding media questions at Prain PR Agency office in Seoul, South Korea.

Over the past three years (2021–2023), we have had some of the most prestigious academic universities ranked among the top 10 Korean institutions publishing with MDPI. Seoul National University had the highest number of publications with MDPI during those three years, publishing nearly 6,000 papers. Universities such as Korea University and Yonsei University also rank among the top 10 Korean institutions publishing with MDPI.

MDPI Hosts Seminar for Academia and Media

As the world’s leading OA publisher, MDPI is actively democratizing science. This is reflected in the seminars we hosted on 21 March to address questions about our editorial processes and ethical standards. The visit garnered media coverage, reflecting our mission to providing high-quality services and fostering open dialogue in the community.

“MDPI is actively democratizing science”

MDPI in the News


Stefan Tochev (CEO, MDPI) leading a seminar on OA and MDPI at Prain PR Agency office in Seoul, South Korea.

Media coverage generated by our visit to Seoul included the following stories:

“Open access is an unstoppable trend…it will lead the development of the knowledge ecosystem.”

“Papers that the public needs, anyone can use quickly… low-quality publishing is a misunderstanding.”

I greatly appreciate the contributions of everyone who took the time to meet with us, share their stories, and hold us accountable for continuing to provide high-quality publishing services while identifying areas for improvement. I am also excited to announce that we have opened an MDPI office in Seoul and will release a press release on MDPI.com, with details, by the end April 2024. The purpose of the office is to establish a local presence to connect with and support the South Korean academic community through institutional partnerships, conferences, author workshops, stakeholder communications, and more.

Impactful Research

Featured Articles on Women’s Leadership and Healthcare

In celebration of International Women’s Day (8 March 2024), MDPI curated a collection of research articles on various topics, including women’s leadership, reproductive health, preventive healthcare, and a selection of articles from our journal Women.

Women’s Leadership

Women’s Reproductive Health

Women’s Preventive Healthcare

Featured Articles in MDPI Journal Women

Below are a few articles from Women, our journal focused on women’s health, the social determinants of health, and the healthcare system that serves women. The aim of Women is to encourage academics to publish their experimental and theoretical results in detail, to aid reproducibility, and in an engaging style, to aid comprehensibility.

Inside MDPI

 

Championing Women’s Healthcare and Access to Healthcare Information

MDPI colleagues from our offices joined in celebrating #IWD2024. In doing so, we emphasized key missions that encompass:

  • Empowering women to assume leadership and decision-making roles in both business and science.
  • Helping women and girls make informed decisions about their health.
  • Recruiting and developing female talent and fostering inclusive workplace environments.

“We are thrilled to recognize the accomplishments of women scientists”

I am proud to see our colleagues enthusiastically supporting the International Women’s Day call to ‘Inspire Inclusion!’ The heart-hands in the collage below symbolize our appreciation of the achievements of women researchers and the recognition of the trailblazers who have courageously made a mark on societies past and present.

We are thrilled to recognize the accomplishments of women scientists through our many MDPI awards and by highlighting success stories. As inspirational figures, female scientists are paving the way for the next generation of women aspiring to pursue careers in engineering, life sciences, computing, and various other STEM fields.

“I consider myself lucky because I work with incredibly talented women who inspire me every day.”
– Dr. Alessandra Pasut, Winner of MDPI's ‘Biology 2023 Young Investigator Award’

“It’s really important to find a supportive and enabling environment in which to do your science; it would have a big impact on you as a person and on your scientific outputs.”
– Dr. Rhea Longley, Winner of the ‘Pathogens 2023 Young Investigator Award’

Open-access publishing, in particular, allows early-career women researchers to share their work more widely, potentially attracting mentorship opportunities and collaborations. This support is crucial for career development and advancement.

Coming Together for Science

MDPI Joins United2Act in Collective Fight to Stop Paper Mills

In my February 2024 CEO Letter, I highlighted some of our recent initiatives aimed at bolstering our commitment to research integrity, including joining the STM Integrity Hub and expanding our Research Integrity and Publication Ethics team (RIPE). Continuing our efforts in coming together for science, I am pleased to share our participation in the United2Act initiative.

The text below is taken from our official announcement:

United2Act represents an international group of stakeholders in the publishing industry committed to addressing the collective challenge posed to research integrity by paper mills.

Scientists and academic publishers have increasingly noted the alarming proliferation of paper mills, recognized as fraudulent entities seeking to manipulate the publication process for financial profit. These entities engage in fraudulent practices such as falsifying or fabricating data, selling co-authorship of fake papers, manipulating peer review, and including inappropriate citations. These actions pose a significant threat to the integrity of the scholarly record, prompting widespread concern among those involved in the academic community.

MDPI has been actively contributing to combat the undermining of the scientific record. Our editors employ a set of tools to detect potential ethical breaches within a manuscript and to tackle the issue of fake papers.

United2Act’s consensus statement is the outcome of a virtual summit held in May 2023. It involved the participation of research bodies, publishers, researchers/sleuths, universities, and publishing infrastructure from 15 countries and resulted in a Consensus Statement outlining five key areas of action for all stakeholders:

  • Education and awareness
  • Improve post-publication corrections
  • Facilitate and organise research on paper mills
  • Enable the development of trust markers
  • Facilitate dialogue between stakeholders

MDPI is committed to promoting transparency and integrity in scholarly publishing and is continuing to work closely with the scientific community toward this goal.

Closing Thoughts


Left to right: Ryo Hirayama (Marketing Specialist, MDPI), Takashi Sasabe (Marketing Specialist, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Stefan Tochev (CEO, MDPI), at MDPI’s office in Tokyo, Japan.

Visit to Tokyo and Kyoto, Japan

In March, I had the opportunity to visit our Tokyo office and engage with stakeholders in Tokyo and Kyoto. During the visit, I also recorded a video message to welcome Japanese scholars working with MDPI and to highlight our operations in Japan.

We held meetings with Editors-in-Chief, librarians, scholars, and external consultants to gather feedback on our efforts to enhance our reputation and explore additional steps we can take in that direction. Japan's rich cultural heritage, characterized by tradition, respect, and formality, provided valuable insights into meeting the publishing needs specific to Japan.

Japan’s Open Access statistics

Over the years, we have seen a shift from subscription-only to gold OA publishing in Japan, despite the lack of an official mandate. Here are some statistics:

  • 2012: 68% of articles were subscription-only, 6% were green Open Access, and 8% were gold Open Access.
  • 2016: 55% of articles were subscription-only, 6% were green Open Access, and 20% were gold Open Access.
  • 2022: 43% of articles were subscription-only, 7% were green Open Access, and 39% were gold Open Access.

To learn more about the history of OA in Japan as well as about future trends, please read this blog post.

“Japan is the ninth-largest contributor to our total publications”


Left to right: Stefan Tochev (CEO, MDPI), Dr. Izumi Yamamoto (Marketing Manager, MDPI), and Dr. Giulia Stefenelli (Chair of Scientific Office Board, MDPI) visiting Kyoto University in Kyoto, Japan.

MDPI and Japan by Numbers

As at 1 April, over 50,000 MDPI articles have been authored by scholars affiliated with Japanese institutions, making the country the ninth-largest contributor to our total publications. Over the past three years (2020–2023), nearly 90,000 authors affiliated with Japanese institutes have published with MDPI, and we have collaborated with over 4,600 Guest Editors from Japan.

In 2023, we published over 8,200 papers from authors associated with Japanese institutions. MDPI collaborates with 41 institutional partnerships in Japan, including the University of Tokyo, Hokkaido University, and Nagoya University. We have over 2,100 active EBMs from Japan, more than 1,050 EBMs having an H-index between 26 and 50, including 13 serving as Editors-in-Chief.

General Feedback – a side note

A general takeaway from our discussions with stakeholders from around the world is that negative perceptions of MDPI often stem from misinformation, misconceptions, or misunderstandings about MDPI and our practices. While we acknowledge our mistakes and work diligently to address them, maintaining a strong editorial procedure and robust peer-review process, I find that educating stakeholders about our how we do what we do and our ongoing improvements tends to help shift opinions.

That said, we recognize the importance of addressing individual concerns. We take feedback seriously and are continuously working to get better while not compromising the core principles that millions of authors appreciate about MDPI.

Stefan Tochev
Chief Executive Officer
MDPI AG

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

23 February 2024
Meet Us at the 144th Annual Meeting of the Pharmaceutical Society of Japan, 28–31 March 2024, Yokohama, Japan


Conference: The 144th Annual Meeting of the Pharmaceutical Society of Japan
Date: 28–31 March 2024
Location: Yokohama, Japan

MDPI will be attending the 144th Annual Meeting of the Pharmaceutical Society of Japan at Booth #79, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

The theme of the 144th Annual General Meeting is: “Creation of a Pharmaceutical Culture that Co-prosperity with “Genes” and “Environment”: Toward the Integration of Sustainable “Digital Therapy”.

With the introduction of vaccines, the sale of therapeutic drugs, and the establishment of treatment systems, the fight against COVID-19 has become a coexistent situation. We hope that this annual general meeting will be an opportunity for many researchers, medical professionals, and educators involved in pharmaceutical research to gather, present the latest research results, and discuss how pharmaceutical education should be. We hope that it will be an opportunity to create sustainable innovations for the future.

The following MDPI journals will be represented:

  • Biomedicines;
  • JPM;
  • Molecules;
  • Pharmaceuticals;
  • Pharmaceuticals.

If you are planning on attending this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://confit.atlas.jp/guide/event/pharm144/top.

5 February 2024
Acknowledgment of the Reviewers of Pharmaceutics in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Pharmaceutics. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, Pharmaceutics received 11020 review reports, from 6532 reviewers. This past year, we worked with reviewers from 94 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Pharmaceutics family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

A. Berenice Aguilar-Guadarrama Krista Delviks-Frankenberry
A. F. M. Motiur Rahman Kristijan Skok
Aamir Jalil Kristina Kantminienė
Abbirami Elangovan Krisztina Takacs-Novak
Abdelbary Elhissi Krzysztof Kuczera
Abdul Aleem Mohammed Krzysztof Zborowski
Abdullah Assiri Ksenia Tereshkina
Abdulqadir Nashwan Kui Zhang
Abhishek Anant Kulkarni Kuldeep Bansal
Abhishek Juluri Kuldeep Gupta
Abhishek Kandwal Kumar Katragunta
Abhishek Kumar Kyriakos Kachrimanis
Abi Jenkins Kyuichi Kawabata
Achilleas Garoufis Lacramioara Popa
Adam Kern Lalit Kumar
Adam Oberstein Lamiaa M. A. Ali
Adam Reich Lara Baticic
Adel Al Fatease László Hazai
Adelina Vlad Laszlo Jicsinszky
Adina Magdalena Musuc László Szilák
Adina Popa Lateef Ahmad
Aditi Mulgaonkar Laura Endres
Aditya Sarode Laura Melendez-Alafort
Aditya Singh Laura Orian
Adrian Florin Spac Laura Vicaș
Adrián Matencio Laura-Marinela Ailioaie
Adrían Rodríguez-Carlos Laurentiu M. Pop
Adrian Topolski Layla Pires
Adriana Erica Miele Le Minh Tu Phan
Afang Zhang Leander Corrie
Affiong Iyire Leda Guzmán
Afrooz Rashnonejad Lei Li
Afzal Hussain Lei Nie
Afzal Shaik Lei Zhang
Agata Wawrzyńczak Lenuţa-Maria Şuta
Agnieszka Szczepek Leonard Ionut Atanase
Agnieszka Szewczyk Leonid Kustov
Agnieszka Wiącek Leszek Szablewski
Agnishwar Girigoswami Leto-Aikaterini Tziveleka
Ahlam Zaid Alkilani Li Liang
Ahmed Abdel Moneim Lídia Gonçalves
Ahmed Abu-Zaid Liewei Wen
Ahmed El Ghorab Lifo Ruan
Ahmed El-Fiqi Lijun Wang
Ahmed Fatimi Liliya Logoyda
Ahmed Hassan Lilya Dzhemileva
Ahmed Noreldin Lim Hwee San
Ahmed Shalabi Linda Hazlett
Ahmet Kertmen Lipeng Qiu
Aidar Gubaidullin Lisa Ryan
Aidin Bordbar-Khiabani Liting Wang
Aiman Abu Ammar Liudmyla V. Garmanchuk
Aisha Farhana Liviu Steier
Aixiang Ding Ljubisa Nikolic
Ajmer Singh Grewal Loredan Niculescu
Akira Yamasaki Loredana Brioschi
Alain Le Faou Lorella Giovannelli
Alanood Almurshedi Lorena Ciumărnean
Alberto Baldelli Lorenzo Vannozzi
Alberto Di Renzo Lu Cai
Alberto García-Peñas Lu Xiao
Alejandro Casas-Alvarado Lubos Cipak
Alejandro Islas-Jácome Luca De Stefano
Alejandro J. Alvarez Luca Filippi
Alejandro Ruiz-Picazo Luca Giannella
Aleksandar Shkondrov Luca Liviu Rus
Aleksandar Ž. Kostić Luca Palugan
Aleksander Czogalla Luca Potestio
Aleksander Mendyk Lucia Baldino
Aleksandra Bondžić Lucia Montenegro
Aleksandra Bukhovets Luciana D'Apice
Aleksandra Józefczyk Luciana Malavolta
Aleksandra Volod'ko Lucinda Bessa
Alena Stupar Lucretia Udrescu
Alessandra Maroni Ludmila Kazdova
Alessandra Sinopoli Luidmila Yakimova
Alessandra Zizzari Luis Alves
Alessandro Parodi Luis Apaza Ticona
Alessandro Venditti Luis Ibarra
Alexa Guglielmelli Luis Oriol
Alexander Bunev Luis Puig
Alexander Demin Luis Soto-Rojas
Alexander Dullenkopf Luis Villarreal-Gómez
Alexander Ewe Łukasz Grabowski
Alexander Lykov Łukasz Szeleszczuk
Alexander Muravsky M. Begoña Delgado-Charro
Alexander Novikov M. Carmen Morán
Alexander Shtil Maciej Przybyłek
Alexander Trujillo Maciej Serda
Alexander Vasil’kov Mafalda Sarraguça
Alexander Yusipovich Magda Abdellattif
Alexandra Zakharenko Magdalena Gierszewska
Alexandre Vetcher Magdalena Matysiak-Kucharek
Alexandrina Nan Magdalena Mizerska-Kowalska
Alexey Chubarov Maha Nasr
Alexey Sokolov Mahmoud Elsayed
Alexios Vlamis Mahmoud Kandeel
Alexis Oliva Mahmoud Khalil
Alexis Stamatikos Mahmoud Younis
Ali Dehshahri Maja Nešić
Ali Hassan Makoto Tsunoda
Ali Ibrahim Maksim Burkin
Ali Mujtaba Małgorzata Jeleń
Ali Raza Małgorzata Przybyło
Ali Zarrabi Małgorzata Starek
Aliaa ElMeshad Małgorzata Sznitowska
Alicia Mansilla Manesh Nautiyal
Alicia Rodríguez-Gascón Manikandan Sivan
Alin Laurentiu Tatu Manoj Neog
Alina Grigor'eva Manolis Fousteris
Alison Luce-Fedrow Mansoor-Ali Vaali-Mohammed
Amanda Iglesias Manuel Cordoba-Diaz
Amany Abdel-Rahman Manuel José Lis Arias
Amardeep Awasthi Manuel Rodríguez-Ortega
Amelia Silva Manuel Sureda
Ami Mehta-Doshi Manuela Chiper
Amir Mellati Mara Mihai
Amjad Khan Marc C. A. Stuart
Ammad Ahmad Farooqi Marc-André Lécuyer
Amr Abu lila Marcela-Elisabeta Barbinta-Patrascu
Ana Carolina Gonçalves Marcello Locatelli
Ana Cazacu Marcio Alvarez-Silva
Ana Dascalu Marcio Basilio
Ana Duarte Marco Antonio Meraz-Ríos
Ana Feregrino-Perez Marco Cavaco
Ana Fernandes Marcus Mareel
Ana Figueiras Marcus Scotti
Ana Isabel Fraguas-Sánchez Marek Mirowski
Ana Maria Carmona-Ribeiro Marek Pokorny
Ana Mornar Marek Staszewski
Ana Podolski-Renić Marek Wesolowski
Ana Popovic Bijelic Margarete Odenthal
Ana Rita Jesus Margarida Miranda
Anamaria Brozovic Margherita De Rosa
Anand Joshi Margherita Eufemi
Anand Kumar Pandey Margherita Neri
Anbazhagan Sathiyaseelan Maria A. Bonifacio
Anders Larsson Maria Addolorata Mariggiò
András Bilkei-Gorzó Maria Angeles Rojo
Andre Luis Barros Maria Antonietta Panaro
André Moreira María Del Rayo Camacho-Corona
André R. T. S.Araujo María Del Rocío Reyes-Montes
Andrea Lipińska Maria Elena Martín
Andrea Mastinu María Esperanza Ruiz
Andrea Mezzetta Maria Gazouli
Andrea Ragusa Maria Giulia Cangi
Andreas Kalogirou Maria Guembe
Andreas Koschella María I. Rodríguez-López
Andreas Ouranidis Maria Ignat
Andreas Tzakos María Isabel Lucío
Andrei Potapov Maria João Moreno
Andrei Sarbu Maria João Ramalho
Andreia Pereira Maria Jose De Jesus Valle
Andrés G. Santana Maria Julia Lamberti
Andrew Kolarik Maria Lepore
Andrew Redfern Maria Lucibello
Andrey Bogomolov Maria Manuela Gaspar
Andrey Glotov Maria Mirabelli
Andrey Gorshkov María Paula García
Andrey Nagdalian Maria Pia Ferraz
Andrey V. Sybachin Maria Scavo
Andrey Zamyatnin Maria V. Chatziathanasiadou
Aneta Ostróżka-Cieślik Maria Xilouri
Angel Guillermo Bracamonte Mariana Palage
Angel Josabad Alonso-Castro Mariano Francesco Caratozzolo
Angel M. Cuesta Mariano Venanzi
Angela Capocefalo Marieta Constantin
Angela Papa Marija Gizdavic-Nikolaidis
Angela Suárez-Jacobo Marija Jankunec
Ángela-Patricia Hernández Marilisa Leone
Angeliki Angelidi Marin Simeonov
Angeliki Chroni Marina Abuçafy
Angelina Angelova Marina Spinu
Anik Karan Mario D'Acunto
Anilkumar Thaghalli Shivanna Mario F. C. Santos
Aninidta De Mario Fruschelli
Anjan Motamarry Mário Rosado
Anjuman Begum Mario Simirgiotis
Ankur Bothra Mario Valenti
Anna Angela Barba Marios Spanakis
Anna Drabczyk Marisa Colone
Anna Jurowska Marival Bermejo
Anna Karewicz Mark Heitz
Anna Lewinska Marko Jovic
Anna Marabotti Marko Krstić
Anna Mielańczyk Markus Leo
Anna Rita Bilia Marta Camprubí Rimblas
Anna Shipovskaya Marta Gallo
Anna Siemiątkowska Marta Kepinska
Anna Syguda Marta Slavkova
Anna Trusek Marta Szekalska
Anna Tsaantili Martin Šíma
Anna V. Vologzhanina Martin Ward
Anna W. Sobańska Mary Luz Uribe
Anna Wiktorowska-Owczarek Mary Maj
Annalisa Chiavaroli Marya Ahmed
Annalisa D'Arco Marzia Di Donato
Annamaria Aloisio Masoumeh Ghalkhani
Annarita Stringaro Massimo Conese
Anne Kasus-Jacobi Mateusz Szudzik
Anne-Marie Caminade Mattias Paulsson
Anthony Harker Maurice Collins
Anton Ivanov Mawieh Hamad
Anton Larenkov Md Khalid Anwer
Anton S. Tsybko Md Sofiqul Islam
Antonella Casiraghi Md. Azad
Antonella Rosa Mehmet Gumustas
Antonello Barresi Melgardt De Villiers
Antonio Barbato Melissa Barker-Haliski
Antonio Di Martino Melissa Burmeister
Antonio Massa Melville Vaughan
Antonio Portoles Meng He
Antreas Kantaros Mengliang Zhang
Anu Rahal Mengze Lyu
Ao Shi Mengze Xu
Apipa Wanasathop Mercedes Lopez-Santalla
Apratim Jash Mershen Govender
Arasu Ganesan Micaela Reddy
Arianna De Mori Michael Arkas
Arif Nuryawan Michael Gray
Ari-Pekka Koivisto Michael Leitges
Aris Giannakas Michael Schirmer
Aristides Dokoumetzidis Michael Seidenstuecker
Arkadij Sobolev Michał Rachwalski
Arnaldo Santos Michele Galluccio
Aron Nemeth Mick Welling
Arpita Roy Miguel Cabrera-Pérez
Artem Rogachev Miguel García-Castro
Artur Khannanov Miguel Hueso
Artur Ratkiewicz Miha Moškon
Artur Ribeiro Mihaela Balas
Arun Kharat Mihaela Deaconu
Arun Kumar Shukla Mihaela Ileana Ionescu
Arun Thirumurugan Mihaela Violeta Ghica
Aruna Dhathathreyan Mihalj Poŝa
Arvind Negi Mikaeel Young
Ashish Kabra Mikhail Proskurnin
Ashu Johri Mikhail Tsurkan
Asif Mahmood Milada Šírová
Asmaa Khafaga Milica Aćimović
Aswani Dutt Vadlapudi Milica Lukic
Athanasios A. Panagiotopoulos Milica Pešić
Athanasios Papakyriakou Milka Mileva
Athina Angelopoulou Milos Kojic
Athina Giannoudis Miloš Mitić
Atsushi Kawahara Miloš Ognjanović
Atul Agrawal Ming-Chi Lu
Aura M. Jiménez Garduño Ming-Wei Lin
Aurica Precupas Miran Ki
Avi Schroeder Miranda Sertić
Aydi Abdelkarim Mircea Ioan Popa
Aykut Aksit Miren Altuna
B. H. Jaswanth Gowda Mirna Jovanović
Badr M. Thamer Miroslav Živić
Bahaa Jawad Miroslava Špaglová
Bai-Yan Li Mitsutaka Kitamura
Balakrishna Pai Moganavelli Singh
Balázs Sarkadi Mohamad Hamdi Zainal-Abidin
Barbara De Filippis Mohamed Balaha
Barbara Giordani Mohamed Ibrahim
Barbara Hausott Mohamed Jaber
Barbara Ruaro Mohamed M. Badran
Barbara Schnierle Mohamed Orabi
Barbara Stella Mohamed S. A. Darwish
Barbara Strzalka-Mrozik Mohamed Shaalan
Bartłomiej Potaniec Mohammad Ansari
Basant Puri Mohammad Ashfaq
Basanth Babu Eedara Mohammad Azad
Baskar Venkidasamy Mohammad Doroudian
Bassam Elgamoudi Mohammad Kamal
Beata Morak-Młodawska Mohammad Mobashir
Beata Zadykowicz Mohammad Momin
Béla Kovács Mohammad Oves
Belén Altava Mohammed El-Magd
Belen Begines Mohammed Emran
Bence Sipos Mohammed Gamal
Benjamin Valdez Mohammed Mehanna
Bennett Elzey Mohd Imran
Berenice Fernández-Rojas Moises Leon Juarez
Bernardo Ribeiro Monica Gomaraschi
Bernhard Spingler Monica Raduly
Bharadwaja Srimat Tirumala Peddinti Monika Krasowska
Bhavani Prasad Vinjamuri Monika Prakash
Bhupendra Prajapati Moon Nyeo Park
Bianca-Maria Tihauan Mostafa Hussien
Biljana Arsic Mounir M. Salem Bekhit
Bin Liu Moustafa Fouda
Binoy Maiti Mrinal Bhattacharjee
Bissera Pilicheva Mrinmoy Das
Blanca Ocampo-García Muhammad Abdel Ghafar
Bo Liu Muhammad Hammad Butt
Boaz Mohar Muhammad Ijaz
Bojana Vasiljevic Muhammad Latif
Bojarska Joanna Muhammad Mohsin
Boleslaw T. Karwowski Muhammad Sajid Hamid Akash
Boris Dzantiev Muhammad Shafiq
Boryana Nikolova-Mladenova Mustapha Imam
Boya Liu Muzaffar Iqbal
Brendan Duggan Myron Szewczuk
Briatico-Vangosa Francesco N. Siddiqi
Brigitte Hantusch Nada Mostafa
Bruce Spittle Nader Tanideh
Bruno Miguel Neves Nadine Darwiche
Bryan Troxell Nae-Cherng Yang
burak tüzün Nafisa Gull
Bwalya Witika Nagavendra Kommineni
C. Cabello-Alvarado Nagendra Chauhan
Cameron Metcalf Nagesh Peddada
Candace Day Nageswara Pilli
Candan Hizel Naoya Kondo
Carla Lucia Esposito Naozumi Teramoto
Carla Zannella Napoleão Argôlo Neto
Carlemi Calitz Narendar Dudhipala
Carlo Aprile Naresh Duvva
Carlo Diaferia Narimantas Čėnas
Carlos Alonso-Moreno Natalia Belosludtseva
Carlos Caro Salazar Natalia Cheshenko
Carlos Cerdán Santacruz Natalia Inada
Carlos F. Geraldes Natalia Linkova
Carlos Garcia Santos-Gallego Natalia Shnayder
Carlos Martinez-Boubeta Nataliya Sumbatyan
Carlos Torres-Torres Nathachit Limjunyawong
Carlotta Marianecci Nathalie Van Den Berge
Carly Filgueira Nauman Khan
Carmelo Sgarlata Naveed Ahmed
Carmen Del Toro Sánchez Nawal Abd EL-Baky
Carmen Ferrero Nawaz Muhammad
Carole D. Thomas Nayden Naydenov
Carolina Otero Neal Davies
Catarina Pereira-Leite Nebojsa Pavlovic
Cátia Ramalhete Neda Baghban
Cecilia Zavala-Tecuapetla Neelesh Mehra
Céline Deraeve Neeraj Kumar Sethiya
Cemil Aydoğan Neeraj Thakur
Chadarat Ampasavate Neha Garg
Chandra Mishra Nemat Ali
Chandrabose Selvaraj Nenad Ignjatović
Chandramani Pathak Nesrin Horzum
Chang Lei Nesrine El Sayed
Chang Li Nethaji Muniraj
Changli Zhao Nhu-Nang Vu
Changshan Niu Nianfeng Sun
Chang-Tong Yang Nicholas Peake
Chao Liu Nicola Carter
Chao Wang Nicola Marziliano
Chao Yin Nicolas Joubert
Charalampos Sarafidis Nicoleta Radu
Charitha Thambiliyagodage Nicoleta Todoran
Charles Norton Nicoleta Vedeanu
Chen Xie Nicoletta Cordani
Cheng Chen Nikita Minaev
Chengyu Wu Nikita Tsvetov
Chenyu Li Nikita Yabbarov
Chenzhen Zhang Nikolai Paul Pace
Cheol Moon Nikolaos Bouropoulos
Chia-Che Chang Nikolaos Lougiakis
Chiara Brignole Nikolaos Naziris
Chiara Calabrese Nikolaos Politakos
Chiara M. Motta Nikolay Goncharov
Chiara Migone Nikolay Polyakov
Chiara Moltrasio Nikolay Pyataev
Chie Kojima Nina Melnikova
Chien Ing Yeo Ning Li
Chie-Shaan Su Ningnagouda Patil
Chiranjeev Sharma Nirav Patel
Chis Adriana Aurelia Nisar Ul Khaliq
Chiung-Hui Liu Nishad Thamban Chandrika
Choo Hock Tan Nobuhito Hamano
Christian Barbato Noé Ontiveros
Christian Lehmann Noopur Bhatnagar
Christian Wiraja Norazlinaliza Salim
Christie Ying Kei Lung Noriaki Iijima
Christina Oetzmann Von Sochaczewski Noriko Sato
Christine Dufès Norma Sofía Torres Pabón
Christopher William Nour E. A. Abd El-Sattar
Christos Georgiou Noureddine Issaoui
Christos Rahiotis Numan Majeed
Chrysoula Voidarou Nuno Ferreira
Chulhun Park Nunzia Gallo
Chunhong Dong Nurbubu Moldogazieva
Claire Jean-Quartier Oksana Velgosova
Clara Gomes Oleg Shuvalov
Cläre Von Neubeck Olga Kopach
Cláudia Mouro Olga Krestinina
Claudio Ferrante Olga Zubkova
Claudiu Morgovan Olivier Escaffre
Claudiu N. Lungu Oliviu Vostinaru
Claus-Michael Lehr Oluwatoyin Adeleke
Concetta Altamura Omid Akhavan
Conicet Axel Hollmann Ondrej Kostov
Constantin Itin Osama Kishta
Constantinos Giaginis Oscar Wiklander
Costanza Maria Cristiani Otávio Augusto Chaves
Costica Caizer Ovidiu Samoila
Cristian Peptu Ovidiu-Cristian Oprea
Cristian Sandoval Oyuna Kozhevnikova
Cristian Scheau Ozgul Gok
Cristina Alina Silaghi P. Ulrich Biedermann
Cristina Chircov Pai Peng
Cristina Lavinia Nistor Paloma De La Torre-Iglesias
Cristina Martin Sabroso Panagiotis Mallis
Cristina Mas-Bargues Pantelis Zebekakis
Cristina Nastasă Paola De Luca
Cyril Fersing Paola Faraoni
Cyril Nicolas Paolo Benna
Daali Youssef Paolo Coghi
Damien Lannoy Paolo Trucillo
Dana Ciobanu Paraskev Nedialkov
Dana Copolovici Partha Narayan Dey
Dancho Danalev Pasquale Stano
Dandan Tu Pasqualina D'ursi
Daniel Arcanjo Patricia Graves
Daniel Bäcker Patrícia Pires
Daniel Fernández-Quiroz Patricio Fernandez-Silva
Daniel Guendel Patrick Arbuthnot
Daniel M. Kamiński Patrick Martin
Daniel Otto Paul Malik
Daniela De Vita Paul Selzer
Daniela Elena Serban Paul Soto
Daniela Hanganu Paula Pinto
Daniela Meleleo Paula Soares
Daniela Montesarchio Paulo Carmo
Daniela Opriş-Belinski Paulo De Morais
Daniela Rusu Pavel Ivchenko
Daniele Nogueira-Librelotto Pavel Makarevich
Daniil Bratashov Pavel Nazarov
Danijela Cvetković Pavel Padnya
Danijela Laketa Pawan Kumar
Danilo Vona Paweł Zmarzły
Daodao Hu Payal Ganguly
Dapeng Chen Pedro Costa
Dario Lirussi Pegi Grabnar
Dario Mizrachi Peihong Ni
Dave Mangindaan Peng Gao
David Aebisher Peng Quan
David Facal Peng Zou
David Gewirtz Petar Ozretić
David Greenhalgh Peter Dubovskii
David Leavesley Peter Gaengler
David Limón Peter Hauser
David P. Lin Peter Jervis
David Sánchez-García Peter O'Connell
De Gong Peter Piko
Deanna Mudie Peter Timmins
Deepak Ahire Petr Ryapolov
Dejan Stojkovic Petr Zamostny
Delly Ramadon Petras Prakas
Demetrios Arvanitis Philip Anderson
Denisa Circioban Philip Hublitz
Devapriya Sinha Philippe Espeau
Dezhi Yang Philippe Lecomte
Di Wu Pia Giovannelli
Diana Ciolacu Pietro Cacialli
Diana Mostafa Pietro Valerio Foti
Diana Pinto Pingyuan Wang
Dianbao Zhang Piotr Dobrowolski
Diego Romano Perinelli Piotr Kurcok
Dignesh Khunt Piotr Michel
Diletta Ami Piyush Baindara
Dilip Singh Piyush Gondaliya
Dina Kassem Piyush Mehta
Dinesh Jaishankar Polliana Mihaela Leru
Dinesh Upadhya Po-Wen Chen
Dinesh Verma Prabhanjan Giram
Dmitrii Maltsev Pradeep Panda
Dmitriy Serov Pradipta Ranjan Rauta
Dmitry Gruzdev Prasenjit Mondal
Dmitry Karpov Prashant Kumar
Dmitry Shulga Prashanth Ravishankar
Dmitry Stetsenko Prasopchai Patrojanasophon
Dmitry Verbenko Pratibha Gopalkrishna
Doaa Alshora Prem Kushwaha
Doaa Zineldeen Priyanka Ray
Dominika Szkatuła Professor Sinclair
Dominique Lunter Pushpa Raj Sharma
Donald Fernandes Pyung-Hwan Kim
Dong Zhang Qi Cai
Dongliang Yang Qi Manlin
Dongyang Zhang Qifan Li
Dorianna Sandonà Qingsen Shang
Doriano Lamba Qixuan Zheng
Dorin Dragoş Quan Pan
Dorota Bartusik-Aebisher Quoc-Viet Le
Dorota Chełminiak-Dudkiewicz Rabia Arshad
Dorota Latek Rachael Crist
Duangjai Tungmunnithum Rachid Touzani
Dusan Dimic Radoslaw Starosta
Dzmitry Shcharbin Radu Albulescu
Ecevit Bilgili Radu Claudiu Fierascu
Eckart Haneke Radu Racovita
Eder Lilia Romero Rafael Baltiérrez-Hoyos
Edit Csapó Rafael Castillo
Edson Da Silva Raffaele Palmirotta
Eduardo Guzmán Solís Raffaele Simeoli
Eduardo Molina Raghunadharao Digumarti
Edward Sayers Ragwa Farid
Egor Verbitskiy Raheel Ahmad
Eiji Yuba Rahul Mandal
Eirini Christodoulou Raisa N. Krasikova
Eishin Morita Raj Kumar
Ekapol Limpongsa Rajavel Krishnamoorthy
Ekaterina F. Kolesanova Rajeev K Singla
Ekaterina Naumenko Rajith Singh Manan
Ekaterina Obluchinskaya Rajiv Pathak
Ekaterina Prikhozhdenko Rajmohan Dharmaraj
Ekaterina Yurchenko Rajni Verma
Ekaterini Goudouris Raju Senthil Kumar
Elaine Dunlop Rakesh Patel
Elamparuthi Ramasamy Raluca Nicu
Elena Dantes Ram Sagar
Elena Dinte Ramanjaneyulu Rayala
Elena Matei Ramendra Pandey
Elena Nikolskaya Ramesa Bhat
Elena Pincu Ramiro López-Medrano
Elena Ryabchikova Ramon Barnadas-Rodríguez
Elena Shipitsyna Ramón Garduño-Juárez
Elena Tchetina Ramona Meanti
Eleni Mavrogonatou Ramya Tokala
Eleonora Alfinito Ran Zhang
Eleonora Russo Randal Buddington
Eleonore Fröhlich Rania Hamed
Elham Kazemirad Ranjit De
Elina Genina Raquel Bridi
Elisa Belluzzi Ravi Pratap Barnwal
Elisa Zavattaro Ravichandran Manickam
Elisabete M. S. Castanheira Ravindra Samarth
Elisabete Santos Raviraj Vankayala
Elisabetta Gavini Rebeca Busto
Elise Margaretha Adriana Slob Reda F. M. Elshaarawy
Elrashdy Redwan Reet Kurg
Elsa Chan Regina Kasperek
Elvira Crescenzi Renata Novak Kujundžić
Elvira Grigorieva Rene Buchet
Elvira Rozhina René Huber
Elżbieta Grześk Reza Shirazi
Elzbieta Salinska Rhitajit Sarkar
Eman Mehanna Ricardo Castro
Emanuel Hernández Núñez Ricardo Ferraz
Emerson Coy Riccardo Beltrami
Emilia Janiszewska-Turak Riccardo Di Corato
Emilio Viñuelas-Zahínos Richard Haynes
Emma Adriana Ozon Rimantas Daugelavicius
Enas Eltamany Ripon Sarkar
Ener Dinleyici Rita Muzzalupo
Engy Elekhnawy Rizwan Wahab
Eric Chappel Roald M. Tiggelaar
Eric Ho Rob Hunter
Eric Huet Robert Kleszcz
Erik Alpizar-Reyes Robert Lafrenie
Erin Reed-Geaghan Robert Liefke
Eszter Ducza Roberta Rocca
Eugene V. Radchenko Roberto Fabiani
Eugenio Ragazzi Robin Cooper
Eun Ji Lee Rodica Olar
Éva Szökő Rogerio Buchaim
Evangelia Vouvoudi Roman Lesyk
Evgen Multia Rong Lu
Evgenia Sitnikova Rong-Fu Chen
Ewa Gniazdowska Rosa María Oliart-Ros
Ewa Huszcza Rosanna Mallamaci
Ewa Oledzka Rosario Gulias Cañizo
Ewa Piotrowska Rosario Mare
Ewoud B. Compeer Roshan Katekar
Fabrício S. Campos Rossana Sirabella
Fabrizio Martora Rossen Todorov
Facultad Farmacia Rostyslav Bilyy
Fa-Guang Zhang Roxana Jijie
Faisal Alzahrani Roxana Liana Lucaciu
Fangyu Zhang Roxana Racoviceanu
Fasih Bintang Ilhami Ruggero Bettini
Fateh Mebarek Oudina Rui Han
Fátima Martel Rui Pereira
Fatma El-Demerdash Rui Tada
Fatouma Mohamed Abdoul-Latif Rui Zhou
Federica Fogacci Rumyana Simeonova
Felicia Gabriela Gligor Runze Li
Felipe Chaves Ruoxing Wang
Fenglin Zhang Ruslan Kashapov
Feng-Qing Yang Ruth Prieto-Montero
Fernando Cardona S. Ganguly
Fernando Notario-Pérez Sabina Fijan
Filipa Mascarenhas-Melo Sabine Matou-Nasri
Filipe Sosa Sabya Sachi Das
Filippo Pierini Saeed Bahadorikhalili
Fiona McCartney Sahar Zinatloo-Ajabshir
Fiorenza Rancan Sainitin Donakonda
Fioretta Asaro Sajal Sen
Firzan Nainu Sajjad Ahmad
Flávia Leão Barbosa Saket Patel
Flavia Zacconi Salvatore Gallo
Fleming Martinez Rodriguez Salvatore Magazu
Florence Siepmann Samad Nejad Ebrahimi
Fortunato Iacovelli Samet Özdemir
Fotios Tsopelas Samir Chtita
Franc Vrečer Samo Fokter
Franca Zanardi Samrita Dogra
Francesca Buttini Samuel Samnick
Francesca Persano Samuele Raccosta
Francesco Ciccarese Samy Jambon
Francesco Maria Fusco Sandeep Kumar Reddy Adena
Francesco Sessa Sandeep Urandur
Francine Johansson Azeredo Sandile Songca
Francisco Alexandrino-Junior Sandra Cabo Verde
Francisco Arriagada Sandra Cvijic
Francisco Cortes-Benitez Sandra Donnini
Francisco Javier De La Mata Sandy Eldridge
Francisco José Ostos Marcos Sanith Cheriyamundath
Francisco Otero-Espinar Sanjay Patel
Franciska Erdő Santiago Daniel Palma
Frank Erdmann Santiago Imperial
Frank Krause Sara Abdel Gaber
Frank Rosenau Sara Carmo
František Trejtnar Sara Granja
Frédérique Servin Sara Metwally
Fredrik Huss Sara Nava
Fulden Ulucan Karnak Sara Nicoli
Fulvio Saccoccia Sarah Tettamanti
Furong Tian Saravana Kumar
Gábor Katona Sarmad Al-Marsoummi
Gabor Pethö Sascha Rohn
Gabriel De Lima Sashi Debnath
Gabriela Mellado-Sanchez Sathish Dharani
Gabriela Vochita Saurabh Mishra
Gabriele Maria Fortunato Saverio Muscoli
Gagandeep Saggu Sawittree Sahakijpijarn
Gajendra Jogdand Sayali Onkar
Gamaleldin Harisa Sayed Goda
Gangqiang Yang Sayed Sartaj Sohrab
Gangwei Pan Sebastian Schwaminger
Gantumur Battogtokh Selestina Gorgieva
Gareth R. Williams Sergei Grishin
Garry Kerch Sergey Ilyin
Garry Laverty Sergey Kudryashov
Geanina Voicu Sergey Makarenko
Geetha Bolla Sergey Netesov
Gema Navarrete Sergey Sedykh
Gennaro Lettieri Sergio Caserta
George Mihai Nitulescu Sergio Comincini
George Sharbeen Serhii Holota
Georgia Valsami Serkan Yílmaz
Georgios Pampalakis Seunghoon Han
Georgios Pappas Shadma Wahab
Gerardo Barbero Shahinaze Fouad
Gergő Tóth Shahla Mirzaeei
Gert Fricker Shane Austin
Gesmi Milcovich Shang Su
Ghassan Ghssein Shantanu Gupta
Ghulam Abbas Shaobin Wang
Gian Luigi Russo Shaobo Ruan
Giancarlo Morelli Shawky Aboelhadid
Gianina Dodi Sheng Zhang
Gil Fraqueza Shengshuai Shan
Giorgio Mangino Sher Singh Meena
Giorgio Treglia Sherien Eldaly
Giovanna Bruni Sherif Fahmy
Giovanna Della Porta Shichao Ding
Giovanna Rassu Shigeru Kawakami
Giovanna Rigillo Shikha Agarwal
Giovanni Colonna Shingen Nakamura
Giovanni Ribaudo Shin-ichi Hirano
Girish Kumar Gupta Shinji Kawabata
Girolamo Casella Shinji Kobuchi
Girum Getachew Shinji Takamatsu
Giulia Baldini Shintaro Fumoto
Giulia Bonacucina Shiva Hemmati
Giulia Di Prima Shivani Rai Shivani
Giulio Fracasso Shu Yuan
Giulio Sancini Shuang Yang
Giuseppe Biagini Shubhra Saha
Giuseppe Cirillo Sibusiso Alven
Giuseppe La Verde Silvestre Bongiovanni Abel
Giuseppe Perna Silvia Bittner Fialová
Giuseppe Pizzolanti Silvia Carvalho
Giuseppe Trapani Silvia Tampucci
Giuseppina Ioele Silvio Naviglio
Gopan Gopalakrishnan Simona Căprărescu
Gordana Wozniak Knopp Simona Dedoni
Graham Burgess Simona Tomaselli
Gratiela Tihan Simona-Delia Nicoara
Groo Anne-Claire Simonetta D'Ercole
Grzegorz Bartosz Simons Svirskis
Grzegorz Cieślar Siriporn Okonogi
Grzegorz Grześk Siu Hong Dexter Wong
Guanglin Zhang Siva Rama Raju Kanumuri
Guan-Jun Yang Sivashanmugam Amirthalingam
Guankui Wang Slawomir Jakiela
Guendalina Zuccari Snehasis Bhakta
Guilan Quan Snježana Kaštelan
Gulali Aktas Sobhi Gomha
Guo-Fu Li Socorro Espuelas
Guoping Guan Sofia Lima
Guoying Zhang Sohail Mumtaz
Guru Raghavendra Valicherla Solomon Viswas Raja
Guzel Ziyatdinova Somdutt Mujwar
Györgyi Műzes Sonia Di Gaetano
Hadel Abo El Enin Sonia Gera
Haijun Liu Sónia Martins
Hailong Qiu Sophelia Hoi Shan Chan
Hala B. El-Nassan Sophia Borisevich
Halilibrahim Ciftci Sophia Hatziantoniou
Hamed Nosrati Søren Christensen
Hamid Osman Soubantika Palchoudhury
Hamilton Cabral Soumyarwit Manna
Hamzah Babkair Sounak Bagchi
Hanady Nada Spyridon Mourtas
Hanan Elnahas Sreekanth Reddy Obireddy
Hani Naseef shtaya Sreekumar Othumpangat
Han-Joo Maeng Srijit Das
Hanna Harant Srinivasa Reddy Bonam
Hans Bäumler Stanislav Naryzhny
Hao Hu Stanislaw Ołdziej
Hao Wu Stefan Kranz
Harald Mischak Stefan Oswald
Harish Ramachandramoorthy Stefania Galdiero
Harm HogenEsch Stefania Scialla
Hashem Alsaab Stefano Bacci
Hassan Almoazen Stefano Castellani
Haya Lorberboum-Galski Stefano Fais
He Yin Stefano Giovagnoli
Heba Sahyon Stelian Sergiu Maier
Héctor García-Ortega Stéphanie Briançon
Hee Eun Kang Stephen Atkin
Helioswilton Sales-Campos Stephen Baker
Hend Abdel Bar Stephen Inbaraj
Herman Woerdenbag Stephen Morris
Hexiao Wang Stephen Tomlin
Hicham Elmsellem Steven F. Gameiro
Hidehiro Uekusa Steven Shave
Hidekazu Hiroaki Subba Cheekatla
Hideo Kato SubbaRao Madhunapantula
Hideyuki Kawauchi Subhadip Mukhopadhyay
Hiroki Ide Subhankar Singha
Hiromu Kondo Subhas Karki
Hiroshi Ueda Sucharat Limsitthichaikoon
Ho-Jin Lee Sudarshan Singh
Hong Wan Sueli Fumie Yamada-Ogatta
Honghua Hu Suhaili Shamsi
Hongli Li Sukanya Saha
Hongliang Wang Sulev Kõks
Hongping Deng Suman Dutta
Hongwei Cheng Sumeet Patiyal
Hooi-Leng Ser Sung-Wook Nam
Hossam Hassan Supandeep Hallan
Hossein Roghani-Mamaqani Supriya Chakraborty
Hsiang-Ning Luk Suresh Babu Naidu Krishna
Hua Wei Suresh Verma
Huan Pang Susanne Haga
Hugh Byrne Susanne Muschert
Hugo Espinosa Andrews Susanne Wiedmer
Hugo Lisboa Susi Burgalassi
Huihua Yuan Suttipun Keawsompong
Hussein Touliabah Svetlana Jeremić
Hyuck Jin Lee Svetlana Saikova
Ian Burgess Svetoslav Todorov
Ichiro Takada Swarbhanu Sarkar
Ichwaku Rastogi Swarup Roy
Ignacija Vlašić Syed Ali Raza Naqvi
Ignacio Rintoul Syed Mahmood
Ignacio Rodríguez-García Syed Mohd Faisal
Igor Eliseev Syed Nasir Abbas Bukhari
Igor Slivac Sylva Holešová
Ik-Hwan Kim Syoichi Tashiro
Ilaria Cacciotti Tachita Vlad-Bubulac
Ilaria Rubino Taiki Miyazawa
Iliana Medina-Ramirez Takashi Yazawa
Iliyan Ivanov Takayuki Furuishi
Ilkay Erdogan Orhan Takehisa Hanawa
Illimar Altosaar Takemichi Fukasawa
Ilya Khodov Takumi Abe
Ilya Klabukov Tamara Lazarevic-Pasti
Ilya Ozhogin Tamas Kalai
Iman Alfagih Tamas Lazar
Indranil Chakraborty Tamás Sovány
Innokenty Mokhosoev Tamás Szabó
Ioana Corina Bocsan Tamer Sakr
Ioana Stanculescu Tanja Jurkin
Ioana-Mirela Vasincu Tanja Miličić
Ioannis Nikolakakis Tao Wang
Ioannis Tsamesidis Tarsila Castro
Iolanda De Marco Tatiana Rakitina
Ion Calina Tejeshwar Rao
Irena Nalepa Telbisz Ágnes
Irene Buj-Corral Teresa Esteves
Irene Ottaviani Teresa Vinuesa
Irfan Khan Teruo Murakami
Irina Balalaeva Thawatchai Phaechamud
Irina Le-Deygen Theofanis Vavilis
Irina Terekhova Thomas Mürdter
Isaac Boateng Tianyu Jiang
Islam Khalil Tilahun Debele
Ismael Hernández-Ávalos Tim Mahony
Ismaheel Lawal Timothy Hubin
Issa Al-Amri Tina Kauss
István Antal Tivadar Kiss
István Budai Tomas Etrych
Istvan Csarnovics Tomasz Gębarowski
Istvan Lekli Tomasz M. Karpinski
Itziar Chapartegui-González Tomasz Szymborski
Ivan Gitsov Tomislav Tosti
Ivan Koprivica Tonghe Zhu
Ivan Savic Tongran Qin
Ivan Stoikov Toni Todorovski
Ivana Aleksić Tony Le Gall
Ivana Drvenica Toshi Nagata
Ivaylo Dimitrov Toyofumi Suzuki
Iwona Golonka Triantafyllos Didangelos
Iyan Sopyan Tudor Pop
Izabel Cristina Rodrigues Da Silva Tzung-Han Chou
Izabela Zakrocka Ubaldo Armato
Iztok Grabnar Udaya Sree Dakarapu
Jacek Wilczyński Ugo D'Amora
Jack Kottwitz ugo de Grazia
Jaejong Park Ulf Anderegg
Jafar Rezaie Urmi Roy
Jagpreet Singh Usman Ghafoor
Jaime Charris V. H. Giang Phan
Jaime Conceição Vadim Elagin
Jaime Mella-Raipán Vahid Jahed
Jaime Santoyo-Salazar Valdir Veiga-Junior
Jamal Rafique Valentina Dini
James Chow Valentina Madia
James G Hecker Valeria Milam
Jamie Rausch Valérie Vanhoorne
Jan Kamps Valery V. Likhvantsev
Jan Zidek Van Du Nguyen
Jandeep Singh Van-An Duong
Janet Kumita Vanessa Bergamin Boralli Marques
Janice Aldrich-Wright Vangelis Daskalakis
Janja Trček Vangelis Economou
Jarek Baran Vangelis Karalis
Jaroslav Pejchal Vanja Tadić
Jarosław Przybył Vanja Travičić
Jasna Prlić Kardum Vanya Bogoeva
Javed Iqbal Vanya Mantareva
Jayakumar Rangasamy Vasanthan Ravichandran
Jayanta Kumar Patra Vasil Garamus
Jean-Philippe Therrien Vasileios P. Papadopoulos
Jeffrey Bryant Travers Vasileios Papavasileiou
Jeffrey Wang Vasilii Otvagin
Jelena Radovanović Vasily Aleshin
Jelena Roganovic Vassya Stefanova Bankova
Jennifer Patterson Veera Venkat Shivaji Rama Rao Edupuganti
Jennifer Walsh Velichka Andonova
Jens Andre Hammerl Venerando Pistarà
Jeong Heo Venkat Chirasani
Jeremy Robertson Venkata Krishna Kowthavarapu
Jesús Adrián López Victor I. Sevastianov
Jesús Hernández Victor Kuz'min
Jia Xian Law Victor Martin
Jiafu Cao Victor Seledtsov
Jian Wu Viet-Khoa Tran-Nguyen
Jianan Zhao Vikas Anand Saharan
Jiangjiang Gu Vikas Bali
Jianlin He Vikram Dalal
Jiao Sun Viktor Zvarych
Jiawei Wang Viliana Gugleva
Jie Tian Vinh Le Ba
Jie Wang Violeta-Carolina Niculescu
Jin Gao Vishakha Tambe
Jinbo Fei Vjekoslav Peitl
Jing Zhang Vladimir Ivanov
Jingan Li Vladimir Korshun
Jing-Jie Wang Vladimir Tikhonov
Jinlong Liu Volodymyr Oberemok
Jintamai Suwanprateeb Vrinda Gote
Jinxiang Xi Wajid Rehman
Jinzhi Han Wakako Fujita
Jitendra Kumar Tripathi Waldemar Wagner
Joachim Storsberg Walied Abdo
Joanna Czerwińska Wanderley Oliveira
Joanna Jaworska Wangxiao He
Joanna Sadowska Wanhe Wang
Joanna Sobiak Waqas Alam Mir
Joanna Wessely-Szponder Wei Huang
João Basso Wei Jiang Goh
João Henrique G. Lago Wei Min Min
Joao Silva Wen Hai Shao
Joaquim C. G. Esteves Da Silva Wen Shi
Joaquim Jaumot Wendy Bollag
Joaquim Suñer-Carbó Wenjie Zhou
Joaquin González-Marrero Wenjing Tao
Jochen Maurer Wenliang Song
Joe Viljoen Wenqiang Wei
John Dirk Vestergaard Nieland Wenyi Li
John Jackson Wing Wong
John M. Perry Wojciech Szlasa
John Mack Xiangxian Ying
Jolanta Gawałek Xiaogang Zhang
Jongho Park Xiaoguang Liu
Joni H. Ylostalo Xiaoming Lyu
Jörg Opitz Xiaosheng Tan
Jorge Feito Xiaoshu Pan
Jorge Padrão Xiaoyang Liu
Jørn Bolstad Christensen Xiaoyu Yan
José A. García-Sanz Xin Li
José B. Fariña Xin Tong
José Catita Xinhong Chen
Jose Escobar Chavez Xinquan Liu
José Fernando Fierro Xinyu Ling
José Justicia Xueqin Gao
Jose M Mendez-Arriaga Xun Tao
José Rafael de Almeida Yamini Krishnan
José Ramiro Fernandes Yan Li
José Ramón Moyano-Mendez Yan Zhang
Jose Tudela Yan Zubavichus
Jose V. Parambil Yan-Ming Xu
Josefa Gonzalez-Santos Yannick Vallée
José-María Sánchez-González Yannis Dotsikas
Joseph Govan Yannis Karamanos
Josip Matić Yanyan Cui
Josué Juarez Yanyan Dong
Jovana Vunduk Yaohua Wei
Juan Guzman-Flores Yara MichelacciI
Juan J. Torrado Yasemin M. Akay
Juan Lázaro-Martínez Yashpal Singh Chhonker
Juan Manuel Germán-Acacio Yasin Tülüce
Juan Pablo Rigalli Yasser Shahzad
Jue Ling Yasushi Arano
Jui-Hung Yen Yen-Ho Chu
Julian Freen-van Heeren Yifei Jin
Julian Muñoz Yimei Jia
Juliana Faria Yin Zhao
Julijana Kristl Yingbin Hu
Jun Liu Yinghuai Zhu
Junbo He Yishen Zhu
Junmei Wang Yogesh Sutar
Junwei Shi Yogeswaran Lokanathan
Junzi Wu Yohann Corvis
Juraj Piestansky Yolanda Moliner
Jurca Tunde Yong Hu
Jyawei Cheng Yongjun Sui
Kabirullah Lutfy Yongmin Yan
Kaili Ma Yongsheng Chen
Kamil Gareev Yordanka Uzunova
Kamil J. Kuder Yoshiyuki Kubo
Kamyar Khoshnevisan Yosuke Senju
Kang Lei Youness Limami
Karel Allegaert Young Hwa Soung
Karen Liby Young Zoon Kim
Karim Osouli Bostanabad Young-Whan Choi
Karl Tsim Youssef Ibrahim
Karol Wróblewski Yu Toyoda
Karola Vorauer-Uhl Yu Zhang
Karthik Kanagaraj Yuriy Knyazev
Katalin Sipos Yuan Liu
Katarina Smiljanić Yuanyuan Shi
Katarzyna Krukiewicz Yücel Ba̧spinar
Katarzyna Malarz Yuchao Lu
Katarzyna Sosnowska Yuerou Zhang
Katarzyna Turecka Yuhki Satou
Katerina Takova Yuh-Yih Lin
Katharina M. Rentsch Yuichi Ohya
Katherine Wall Yulia Kondratenko
Kathiravan Suppan Yung-Hsiang Chen
Katie Ardipradja Yunhai Cui
Katsuhisa Inoue Yunia Verónica García Tejeda
Kausik Bishayee Yunwen Tao
Kavindra Nath Tiwari Yuqin Zhang
Kazuhiro Tsuchiya Yutaka Ohsedo
Kazuomi Sato Yutian Ma
Ke Cheng Yutian Zou
Kejun Dong Yuyan Jiang
Kemao Xiu Yuyang Jiang
Kenji Hayashida Yves Bayon
Kenji Ono Zacharoula Iatridi
Kentaro Kato Zeid ALOthman
Kenzo Koike Zeljko Petrovski
Keumhan Noh Zhanchao Li
Keun-Yeong Jeong Zhanying Hu
Kevin Dzobo Zhaoqing Cong
Kevin Ita Zhao-Ying Liu
Kevin T. Batty Zhen Xiao
Kevin Ward Zheng Jiao
Khalil Karimi Zhengwei Huang
Ki-cheong Park Zhengzhong Tan
Kifayat Ullah Shah Zhenjia Wang
Kim Van Vliet Zhenyu Wang
Kiran Lokhande Zhixin Jia
Kirill Cherednichenko Zhiyong He
Kirill Laptinskiy Zhiyuan Xu
Kishwor Poudel Zhonglei Wang
Kit-Leong Cheong Zihua Wang
Kohei Yamada Zihua Zeng
Kok Lun Pang Zilvinas Anusevicius
Konstantin Volcho Ziwan Xu
Konstantinos Dimas Zofia Mazerska
Konstantinos Gardikis Zoltán Bánóczi
Kordali Saban Zoltan Szucs
Koteshwara Mudigonda Zorana Dobrijević
Koyeli Girigoswami Zuohui Zhang
Krishna Sharma Zuoxu Xie
Krishna Yadav Zvezdelina Yaneva
Krishnan Sriram Zygmunt Warzecha
Krist V. Gernaey  

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

9 January 2024
Meet Us at the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 18–21 March 2024, Vienna, Austria


Conference: The 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
Date: 18–21 March 2024
Location: Vienna, Austria

MDPI will be attending the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology at Booth #06, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference has had an ever-increasing impact among pharmaceutical scientists, and it is organized every two years, in March or April of even years.

The entire spectrum of topics ranging from engineering aspects of the manufacturing process, the portfolio of commercially available excipients enabling the formulation of a large variety of medicinal products, the underlying physico-chemical principles, cutting-edge characterization techniques as well as potential pitfalls and hurdles to be overcome during product development, manufacturing and characterisation will be addressed.

Young and experienced scientists from academia and industry will present their latest research achievements in the form of poster presentations, allowing for fruitful scientific exchanges with the authors.

The meeting is intended to bring together people working in fundamental and applied academic research, in the chemical and pharmaceutical industry and the regulatory field, offering the opportunity to initiate fruitful discussions and collaborations.

The following MDPI journals will be represented:

  • Pharmaceutics;
  • Pharmaceuticals;
  • IJMS;
  • DDC;
  • Molecules;
  • Biomedicines;
  • CIMB;
  • Applied Biosciences;
  • BioMedInformatics;
  • Medicines;
  • Cosmetics;
  • Biomolecules.
If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.worldmeeting.org/home/about-world-meeting/

2 January 2024
MDPI Insights: The CEO’s Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Nobel Prize Laureates Entrust MDPI with Their Research

The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.

Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, PharmaceuticsPhotonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.

The best of the best trust us with their work.

Nobel Prize Laureates Who Have Published with MDPI

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.

The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.

2023 Nobel Prize Winners Published by MDPI

Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)

Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.

In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.

Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".

We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.

Read more:

Impactful Research

MDPI Journals Newly Indexed in 2023

The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.

Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.

In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.

The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.

MDPI’s journals are indexed in all major global databases.

Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.

Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)

Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.

Read more:

Inside MDPI

MDPI Appoints New Chief Operating Officer (COO)

Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.

Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.

As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.

Coming Together for Science

MDPI’s 2024 In-Person Academic Events Schedule

MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.

Here's a glimpse of the notable events we currently have scheduled for 2024:

14–16 February, 2024
Viruses 2024 – A World of Viruses
Location: Barcelona, Spain
We are honoured to feature Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes as keynote speakers for this 5th edition.
Event details

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities 
Location: Barcelona, Spain
Esteemed speakers include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Event details

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
We look forward to welcoming renowned experts like Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Event details

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Event details

Upcoming events with details to be announced:

  • September 2024, Materials 2024 – Basel, Switzerland
  • 1921 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
  • October 2024, ncRNA 2024 – Basel, Switzerland
  • November 2024, Pharmaceuticals 2024 – Barcelona, Spain
  • 2226 November 2024, International Conference on Science of Electronics – Wuhan, China
  • Stay tuned for more details on the Sustainable Publishing Forum 2024.

Click here for all upcoming MDPI events.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Reflecting on 2023 and Looking Ahead to 2024

As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.

Becoming a stronger organisation

While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.

I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.

“I am committed to taking MDPI to a new level of excellence.”

Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.

Accountability and communication

As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.

Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.

Here’s to a joyous and prosperous 2024!

Stefan Tochev
Chief Executive Officer
MDPI AG

26 December 2023
Pharmaceutics Editor-in-Chief Prof. Patrick J. Sinko Joins 2023 Class of National Academy of Inventors (NAI) Fellows

We want to congratulate Prof. Patrick J. Sinko, Pharmaceutics (ISSN: 1999-4923) Editor-in-Chief, for joining the 2023 Class of National Academy of Inventors (NAI) Fellows! The election as an Academy Fellow is the highest professional distinction awarded solely to inventors.

Dr. Patrick J. Sinko is a distinguished professor and the Parke-Davis Endowed Chair in Pharmaceutics and Drug Delivery in the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey, USA. He is also the Editor of Martin’s Physical Pharmacy and Pharmaceutical Sciences (Fifth, Sixth, Seventh, and Eighth editions). Dr. Sinko has authored or co-authored over 540 publications, including research papers, abstracts, and book chapters (h-index = 65). He is the Principal Investigator of an active research laboratory that focuses on biopharmaceutics, pharmaceutical formulations, and molecular-, nano-, and micro-scale drug delivery with specific applications to treat or prevent HIV/AIDS, breast and lung cancer, chemical terrorism countermeasures, and TB.

“This year’s class of NAI Fellows showcases the caliber of researchers found within the innovation ecosystem. Each of these individuals is making significant contributions to science and society through their work,” said Dr. Paul R. Sanberg, FNAI President of the NAI. “This new class, in conjunction with our existing Fellows, are creating innovations that are driving crucial advancements across a variety of disciplines and are stimulating the global and national economy in immeasurable ways as they move these technologies from lab to marketplace. We are honored to welcome these highly regarded innovators to the Academy and look forward to formally inducting them at our 2024 Annual Conference in the Research Triangle of North Carolina.”

Please join us in congratulating Prof. Sinko on his meaningful work!

25 December 2023
Meet Us at the International Conference on Nanomedicine and Nanobiotechnology (ICONAN 2024), 15–17 January 2024, Barcelona, Spain


Nanomedicine and nanobiotechnology have tremendous potential for tomorrow’s patient care in a wide variety of disease management, and numerous theoretical concepts are currently being translated into preclinical and clinical studies. The fifth edition of the ICONAN conference brings together high-profile plenary speakers and world-class researchers who have successfully developed and translated nanomedicines over the last decades, offering a vibrant platform for oral and poster presentations, sponsor exhibits, and networking. The conference topics include targeted drug delivery, organ biodistribution and nanocarriers, nanomedicine for the immune system and cancer diagnosis and therapy, biological and medical nanodevices and biosensor 3D models, tissue engineering and regenerative nanomedicine toxicology, risk assessment of nanomedicine systems nano-imaging for diagnosis, etc.

MDPI will attend the International Conference On Nanomedicine And Nanobiotechnology (ICONAN 2024); we welcome researchers from different backgrounds to visit and share their latest ideas.

The following MDPI journals will be represented:

If you plan to attend this conference, please contact us online. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://premc.org/conferences/iconan-nanomedicine-nanobiotechnology/.

18 December 2023
Editorial Board Members from Pharmaceutics Featured in the 2023 Highly Cited Researchers List Published by Clarivate


Recently, the 2023 Highly Cited ResearchersTM list was published. This is an annual recognition of globally influential scientists and social scientists, who have made significant contributions in their fields. It includes influential researchers at universities, research institutes, and commercial organizations around the world.

The evaluation and selection process identified 6,849 researchers from institutions in 67 countries and awarded 7,125 individual researchers the title of 2023 Highly Cited Researcher, making this a truly global list. These highly cited researchers were named from the top 1% of publications in the Web of ScienceTM Citation Index, by field and year of publication.

Eight members of the Editorial Board of Pharmaceutics (ISSN: 1999-4923) have been featured in the 2023 list of Highly Cited Researchers published by ClarivateTM. They have been recognized for their high-quality scientific research and outstanding contributions to the field of pharmaceutics. The Pharmaceutics Editorial Office sincerely congratulates all of the selected editorial members and hopes that they will continue to have an academically productive relationship with the journal.

Researcher

Category

Affiliation

Basit, Abdul W.

Pharmacology and Toxicology

University College London, United Kingdom

Kiessling, Fabian

Pharmacology and Toxicology

RWTH Aachen University, Germany

Gao, Huile

Pharmacology and Toxicology

Sichuan University, China

Hanes, Justin

Pharmacology and Toxicology

Johns Hopkins University, United States of America

Mei, Lin

Pharmacology and Toxicology

Chinese Academy of Medical Sciences Peking Union Medical College, China

Gaisford, Simon

Pharmacology and Toxicology

University College London, United Kingdom

Preat, Veronique

Pharmacology and Toxicology

Universite catholique de Louvain, Belgium

Weitschies, Werner

Pharmacology and Toxicology

Ernst-Moritz-Arndt University of Greifswald, Germany

30 November 2023
MDPI Insights: The CEO’s Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Spain Summit


Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.

On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.

With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.

The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.

The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.

Connecting with Editorial Board Members


Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."

Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.

From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.

As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.

Open Access in Spain

In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.

For further details of Spain's OA policy and the history of government mandates, click here.

Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus. 

A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!


MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.

I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.

Impactful Research

769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023

Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.

Click here to view the full list of 769 Editorial Board Members.

Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.

Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!

Inside MDPI

Corporate Marketing and Communications Strategy Session


Members of MDPI’s Corporate Marketing & Communications team.

For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.

This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.

We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.

The strategy session also serves as a team-building activity, during which the team voted on bowling!

Strategy Session

In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.

To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.

I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.

Coming Together for Science

ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home


Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.

When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.

In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.

While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.

The press release below provides further details.

Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023

ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.  

This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.

Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.

Closing Thoughts

November is Men’s Health Awareness Month


Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.

November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.

I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.

Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.

Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.

Healthy men help build healthy families and a healthy society

Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.

From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.

Mindfulness

Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:

Stefan Tochev
Chief Executive Officer
MDPI AG

21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023


We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.

Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!


Abate, Antonio
Aguilera, Ruth V.
Ahmed, Warish
Ahn, Myung-Ju
An, Qiaoshi
Anasori, Babak
Andersson, Dan I.
Angeletti, Silvia
Annabi, Nasim
Antinori, Spinello
Ariga, Katsuhiko
Asa, Sylvia L.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Balsamo, Gianpaolo
Bandodkar, Amay J.
Banks, William A.
Bao, Yan-Ping
Barba, Francisco J.
Barnes, Peter J.
Barnholtz-Sloan, Jill S.
Barrow, Colin J.
Bashir, Ali Kashif
Basit, Abdul W.
Bassetti, Matteo
Batley, Jacqueline
Battino, Maurizio
Behnood, Ali
Benediktsson, Jon Atli
Biondi, Antonio
Bjarnsholt, Thomas
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boczkaj, Grzegorz
Bogers, Marcel
Bonomo, Robert A.
Boyd, Robert W.
Boyer, Cyrille
Braeckmans, Kevin
Bragazzi, Nicola Luigi
Bu, Wenbo
Bursać Kovačević, Danijela
Bush, Ashley I.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cambria, Erik
Cao, Guozhong
Cao, Xingzhong
Capasso, Raffaele
Carvalho, Andre F.
Casper, Jonathan
Castellanos-Gomez, Andres
Cavalli, Giacomo
Chai, Siang-Piao
Chan, Jasper Fuk-Woo
Chan, Timothy A.
Chang, Chih-Hao
Chang, Guoqing
Chao, Dongliang
Chen, Bo
Chen, Chaoji
Chen, Fahu
Chen, Gang
Chen, Jianmin
Chen, Jun
Chen, Jun
Chen, Jun
Chen, Lidong
Chen, Lingxin
Chen, Min
Chen, Mou
Chen, Peng
Chen, Qian
Chen, Qianwang
Chen, Shaowei
Chen, Shuangming
Chen, Wei
Chen, Xiaobo
Chen, Yimin
Chen, Yu
Chen, Yulin
Chen, Zhong
Chen, Zonghai
Cheng, Gong
Cheng, Huanyu
Cheng, Laifei
Cheng, Qiang
Chew, Kit Wayne
Chiclana, Francisco
Choi, Wonyong
Choi, Young Hae
Chowdhary, Anuradha
Cichocki, Andrzej
Clevers, Hans
Coops, Nicholas C.
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Creutzig, Felix
Crommie, Michael F.
Cuadrado, Antonio
Cui, Haiying
Cui, Yi
Curigliano, Giuseppe
Dai, Sheng
Dai, Shifeng
Daiber, Andreas
Davies, Michael J.
Davis, Thomas P.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Delord, Jean-Pierre
Demaria, Marco
Deng, Xiangzheng
Desneux, Nicolas
Dikic, Ivan
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Ding, Jianxun
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Chung-Li
Dou, Shi Xue
Dragicevic, Tomislav
Du, Bo
Du, Qian
Du, Yonghua
Duan, Xidong
Dufresne, Alain
Dummer, Reinhard
Edwards, David
Elaissari, Abdelhamid
ElMasry, Gamal
Enjuanes, Luis
Fabbro, Doriano
Facchetti, Antonio
Fan, Junliang
Fan, Kelong
Fan, Xiulin
Fan, Zhanxi
Fang, Baizeng
Fang, Chuanglin
Fang, Yongjin
Fasano, Alessio
Feng, Liangzhu
Feng, Xuning
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Filippi, Massimo
Flavian, Carlos
Fortino, Giancarlo
Fowler, Michael
Franceschi, Claudio
Frattini, Federico
Friston, Karl J.
Fu, Gengtao
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gao, Feng
Gao, Huijun
Gao, Huile
Gao, Peng
Gao, Wei
Garbe, Claus
Garg, Abhishek D.
Gasbarrini, Antonio
Gastaldelli, Amalia
Gautier, Emmanuel L.
Genevet, Patrice
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghaffari, Roozbeh
Ghamisi, Pedram
Giacobbe, Daniele Roberto
Giampieri, Francesca
Gillies, Robert J.
Godos, Justyna
Gogotsi, Yury
Golding, Nick
Gong, Jinlong
Gong, Peng
Gong, Yongji
Govindan, Kannan
Gozal, David
Grancini, Giulia
Grant, William B.
Graus, Francesc
Green, Douglas R.
Grosso, Giuseppe
Gu, Meng
Gu, Zhanjun
Guan, Cao
Gueimonde, Miguel
Gui, Guan
Guigo, Roderic
Guo, Hengyu
Guo, Jianping
Guo, Lin
Guo, Song
Guo, Yan
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Hagger, Martin S.
Hall, C. Michael
Han, Fudong
Han, Heesup
Hanes, Justin
Hartung, Hans-Peter
He, Bao-Jie  
He, Debiao
He, Hongwen
He, Jiaqing
He, Jie
He, Jr-Hau
He, Qiong
He, Xiangming
He, Xijun
He, Zhili
Heneka, Michael T.
Herrera, Francisco
Herrera-Estrella, Luis
Herrera-Viedma, Enrique
Hetz, Claudio
Holick, Michael F.
Hong, Danfeng
Hong, Xuechuan
Hsueh, Po-Ren
Hu, Bin
Hu, Enyuan
Hu, Jin-Song
Hu, Weida
Hu, Wenbin
Hu, Xiaosong
Huang, Baibiao
Huang, Hongwei
Huang, Jianliang
Huang, Jianping
Huang, Peng
Huang, Xin
Hubacek, Klaus
Hussain, Saddam
Italiano, Antoine
Iwata, Hiroji
Jaeschke, Hartmut
Jain, Atul

Jaiswal, Amit K.
Jankovic, Joseph
Janssens, Ivan A.
Jelezko, Fedor
Jeon, Byong-Hun
Ji, Guangbin
Ji, Qiang
Ji, Wei
Ji, Xiaobo
Ji, Xiaoyuan
Jiang, Bin
Jiang, Hong
Jiang, Junjun
Jiang, Lianzhou
Jiang, Qing
Jiang, Shibo
Jiang, Yuyan
Jiang, Zhongyi
Jiao, Licheng
Jin, Shi
Jin, Zhong
Kalantar-zadeh, Kourosh
Kamal, Mohammad Amjad
Kaner, Richard B.
Kaneti, Yusuf Valentino
Kang, Zhenhui
Karagiannidis, George K.
Karniadakis, George Em
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Kepp, Oliver
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kildishev, Alexander V.
Kim, Haegyeom
Kim, Jeonghun
Kim, Jin-Hoi
Kim, Jong Seung
Kim, Ki-Hyun
Kirkwood, John M.
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Kong, Baohua
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kroemer, Guido
Kuang, Dai-Bin
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Prashant
Kumar, Sudhir
Kurths, Juergen
Kurzrock, Razelle
Kuzyakov, Yakov
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lan, Ke
Lancellotti, Patrizio
Landi, Francesco
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Chengkuo
Lee, Jechan
Lee, Jin-Wook
Lee, Pooi See
Lee, Sang Soo
Lehmann, Johannes
Lei, Yaguo
Li, Bin
Li, Chunzhong
Li, Dongsheng
Li, Feng
Li, Hai
Li, Heng
Li, Hongyi
Li, Hui
Li, Jinghong
Li, Jun
Li, Li
Li, Linlin
Li, Neng
Li, Ning
Li, Shuai
Li, Shutao
Li, Wei
Li, Wentao
Li, Xiang
Li, Xuecao
Li, Xuelong
Li, Yat
Li, Yurui
Li, Zhijun
Liang, Chao
Liang, Shuquan
Liaw, Peter K.
Lin, Jun
Lin, Yuehe
Lippi, Giuseppe
Lister, Ryan
Liu, Chengmei
Liu, Gang
Liu, Hong
Liu, Hui
Liu, Jian
Liu, Jinyan
Liu, Jun
Liu, Meilin
Liu, Pan
Liu, Wei
Liu, Xianhu
Liu, Xiaoping
Liu, Xuejun
Liu, Yang
Liu, Yu
Liu, Yuan
Lonardo, Amedeo
Long, Hualou
Long, Ying
Lu, Bingan
Lu, Junling
Lu, Lu
Lu, Nanshu
Lu, Rongxing
Lucey, Brian
Lucieer, Arko
Lugato, Emanuele
Lund, Henrik
Luo, Yangchao
Luo, Yi
Luo, Zisheng
Lv, Wei
Lyons, Timothy W.
Ma, Haile
Ma, Jianmin
Ma, Jun
Ma, Tianyi
Ma, Wei
Ma, Yanming
Madabhushi, Anant
Mahmoudi, Morteza
Mai, Liqiang
Mai, Wenjie
Makridakis, Spyros
Mandala, Mario
Mantovani, Alberto
Mao, Jianfeng
Mao, Like
Mardani, Abbas
Mathivanan, Suresh
Matyjaszewski, Krzysztof
McCabe, Matthew F.
McCauley, Darren
McClements, David Julian
Mei, Lin
Melenhorst, Jan Joseph
Melero, Ignacio
Meyerholz, David K.
Van Mierlo, Joeri
Miroshnichenko, Andrey E.
Mittler, Ron
Mu, Shichun
Mubarak, Mohammad S.
Mueller, Lukas A.
Muhammad, Khan
Mumtaz, Shahid
Munekata, Paulo Eduardo Sichetti
Nakagawa, Shinichi
Nauen, Ralf
Newman, David J.
Niaura, Raymond S.
Nidheesh, P. V.
Niu, Ben
Nussinov, Ruth
O'Connor, David
Odintsov, Sergei D.
Omri, Anis
Orsini, Nicola
Ostrikov, Kostya (Ken)
Oswald, Isabelle P.
Oudard, Stephane
Ouyang, Minggao
Ozcan, Aydogan
Pan, Anlian
Pan, Anqiang
Pan, Caofeng
Pan, Genxing
Pan, Likun
Pan, Quan-Ke
Pan, Xiaoqing
Pandolfi, Pier Paolo
Parati, Gianfranco
Pateiro, Mirian
Peng, Qiang
Peng, Qing
Peng, Shushi
Perc, Matjaz
Perlin, David S.
Perlman, Stanley
Petruzzelli, Antonio Messeni
Pitt, Bertram
Pöhlmann, Stefan
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Potenza, Marc N.
Preat, Veronique
Prinsep, Michele R.
Pu, Kanyi
Putnik, Predrag
Qin, Yuanwei
Qiu, Jieshan
Qu, Xiaogang
Ragauskas, Arthur J.
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Rao, Zhonghao
Recio, Isidra
Ren, Jinsong
Rengel, Zed
Rho, Junsuk
Riahi, Keywan
Ribeiro-Soriano, Domingo
Richardson, Paul G.
Robert, Caroline
Rocca, Maria A.
Rodriguez-Manas, Leocadio
Rojas, Orlando J.
Rojo, Teofilo
Roubaud, David
Saad, Fred
Saad, Walid
Sadorsky, Perry
Saliba, Michael
Sander, Chris
Sangaiah, Arun Kumar
Santamouris, Mattheos
Santoro, Gabriele
Scaldaferri, Franco
Schatzberg, Alan F.
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scott, Daniel
Serruys, Patrick W.
Setzer, William N.
Shahzad, Babar
Shao, Shuai
Shao, Zongping
Shen, Guozhen
Shen, Liyin

Shen, Zexiang
Shi, Peng
Shi, Yi
Siano, Pierluigi
Simões, Manuel
Sing, Swee Leong
Singh, Vijay P.
Smagghe, Guy
Smith, Lee
Soffietti, Riccardo
Song, Houbing
Song, Jibin
Song, Yu
Sood, Anil K.
Souto, Eliana B.
Stadler, Marc
Stanley, H. Eugene
Stephanopoulos, Gregory
Sternberg, Cora N.
Stoumpos, Constantinos C.
Stunnenberg, Hendrik G.
Su, Shiliang
Sun, Baoguo
Sun, Cuixia
Sun, Fengchun
Sun, Hongqi
Sun, Jie
Sun, Lijun
Sun, Litao
Sun, Runcang
Sun, Yanjuan
Sun, Zaicheng
Sun, Zhipei
Sureda, Antoni
Svenning, Jens-Christian
Tan, Chaoliang
Tan, Weihong
Tang, Chuan-He
Tang, Chuyang
Tang, Dianping
Tang, Yongbing
Tanzi, Rudolph E.
Terpos, Evangelos
Teschendorff, Andrew E.
Tian, He
Timsit, Jean-Francois
Tiwari, Aviral Kumar
Tohge, Takayuki
Tousoulis, Dimitris
Tran, Lam-Son Phan
Tress, Wolfgang
Trivedi, Pankaj
Tsao, Rong
Tully, Mark A.
Tung, Chen-Ho
Van der Bruggen, Bart
Vandenbroucke, Roosmarijn E.
Vangronsveld, Jaco
Varsani, Arvind
Vatanen, Tommi
Verbeke, Kristin
Vermote, Eric
Verpoorte, Robert
Vieta, Eduard
Vincent, Jean-Louis
Vita, Antonio
Wan, Jiafu
Wan, Shaohua
Wanek, Wolfgang
Wang, Bin
Wang, Bo
Wang, Chao
Wang, Chuanyi
Wang, Chunsheng
Wang, Dan
Wang, Feng
Wang, Gongming
Wang, Guoxiu
Wang, Haihui
Wang, Hao
Wang, Huanqing
Wang, Huanting
Wang, Hui
Wang, Jian
Wang, Jie
Wang, Jing
Wang, John
Wang, Joseph
Wang, Lianzhou
Wang, Lihui
Wang, Meng
Wang, Peng
Wang, Pengfei
Wang, Qi
Wang, Qi
Wang, Qiang
Wang, Qilin
Wang, Qin
Wang, Qing
Wang, Shaojian
Wang, Sibo
Wang, Tao
Wang, Ying
Wang, Yong
Wang, Zhen
Wang, Zhong Lin
Wang, Zhongrui
Wang, Zifa
Wang, Zuankai
Wei, Haotong
Wei, Leyi
Wei, Zhixiang
Wei, Zhongbao
Weissleder, Ralph
Weitschies, Werner
Wen, Guanghui
Wesemael, Bas van
Willerslev, Eske
Witlox, Frank
Wu, Haijun
Wu, Hao Bin
Wu, Hui
Wu, Jun
Wu, Qinglin
Wu, Shuilin
Wu, Xiaojun
Wu, Yongzhen
Wu, Yuping
Wu, Zheng-Guang
Wu, Zhong-Shuai
Xia, Jianguo (Jeff)
Xia, Meimei
Xia, Xinhui
Xia, Yongyao
Xia, Zhiguo
Xiang, Quanjun
Xiao, Fuyuan
Xiao, Jie
Xin, Sen
Xing, Baoshan
Xing, Wei
Xiong, Rui
Xu, Hui
Xu, Li Da
Xu, Ping
Xu, Yi-Jun
Xu, Zhenjiang Zech
Yan, Chong
Yan, He
Yan, Huaicheng
Yan, Kai
Yan, Ruqiang
Yang, Bing
Yang, Chenguang
Yang, Hongshun
Yang, Hui
Yang, Jian
Yang, Jianping
Yang, Jie
Yang, Jun
Yang, Kai
Yang, Shihe
Yang, Xiaofeng
Yang, Xinsong
Yang, Yun-Gui
Yao, Yonggang
Yigitcanlar, Tan
Yin, Shen
Yin, Shou-Wei
Yin, Yulong
Yin, Zongyou
Yokoya, Naoto
Young, Allan H.
Yu, Guihua
Yu, Jun
Yu, Le
Yu, Minghao
Yu, Shu-Hong
Yu, Wei
Yu, Wenwu
Yuan, Qiangqiang
Yuan, Yifei
Yuan, Yuan
Yuen, Chau
Zeadally, Sherali
Zhai, Tianyou
Zhang, Bing
Zhang, Dengsong
Zhang, Fan
Zhang, Fusuo
Zhang, Guangyu
Zhang, Guowen
Zhang, Hengjie
Zhang, Hongjie
Zhang, Hui
Zhang, Lai-Chang
Zhang, Lefei
Zhang, Lei
Zhang, Liangpei
Zhang, Lijun
Zhang, Min
Zhang, Peng
Zhang, Qiang
Zhang, Qiaobao
Zhang, Qichun
Zhang, Shicheng
Zhang, Shujun
Zhang, Tierui
Zhang, Wei
Zhang, Weili
Zhang, Xian-Ming
Zhang, Xiaodong
Zhang, Xiaogang
Zhang, Xiaoling
Zhang, Yang
Zhang, Yaobin
Zhang, Yi
Zhang, Yi-Zhou
Zhang, Yong
Zhang, Yu Shrike
Zhang, Yue-Jun
Zhang, Yuelin
Zhang, Zheng
Zhang, Zhicheng
Zhang, Zhien
Zhao, Guochun
Zhao, Jie
Zhao, Li-Dong
Zhao, Qing
Zhao, Yi
Zheng, Hao
Zheng, Weitao
Zheng, Yufeng
Zhong, Cheng
Zhou, Jie
Zhou, Jizhong
Zhou, Kun
Zhou, Liang
Zhou, Peng
Zhou, Qi
Zhou, Wei
Zhou, Weiqi
Zhu, Chengzhou
Zhu, Hongwei
Zhu, Junfa
Zhu, Jun-Jie
Zhu, Lei
Zhu, Mingshan
Zhu, Quanxin
Zhu, Yi
Zhu, Yongfa
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan
Zou, Ruqiang
Zuo, Chao

20 November 2023
Pharmaceutics | Seeking Cooperation with Academic Conferences


Pharmaceutics (ISSN: 1999-4923) released its inaugural issue in 2009 and is now published monthly through MDPI. Over the years, Pharmaceutics has aimed to provide a professional publishing service to the scientific community, has strived toward the effective dissemination of high-caliber scientific work, and has evolved into a scholarly outlet. In 2013, Pharmaceutics joined PubMed, followed by inclusion in the Science Citation Index Expanded (SCIE), Web of Science, and Scopus (Elsevier) in 2017, achieving an Impact Factor of 5.4 in 2022, with a 5-Year Impact Factor of 6.0. Pharmaceutics’ CiteScore (Scopus) for 2022 reached 6.9, which equals a ranking of 50/278 (Q1) in the “Pharmacology & Pharmacy” category.

Pharmaceutics has forged affiliations with esteemed organizations, including the Academy of Pharmaceutical Sciences (APS), the Korean Society of Pharmaceutical Sciences and Technology (KSPST), the Pharmaceutical Solid State Research Cluster (PSSRC), and the Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG). Committed to supporting the scientific community, Pharmaceutics has cooperated with various academic conferences.

For inquiries or to express your interest in collaboration, please contact the Pharmaceutics Editorial Office at pharmaceutics@mdpi.com.

7 November 2023
Two Authors in Pharmaceutics Awarded the Physiology or Medicine Nobel Prize


The Nobel Prize in Physiology or Medicine 2023 was recently awarded to Prof. Dr. Katalin Karikó and Prof. Dr. Drew Weissman for their discoveries regarding nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19, saving millions of lives worldwide.

The laureates found that the chemical conversion of uridine, a nucleotide of mRNA, to pseudouridine, appeared to prevent the body from perceiving the mRNA as an intruder and destroying it, a finding reported in a 2005 seminal paper. Without the unwanted immune response, mRNA can infiltrate the cells to carry out its intended function and provide cells with plans for making proteins.

Two years ago, Pharmaceutics (ISSN: 1999-4923) released a Special Issue “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, featuring ten articles published between August 2021 and February 2022. Prof. Dr. Karikó and her team at the biotech company, BioNTech, published an article for this Special Issue titled “Ribozyme Assays to Quantify the Capping Efficiency of In Vitro-Transcribed mRNA”.

Prof. Dr. Weissman, in collaboration with colleagues at Pennsylvania University and George Mason University, published an article titled “Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids” that appeared in the Special Issue “Dendrimers: A Themed Issue in Honor of Professor Donald A. Tomalia on the Occasion of His 85th Birthday for His Outstanding Achievements in Advancing the Field of Dendrimers”.

We offer our congratulations to this year's recipients of the Physiology or Medicine Nobel Prize!

1 November 2023
MDPI Insights: The CEO’s Letter #5 - OA Week, UK, and Strategy

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access Week 2023 – the Global Drive to Open Continues

As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.

International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.

Core principles of OA publishing

Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.

One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.

OA holds the potential to democratize knowledge, advance science, and drive positive societal change.

Policy driving change

Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the USEU and China

OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.

For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.

MDPI is proud to lead the transition to open access.

Read more:

Impactful Research

Spotlight on Smart Cities

Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.

As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.

Highly cited papers in Smart Cities

Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.

1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.

2. “A Review on Electric Vehicles: Technologies and Challenges
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.

3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.

4. “Artificial Intelligence Techniques in Smart Grid: A Survey
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.

5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.

Testimonial

“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators. – Dr. Luís Rosa, University of Minho

Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility

Inside MDPI

MDPI Manchester office, UK Visit


Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.

In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.

Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.

I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.

The UK by numbers

The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.

As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.

According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.

We are currently hiring EEs in various locations worldwide.

English Editing at MDPI

Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.

While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.

Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.

Testimonials

“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam

“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño

Read more:

Coming Together for Science

STM and Frankfurt Book Fair

Attending STM

MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.

Meeting with Web of Science

On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.

“We discussed ways to improve our communication and collaboration.”

I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.

75th Frankfurt Book Fair


Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.

For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.

MDPI Books

Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?

The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.

If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.

Closing Thoughts

MDPI Strategy Meeting

As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.

Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.

“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”

As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!

Stefan Tochev
Chief Executive Officer
MDPI AG

19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues


MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.

In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!

Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.

The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.

Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.

Promoting the values of accessibility, transparency, and collaboration

Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations. 

Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways. 

One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges. 

Funders' policies are getting aligned with open science

Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the USEU and China

Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. 

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing. 

For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change. 

MDPI is proud to be a leader in the transition to open access.

12 October 2023
Pharmaceutics | Selected Papers in 2021 in the Section “Nanomedicine and Nanotechnology”


1. “Magnetic Nanoparticles in Biology and Medicine: Past, Present, and Future Trends”
by Deanna D. Stueber, Jake Villanova, Itzel Aponte, Zhen Xiao and Vicki L. Colvin
Pharmaceutics 2021, 13(7), 943; https://doi.org/10.3390/pharmaceutics13070943
Available online: https://www.mdpi.com/1999-4923/13/7/943

2. “Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations”
by Paola Mura, Francesca Maestrelli, Mario D’Ambrosio, Cristina Luceri and Marzia Cirri
Pharmaceutics 2021, 13(4), 437; https://doi.org/10.3390/pharmaceutics13040437
Available online: https://www.mdpi.com/1999-4923/13/4/437

3. “Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems”
by Daniela Placha and Josef Jampilek
Pharmaceutics 2021, 13(1), 64; https://doi.org/10.3390/pharmaceutics13010064
Available online: https://www.mdpi.com/1999-4923/13/1/64

4. “Chitosan Nanoparticles at the Biological Interface: Implications for Drug Delivery”
by Noorjahan Aibani, Raj Rai, Parth Patel, Grace Cuddihy and Ellen K. Wasan
Pharmaceutics 2021, 13(10), 1686; https://doi.org/10.3390/pharmaceutics13101686
Available online: https://www.mdpi.com/1999-4923/13/10/1686

5. “Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment”
by Kristin Entzian and Achim Aigner
Pharmaceutics 2021, 13(8), 1135; https://doi.org/10.3390/pharmaceutics13081135
Available online: https://www.mdpi.com/1999-4923/13/8/1135

6. “Advances in Cancer Therapeutics: Conventional Thermal Therapy to Nanotechnology-Based Photothermal Therapy”
by Sangeeta Kumari, Nilesh Sharma and Shivendra V. Sahi
Pharmaceutics 2021, 13(8), 1174; https://doi.org/10.3390/pharmaceutics13081174
Available online: https://www.mdpi.com/1999-4923/13/8/1174

7. “Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB”
by Mantosh Kumar Satapathy, Ting-Lin Yen, Jing-Shiun Jan, Ruei-Dun Tang, Jia-Yi Wang, Rajeev Taliyan and Chih-Hao Yang
Pharmaceutics 2021, 13(8), 1183; https://doi.org/10.3390/pharmaceutics13081183
Available online: https://www.mdpi.com/1999-4923/13/8/1183

8. “Osteochondral Tissue Engineering: The Potential of Electrospinning and Additive Manufacturing”
by Andreia M. Gonçalves, Anabela Moreira, Achim Weber, Gareth R. Williams and Pedro F. Costa
Pharmaceutics 2021, 13(7), 983; https://doi.org/10.3390/pharmaceutics13070983
Available online: https://www.mdpi.com/1999-4923/13/7/983

9. “Towards the Development of a Female Animal Model of T1DM Using Hyaluronic Acid Nanocoated Cell Transplantation: Refinements and Considerations for Future Protocols”
by Fernanda Zamboni, Ibrahim F. Cengiz, Ana M. Barbosa, Antonio G. Castro, Rui L. Reis, Joaquim M. Oliveira and Maurice N. Collins
Pharmaceutics 2021, 13(11), 1925; https://doi.org/10.3390/pharmaceutics13111925
Available online: https://www.mdpi.com/1999-4923/13/11/1925

10. “Design of 3D Scaffolds for Hard Tissue Engineering: From Apatites to Silicon Mesoporous Materials”
by Ana García, María Victoria Cabañas, Juan Peña and Sandra Sánchez-Salcedo
Pharmaceutics 2021, 13(11), 1981; https://doi.org/10.3390/pharmaceutics13111981
Available online: https://www.mdpi.com/1999-4923/13/11/1981

You can check all publications in the Section “Nanomedicine and Nanotechnology” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1027.

12 October 2023
Pharmaceutics | Selected Papers in 2021 in the Section “Gene and Cell Therapy”


1. “Combination of Nanomaterials in Cell-Based Drug Delivery Systems for Cancer Treatment”
by Lu Tang, Shun He, Yue Yin, Hening Liu, Jingyi Hu, Jie Cheng and Wei Wang
Pharmaceutics 2021, 13(11), 1888; https://doi.org/10.3390/pharmaceutics13111888
Available online: https://www.mdpi.com/1999-4923/13/11/1888

2. “Mesenchymal Stromal Cell Secretome for the Treatment of Immune-Mediated Inflammatory Diseases: Latest Trends in Isolation, Content Optimization and Delivery Avenues”
by Elena Munoz-Perez, Ainhoa Gonzalez-Pujana, Manoli Igartua, Edorta Santos-Vizcaino and Rosa Maria Hernandez
Pharmaceutics 2021, 13(11), 1802; https://doi.org/10.3390/pharmaceutics13111802
Available online: https://www.mdpi.com/1999-4923/13/11/1802

3. “Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery”
by Magdalena M. Żak and Lior Zangi
Pharmaceutics 2021, 13(10), 1675; https://doi.org/10.3390/pharmaceutics13101675
Available online: https://www.mdpi.com/1999-4923/13/10/1675

4. “Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia”
by Patrick Connerty, Ernest Moles, Charles E. de Bock, Nisitha Jayatilleke, Jenny L. Smith, Soheil Meshinchi, Chelsea Mayoh, Maria Kavallaris and Richard B. Lock
Pharmaceutics 2021, 13(10), 1681; https://doi.org/10.3390/pharmaceutics13101681
Available online: https://www.mdpi.com/1999-4923/13/10/1681

5. “B3Pred: A Random-Forest-Based Method for Predicting and Designing Blood–Brain Barrier Penetrating Peptides”
by Vinod Kumar, Sumeet Patiyal, Anjali Dhall, Neelam Sharma and Gajendra Pal Singh Raghava
Pharmaceutics 2021, 13(8), 1237; https://doi.org/10.3390/pharmaceutics13081237
Available online: https://www.mdpi.com/1999-4923/13/8/1237

6. “Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment”
by Dima Hattab, Amirah Mohd Gazzali and Athirah Bakhtiar
Pharmaceutics 2021, 13(7), 1009; https://doi.org/10.3390/pharmaceutics13071009
Available online: https://www.mdpi.com/1999-4923/13/7/1009

7. “Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines”
by Saed Abbasi and Satoshi Uchida
Pharmaceutics 2021, 13(5), 644; https://doi.org/10.3390/pharmaceutics13050644
Available online: https://www.mdpi.com/1999-4923/13/5/644

8. “Hepatocellular-Targeted mRNA Delivery Using Functionalized Selenium Nanoparticles In Vitro”
by Dhireshan Singh and Moganavelli Singh
Pharmaceutics 2021, 13(3), 298; https://doi.org/10.3390/pharmaceutics13030298
Available online: https://www.mdpi.com/1999-4923/13/3/298

You can check all publications in the Section “Gene and Cell Therapy” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1033.

12 October 2023
Pharmaceutics | Selected Papers in 2021 in the Section “Drug Delivery and Controlled Release”


1. “Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery”
by Rebekah Omarkhail Elliott and Mei He
Pharmaceutics 2021, 13(1), 122; https://doi.org/10.3390/pharmaceutics13010122
Available online: https://www.mdpi.com/1999-4923/13/1/122

2. “Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives”
by Hyeong Min Kim and Se Joon Woo
Pharmaceutics 2021, 13(1), 108; https://doi.org/10.3390/pharmaceutics13010108
Available online: https://www.mdpi.com/1999-4923/13/1/108

3. “Peptide-Based Strategies for Targeted Tumor Treatment and Imaging”
by Abiodun Ayo and Pirjo Laakkonen
Pharmaceutics 2021, 13(4), 481; https://doi.org/10.3390/pharmaceutics13040481
Available online: https://www.mdpi.com/1999-4923/13/4/481

4. “Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation”
by Felipe M. González-Fernández, Annalisa Bianchera, Paolo Gasco, Sara Nicoli and Silvia Pescina
Pharmaceutics 2021, 13(4), 447; https://doi.org/10.3390/pharmaceutics13040447
Available online: https://www.mdpi.com/1999-4923/13/4/447

5. “Formulation Considerations for the Management of Dry Eye Disease”
by Priyanka Agarwal, Jennifer P. Craig and Ilva D. Rupenthal
Pharmaceutics 2021, 13(2), 207; https://doi.org/10.3390/pharmaceutics13020207
Available online: https://www.mdpi.com/1999-4923/13/2/207

6. “Mesoporous Silica Particles as Drug Delivery Systems—The State of the Art in Loading Methods and the Recent Progress in Analytical Techniques for Monitoring These Processes”
by Katarzyna Trzeciak, Agata Chotera-Ouda, Irena I. Bak-Sypien and Marek J. Potrzebowski
Pharmaceutics 2021, 13(7), 950; https://doi.org/10.3390/pharmaceutics13070950
Available online: https://www.mdpi.com/1999-4923/13/7/950

7. “Microemulsion-Based Media in Nose-to-Brain Drug Delivery”
by Anna Froelich, Tomasz Osmałek, Barbara Jadach, Vinam Puri and Bozena Michniak-Kohn
Pharmaceutics 2021, 13(2), 201; https://doi.org/10.3390/pharmaceutics13020201
Available online: https://www.mdpi.com/1999-4923/13/2/201

8. “Nanomaterials for Protein Delivery in Anticancer Applications”
by Anne Yau, Jinhyung Lee and Yupeng Chen
Pharmaceutics 2021, 13(2), 155; https://doi.org/10.3390/pharmaceutics13020155
Available online: https://www.mdpi.com/1999-4923/13/2/155

9. “Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics”
by Kai K. Ewert, Pablo Scodeller, Lorena Simón-Gracia, Victoria M. Steffes, Emily A. Wonder, Tambet Teesalu and Cyrus R. Safinya
Pharmaceutics 2021, 13(9), 1365; https://doi.org/10.3390/pharmaceutics13091365
Available online: https://www.mdpi.com/1999-4923/13/9/1365

10. “Transdermal Delivery of Chemotherapeutics: Strategies, Requirements, and Opportunities”
by Rabin Neupane, Sai H. S. Boddu, Mariam Sami Abou-Dahech, Rinda Devi Bachu, David Terrero, R. Jayachandra Babu and Amit K. Tiwari
Pharmaceutics 2021, 13(7), 960; https://doi.org/10.3390/pharmaceutics13070960
Available online: https://www.mdpi.com/1999-4923/13/7/960

11. “3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery”
by Rafaela Santos de Oliveira, Stephani Silva Fantaus, Antonio José Guillot, Ana Melero and Ruy Carlos Ruver Beck
Pharmaceutics 2021, 13(11), 1946; https://doi.org/10.3390/pharmaceutics13111946
Available online: https://www.mdpi.com/1999-4923/13/11/1946

12. “Graphene Oxide and Graphene Quantum Dots as Delivery Systems of Cationic Porphyrins: Photo-Antiproliferative Activity Evaluation towards T24 Human Bladder Cancer Cells”
by Luca Menilli, Ana R. Monteiro, Silvia Lazzarotto, Filipe M. P. Morais, Ana T. P. C. Gomes, Nuno M. M. Moura, Sara Fateixa, Maria A. F. Faustino, Maria G. P. M. S. Neves, Tito Trindade et al.
Pharmaceutics 2021, 13(9), 1512; https://doi.org/10.3390/pharmaceutics13091512
Available online: https://www.mdpi.com/1999-4923/13/9/1512

13. “Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability”
by Daniel Andrés Real, Karen Bolaños, Josefina Priotti, Nicolás Yutronic, Marcelo J. Kogan, Rodrigo Sierpe and Orlando Donoso-González
Pharmaceutics 2021, 13(12), 2131; https://doi.org/10.3390/pharmaceutics13122131
Available online: https://www.mdpi.com/1999-4923/13/12/2131

14. “PEGylated Mesoporous Silica Nanoparticles (MCM-41): a Promising Carrier for the Targeted Delivery of Fenbendazole into Prostrate Cancer Cells”
by Maedeh Koohi Moftakhari Esfahani, Seyed Ebrahim Alavi, Peter J. Cabot, Nazrul Islam and Emad L. Izake
Pharmaceutics 2021, 13(10), 1605; https://doi.org/10.3390/pharmaceutics13101605
Available online: https://www.mdpi.com/1999-4923/13/10/1605

You can check all publications in the Section “Drug Delivery and Controlled Release” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1031.

12 October 2023
Pharmaceutics | Selected Papers in 2021 in the Section “Drug Targeting and Design”


1. “Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases”
by Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, Simone Sampaolo and Mariarosa Anna Beatrice Melone
Pharmaceutics 2021, 13(11), 1897; https://doi.org/10.3390/pharmaceutics13111897
Available online: https://www.mdpi.com/1999-4923/13/11/1897

2. “Selective CNS Targeting and Distribution with a Refined Region-Specific Intranasal Delivery Technique via the Olfactory Mucosa”
by Frank Maigler, Simone Ladel, Johannes Flamm, Stella Gänger, Barbara Kurpiers, Stefanie Kiderlen, Ronja Völk, Carmen Hamp, Sunniva Hartung, Sebastian Spiegel et al.
Pharmaceutics 2021, 13(11), 1904; https://doi.org/10.3390/pharmaceutics13111904
Available online: https://www.mdpi.com/1999-4923/13/11/1904

3. “Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan”
by Ayah Mohammad Burhan, Butsabarat Klahan, Wayne Cummins, Vanessa Andrés-Guerrero, Mark E. Byrne, Niall J. O’Reilly, Anuj Chauhan, Laurence Fitzhenry and Helen Hughes
Pharmaceutics 2021, 13(10), 1685; https://doi.org/10.3390/pharmaceutics13101685
Available online: https://www.mdpi.com/1999-4923/13/10/1685

4. “Ruthenium Complexes in the Fight against Pathogenic Microorganisms. An Extensive Review”
by Alexandra-Cristina Munteanu and Valentina Uivarosi
Pharmaceutics 2021, 13(6), 874; https://doi.org/10.3390/pharmaceutics13060874
Available online: https://www.mdpi.com/1999-4923/13/6/874

5. “Optimization of Collagen Chemical Crosslinking to Restore Biocompatibility of Tissue-Engineered Scaffolds”
by Mohammad Mirazul Islam, Dina B. AbuSamra, Alexandru Chivu, Pablo Argüeso, Claes H. Dohlman, Hirak K. Patra, James Chodosh and Miguel González-Andrades
Pharmaceutics 2021, 13(6), 832; https://doi.org/10.3390/pharmaceutics13060832
Available online: https://www.mdpi.com/1999-4923/13/6/832

6. “Hybrid 3D Printing of Advanced Hydrogel-Based Wound Dressings with Tailorable Properties”
by Marko Milojević, Gregor Harih, Boštjan Vihar, Jernej Vajda, Lidija Gradišnik, Tanja Zidarič, Karin Stana Kleinschek, Uroš Maver and Tina Maver
Pharmaceutics 2021, 13(4), 564; https://doi.org/10.3390/pharmaceutics13040564
Available online: https://www.mdpi.com/1999-4923/13/4/564

7. “Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside”
by Stephen Ahenkorah, Irwin Cassells, Christophe M. Deroose, Thomas Cardinaels, Andrew R. Burgoyne, Guy Bormans, Maarten Ooms and Frederik Cleeren
Pharmaceutics 2021, 13(5), 599; https://doi.org/10.3390/pharmaceutics13050599
Available online: https://www.mdpi.com/1999-4923/13/5/599

8. “Atorvastatin-Eluting Contact Lenses: Effects of Molecular Imprinting and Sterilization on Drug Loading and Release”
by Ana F. Pereira-da-Mota, María Vivero-Lopez, Ana Topete, Ana Paula Serro, Angel Concheiro and Carmen Alvarez-Lorenzo
Pharmaceutics 2021, 13(5), 606; https://doi.org/10.3390/pharmaceutics13050606
Available online: https://www.mdpi.com/1999-4923/13/5/606

9. “Current Insights into 3D Bioprinting: An Advanced Approach for Eye Tissue Regeneration”
by Sandra Ruiz-Alonso, Ilia Villate-Beitia, Idoia Gallego, Markel Lafuente-Merchan, Gustavo Puras, Laura Saenz-del-Burgo and José Luis Pedraz
Pharmaceutics 2021, 13(3), 308; https://doi.org/10.3390/pharmaceutics13030308
Available online: https://www.mdpi.com/1999-4923/13/3/308

10. “Neuroinflammation as a Therapeutic Target in Retinitis Pigmentosa and Quercetin as Its Potential Modulator”
by Joseph Thomas Ortega and Beata Jastrzebska
Pharmaceutics 2021, 13(11), 1935; https://doi.org/10.3390/pharmaceutics13111935
Available online: https://www.mdpi.com/1999-4923/13/11/1935

You can check all publications in the Section “Drug Targeting and Design” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1034.

2 October 2023
MDPI Insights: The CEO’s Letter #4 - MDPI Presence in China

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access in China

It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.

Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!

Open Access Policy in China

As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.

Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.

In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.

In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.

MDPI Offices in China

 While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.


Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.

In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

Our Strength is in Our People

With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.

In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.

Impactful Research

MDPI Awards

To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.

In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.

Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.

To learn more about MDPI Awards and to find out which are currently available, please click here.

MDPI Awards to Scholars from China

Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.

MDPI’s Tu Youyou Award


Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).

In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.

The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.

2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu

Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.

Highly Cited Articles by Chinese Scholars Published in MDPI

Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.

Read more:

Inside MDPI

Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.

Marketing Department in China

During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.

I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.

Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.

Coming Together for Science

Collaborations, Scholarships and Meetings

MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.

Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.

Scholarships in China

Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).

Meeting with the Society of Chinese University Journals (CUJS)


Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.

I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.

We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.

MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.

Meeting with National Science Library, Chinese Academy of Sciences (NSLC)


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.

We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our  IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.

In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.

The Numbers

As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.

At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.

Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.

Closing Thoughts

Final Reflections on our MDPI Offices in Beijing and Wuhan


Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.

I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.

Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.

95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).

91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.

Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.

Hospitality and Service

Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.

I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.

Stefan Tochev
Chief Executive Officer
MDPI AG

19 September 2023
Meet Us at the 13th Member Congress of the Chinese Society of Biochemistry and Molecular Biology and 2023 National Academic Congress, 19–22 October 2023, Hefei, China


MDPI will attend the 13th Member Congress of the Chinese Society of Biochemistry and Molecular Biology and 2023 National Academic Congress. This event will be held from 19 to 22 October 2023 in Hefei, China, and is hosted by the Chinese Society of Biochemistry and Molecular Biology.

This event includes invited reports of the conference, branch (special topic) reports, and posters. The theme of this conference is gene expression and regulation; RNA function and regulation; protein modification and function; metabolic homeostasis and networks; frontier technology and application, etc.

The following MDPI journals will be represented:

  • Biomolecules (leading);
  • Genes (leading);
  • IJMS (leading);
  • Cancers;
  • Cells;
  • Pharmaceutics;
  • CIMB;
  • Biology;
  • Symmetry.

If you plan on attending this conference, please feel free to stop by our booth (#C07) and chat with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.csbmb.org.cn/2023/.

6 September 2023
Recap of Awards Granted to Scholars in 2022


MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.

In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.

The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.

MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

To explore more MDPI awards, please click here.

5 September 2023
Meet Us at the 16th China Pharmaceutical Preparations Conference, 15–17 September 2023, Changsha, China


The upcoming conference is the 16th so far, and it has become an important conference in the field of pharmaceutical research in China. The theme of this formulation conference is "New Technologies, New Opportunities, and New Challenges" which will be held in Changsha, China. Experts from various fields and directions in pharmacy at home and abroad will be invited to conduct exchanges and discussions on theoretical research, technology applications, policies, and regulations on pharmaceutical formulations. In addition to the main venue, the conference also has a basic pharmacy forum (targeted drug delivery strategy, controlled release strategy), industrial pharmacy forum, International Controlled Release Association China Branch Forum, external preparations forum, improved new drugs and clinical research forum, medicinal excipients and pharmaceutical packaging materials forum, preparation R&D services and equipment forum, young pharmaceutical workers forum, graduate student forum, and other sub-venues.

Pharmaceutics (ISSN: 1999-4923) is a peer-reviewed, open access journal on the science and technology of pharmaceutics and biopharmaceutics, and it is published monthly online by MDPI. Pharmaceutics will participate in this event as an exhibitor together with seven other MDPI journals.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth #A39. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information, please feel free to contact the Pharmaceutics Editorial Office at pharmaceutics@mdpi.com.

30 August 2023
MDPI Insights: The CEO’s Letter #3 - Sustainability and Co-opetition

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Our Commitment to Sustainability

As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.

In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.

MDPI and the Sustainable Development Goals (SDGs)

In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.

“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]

As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:

MDPI journals specializing in sustainability-related topics:

  • 2009: Sustainability
  • 2012: Resources
  • 2013: Climate
  • 2014: Environments
  • 2016: Recycling
  • 2019: Clean Technologies
  • 2020: Sustainable Chemistry
  • 2021: Wind, Biomass, Conservation, Pollutants, Solar
  • 2022: Waste, Microplastics

Read more:

Impactful Research

Highly Cited Articles in Sustainability

In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.

We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.

“Sustainability received a 2022 CiteScore of 5.8”

While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.

Highly Cited Papers in Sustainability

Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.

1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?
Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792; https://doi.org/10.3390/su14084792
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)

This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.

2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety
Author: Panu Pihkala
Sustainability 2020, 12(19), 7836; https://doi.org/10.3390/su12197836
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)

This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.

3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review
Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318; https://doi.org/10.3390/su13031318
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)

This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.

4. Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions
Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963; https://doi.org/10.3390/su13179963
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)

This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.

Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).

Read more:

Inside MDPI

President of Ireland Authors Editorial in MDPI Journal Sustainability

It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:

This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.

The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.

As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.

Read the completed editorial here:

Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683; https://doi.org/10.3390/su15129683

Coming Together for Science

The World Sustainability Forum 2023

The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.

This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:

  • The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
  • The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
  • The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.

MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research

The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:

  1. The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
  2. The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.

The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.

2023 World Sustainability Award Winners

  1. Professor Michael R. Templeton
  2. Professor Tom Lyon
  3. Dr Krithi K. Karanth

Interviews with 2023 Emerging Sustainability Leader Award Finalists

  • Dr. Bahareh Kamranzad
  • Dr. Youjin Kim
  • Dr. Julia Lohmann

As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.

Read more:

Closing Thoughts

“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier

I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.

MDPI’s Interaction with Elsevier

In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.

“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”

Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.

It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.

‘Fully OA’ Organizations Dedicated to Open Access

MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.

This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.

As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”

Stefan Tochev
Chief Executive Officer
MDPI AG

18 August 2023
Meet Us at the 2023 China Biomaterials Conference, 12–15 October 2023, Chongqing, China


Conference: 2023 China Biomaterials Conference (CSBM2023)
Date: 12–15 October 2023
Booth: #B4

MDPI journals will be attending the 2023 China Biomaterials Conference (CSBM2023) as an exhibitor. This meeting will be held in Chongqing, China, from 12 to 15 October 2023.

The theme of the conference is “Innovative Biomaterials to Protect People's Health”, focusing on the frontiers of biomaterials science, technological innovation, achievement transformation, regulatory science, etc., to discuss and share the latest developments in the current field of biomaterials.

The following MDPI journals will be represented:

  • IJMS;
  • JFB;
  • Bioengineering;
  • Biomimetics;
  • Marine Drugs;
  • Polymers;
  • Nanomaterials;
  • Biomedicines;
  • Micromachines;
  • Pharmaceutics;
  • Electrochem.

If you plan on attending this conference, please feel free to stop by our booth (#B4) and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit http://2023.csbm.org.cn/index.php/index/index/index.html.

18 August 2023
MDPI’s 2022 Young Investigator Awards in Medicine and Pharmacology—Winners Announced


MDPI’s Young Investigator Awards recognize promising young researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in medicine and pharmacology. The winners were selected by the journals’ Award Evaluation Committee.

We would like to warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

  • Yuyan Jiang, Stanford University, USA
  • Billy Wai-Lung Ng, Chinese University of Hong Kong, China

Cancers:

  • Ashleigh Poh, The Olivia Newton-John Cancer Research Institute, Australia
  • Miranda Fidler-Benaoudia, University of Calgary, Canada

Current Oncology:

  • Bishal Gyawali, Queen’s University, Canada

Healthcare:

  • Shahnawaz Anwer, Hong Kong Polytechnic University, Hong Kong

JCM:

  • Jan Bednarsch, Universitätsmedizin Berlin, Germany

JPM:

  • Anda Mihaela Naciu, Fondazione Policlinico Universitario Campus Bio-Medico, Italy
  • Jerome Lechien, University of Mons, Belgium

Pharmaceuticals:

  • Daniele Bertoglio, University of Antwerp, Belgium

Pharmaceutics:

  • Gregor Fuhrmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

TropicalMed:

  • Haley Adcox, Virginia Commonwealth University, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and a form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to the advancement of their fields.

For more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Travel Awards in Medicine and Pharmacology—Winners Announced


We are proud to recognize the winners of MDPI’s 2022 Travel Awards in medicine and pharmacology category for their outstanding presentations.

MDPI journals regularly offer Travel Awards to encourage talented junior scientists to present their research at academic conferences in specific fields, which helps to enhance their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to congratulate the winners of the 2022 Travel Awards and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Antibiotics:

  • Filip Jansåker, Lund University, Lund, Sweden
  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

Cancers:

  • Diego de Miguel Perez, Icahn School of Medicine at Mount Sinai, USA
  • Luigi Russo, Italian Institute of Technology (IIT), Italy

Current Oncology:

  • Sneha Sethi, University of Adelaide, Australia
  • Xiyin Wang, Indiana University School of Medicine, USA

Dentistry Journal:

  • Sonia Nath, University of Adelaide, Australia
  • Konstantina Kritikou, Carol Davila University of Medicine and Pharmacy, Romania

Diagnostics:

  • Adrien Holzgreve, The University Hospital of Munich, Germany

Hemato:

  • Antonella Padella, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Italy

JCDD:

  • Susanna Cooper, St. George’s University of London, UK
  • Renée Tillie, Maastricht University Medical Center, the Netherlands

JCM:

  • Max Lennart Eckstein, University of Bayreuth, Germany
  • Lorenzo Bertani, University of Pisa, Italy

Pharmaceutics:

  • Yuxue Cao, University of Queensland, Australia
  • Flávia Sousa, Italian Institute of Technology, Italy

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form ot recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Medicine and Pharmacology—Winners Announced


In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize the winners for the year 2022 in medicine and pharmacology for their outstanding contributions among the extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

  • Maxime Pichon, Centre Hospitalier Universitaire de Poitiers, France
  • Violeta Popovici, Ovidius University of Constanta, Romania
  • Yosra A. Helmy, University of Kentucky, USA

Cancers:

  • Antonio G. Solimando, Aldo Moro University of Bari, Italy
  • Linlin Guo, The Ohio State University Medical Center, USA
  • Ravindra Deshpande, Wake Forest School of Medicine, USA
  • Songli Zhu, Fred Hutchinson Cancer Research Center, USA
  • Antonella Argentiero, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Italy
  • Camelia Coada, Alma Mater Studiorum-University of Bologna, Italy
  • Chenghui Li, University of Arkansas for Medical Sciences, USA
  • Laurentiu Pop, University of Texas Southwestern Medical Center, USA
  • Muhammad Fazal Ijaz, Dongguk University, Republic of Korea
  • Rafał Watrowski, University of Freiburg, Germany
  • Ruben C. Petreaca, The Ohio State University, USA
  • Ruchi Roy, Rush University Medical Center, USA
  • Salvatore Cocuzza, University of Catania, Italy
  • Santosh Kumar Singh, Morehouse School of Medicine, USA
  • Sergei Boichuk, Kazan State Medical University, Russia
  • Simon John Christoph Soerensen, Stanford University, USA
  • Takuya Koie, Gifu University, Japan
  • Teresa Rubio-Tomás, Foundation for Research and Technology Hellas, Greece
  • Teruki Nii, Kyushu University, Japan
  • Tomasz Marjanski, Medical University of Gdansk, Poland

Current Oncology:

  • Kristen Haase, The University of British Columbia, Canada
  • Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
  • Makoto Endo, Kyushu University, Japan

Healthcare:

  • Tefera Tadesse, Addis Ababa University, Ethiopia
  • Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
  • Ryuichi Ohta, Unnan City Hospital, Japan

JCM:

  • Henry Sutanto, Cardiovascular Research Institute Maastricht, the Netherlands
  • José-María Sánchez-González, University of Seville, Spain
  • Emmanouil Kapetanakis, General Hospital of Piraeus “Tzaneio”, Greece

JPM:

  • Eleonora Topino, Libera Università Maria Santissima Assunta (LUMSA), Italy
  • Rodolfo Reda, Sapienza University of Rome, Italy
  • Giulio Francesco Romiti, Sapienza University of Rome, Italy
  • Maria Gabriella Melchiorre, IRCCS INRCA—National Institute of Health and Science on Ageing, Italy
  • James Walter, 1Hines VA Hospital, USA; 2 Loyola Medical Center, USA

Medical Sciences:

  • Vasiliki Tsigkou, Sotiria Hospital, Greece

Pharmaceutics:

  • Flavia Zacconi, Pontificia Universidad Católica de Chile, Chile
  • Bhupendra Prajapati, Ganpat University, India
  • Van-An Duong, Gachon University, Republic of Korea
  • Ashish Agrawal, Indian Institute of Technology (BHU), India

Tomography:

  • Aydin Eresen, University of California Irvine, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Medicine and Pharmacology—Winners Announced


MDPI’s Best PhD Thesis Awards aim to recognize young scholars who are deemed to have produced the most outstanding PhD thesis in their fields of research and to encourage them to continue their outstanding work and further contributions to their field.

We would like to congratulate the winners of the 2022 Best PhD Thesis Awards in medicine and pharmacology and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Cancers:

  • “Uncovering Novel Prognostic and Predictive Epigenetic Biomarkers in Malignant Testicular Germ Cell Tumors”

by João Pedro da Silva Machado Lobo, University of Porto, Portugal

  • “Metastatic Recurrence in Colorectal Cancer Arises from Residual EMP1+ Cells”

by Adrià Cañellas Socias, University of Barcelona, Spain

Healthcare:

  • “Investigating Novel Aspects of the Blood–Brain Barrier Using High-Resolution Electron Microscopy”

by Shireen Mentor, University of Cape Town, South Africa

JPM:

  • “An Epidemiological Approach to Study The Interplay between Genome, Epigenome and Exposome in Women”

by Roberta Magnano San Lio, University of Catania, Italy

Pharmaceutics:

  • “Intravitreal Liposomes as Ocular Drug Delivery Systems: Vitreal Interactions, Retinal Permeation and Drug Release Characteristics”

by Shirin Tavakoli, University of Helsinki, Finland

TropicalMed:

  • “Microbiome-Mediated Colonization Resistance: Defense against Enteropathogens and Multi-Drug Resistant Organisms”

by Quinten Ducarmon, Leiden University Medical Center, the Netherlands

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

For more MDPI awards, please click here.

18 August 2023
MDPI’s Best Paper Awards in Medicine and Pharmacology—Winners Announced in 2022


The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected review and research papers through a rigorous evaluative process based on criteria such as the scientific merit, overall impact, and quality of presentation of the papers published in the journal.

We are honored to present the winners for the year 2022 in medicine and pharmacology, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

Dentistry Journal:

Healthcare:

JCM:

JPM:

Pharmaceutics:

Pharmacy:

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

8 August 2023
Pharmaceutics | Selected Special Issue Reprints in 2021–2022

We are pleased to invite you to read the selected Special Issue reprints in 2021 and 2022 in Pharmaceutics (ISSN: 1999-4923). The reprints are listed as follows:

1. “Preclinical Evaluation of Lipid-Based Nanosystems”
Guest Editors: Dr. Ana Catarina Silva and Prof. Dr. José Manuel Sousa Lobo
Published: July 2021, Pages: 352, ISBN 978-3-0365-1550-2 (hardback); ISBN 978-3-0365-1549-6 (PDF), https://doi.org/10.3390/books978-3-0365-1549-6
Available online: https://www.mdpi.com/books/book/4039

2. “Advanced Blood-Brain Barrier Drug Delivery”
Guest Editor: Prof. Dr. William M. Pardridge
Published: January 2023, Pages: 496, ISBN 978-3-0365-6417-3 (hardback); ISBN 978-3-0365-6416-6 (PDF), https://doi.org/10.3390/books978-3-0365-6416-6
Available online: https://www.mdpi.com/books/book/6675

3. “Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis, Monitoring and Treatment of Disease: From Bench to Bedside”
Guest Editor: Dr. Oya Tagit
Published: June 2022, Pages: 296, ISBN 978-3-0365-4490-8 (hardback); ISBN 978-3-0365-4489-2 (PDF), https://doi.org/10.3390/books978-3-0365-4489-2
Available online: https://www.mdpi.com/books/book/5741

4. “Delivery of Molecules Using Nanoscale Systems for Cancer Treatment and/or Diagnosis”
Guest Editors: Dr. Marina Santiago Franco and Prof. Dr. Yu Seok Youn
Published: August 2022, Pages: 302, ISBN 978-3-0365-4961-3 (hardback); ISBN 978-3-0365-4962-0 (PDF), https://doi.org/10.3390/books978-3-0365-4962-0
Available online: https://www.mdpi.com/books/book/5975

5. “Drug Absorption Studies: In Situ, In Vitro and In Silico Models”
Guest Editor: Prof. Dr. Im-Sook Song
Published: December 2021, Pages: 189, ISBN 978-3-0365-2461-0 (hardback); ISBN 978-3-0365-2460-3 (PDF), https://doi.org/10.3390/books978-3-0365-2460-3
Available online: https://www.mdpi.com/books/book/4689

6. “Solid Dispersions for Drug Delivery: Applications and Preparation Methods”
Guest Editors: Prof. Dr. Vitaliy Khutoryanskiy and Dr. Hisham Al-Obaidi
Published: January 2022, Pages: 244, ISBN 978-3-0365-2639-3 (hardback); ISBN 978-3-0365-2638-6 (PDF), https://doi.org/10.3390/books978-3-0365-2638-6
Available online: https://www.mdpi.com/books/book/4817

7. “Novel Anticancer Strategies (Volume II)”
Guest Editor: Dr. Hassan Bousbaa
Published: March 2023, Pages: 700, ISBN 978-3-0365-7033-4 (hardback); ISBN 978-3-0365-7032-7 (PDF), https://doi.org/10.3390/books978-3-0365-7032-7
Available online: https://www.mdpi.com/books/book/6986

8. “Special Issue in Honor of Dr. Michael Weber's 70th Birthday: Photodynamic Therapy: Rising Star in Pharmaceutical Applications”
Guest Editors: Prof. Dr. Udo Bakowsky, Dr. Matthias Wojcik, Dr. Eduard Preis and Prof. Dr. Gerhard Litscher
Published: November 2022, Pages: 528, ISBN 978-3-0365-5960-5 (hardback); ISBN 978-3-0365-5959-9 (PDF), https://doi.org/10.3390/books978-3-0365-5959-9
Available online: https://www.mdpi.com/books/book/6387

9. “Model-Informed Precision Dosing”
Guest Editors: Dr. Jonás Samuel Pérez-Blanco and Prof. Dr. José Martínez Lanao
Published: March 2023, Pages: 320, ISBN 978-3-0365-6896-6 (hardback); ISBN 978-3-0365-6897-3 (PDF), https://doi.org/10.3390/books978-3-0365-6897-3
Available online: https://www.mdpi.com/books/book/7075

10. “In Silico Strategies for Prospective Drug Repositionings”
Guest Editors: Dr. Lucreția Udrescu, Prof. Dr. Ludovic Kurunczi, Prof. Dr. Paul Bogdan and Prof. Dr. Mihai Udrescu
Published: January 2023, Pages: 288, ISBN 978-3-0365-6134-9 (hardback); ISBN 978-3-0365-6133-2 (PDF), https://doi.org/10.3390/books978-3-0365-6133-2
Available online: https://www.mdpi.com/books/book/6556

27 July 2023
MDPI Insights: The CEO’s Letter #2 - Open Peer-Review and IJERPH

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Peer Review Reports

Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.

MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.

Start and Growth of Open Peer Review at MDPI

The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.

As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.

Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.

Benefits of Open Peer Review

The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.

As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.

Impactful Research

MDPI Papers Cited in the News – IJERPH edition

Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.

During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.

Highly Cited Journal Publications

IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:

  • International Journal of Environmental Research and Public Health: 3509 mentions
  • Nutrients: 2698 mentions
  • International Journal of Molecular Sciences: 1701 mentions
  • Journal of Clinical Medicine: 1131 mentions
  • Viruses: 1111 mentions

These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.

Example of Recent Mentions

During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:

The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper:Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments

Harvard Business Review: “How to Take Better Breaks at Work, According to Research
IJERPH paper:Canine-Assisted Therapy Improves Well-Being in Nurses

National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way
IJERPH paper:Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease

Inside MDPI

MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process

At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.

Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.

To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.

The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.

In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.

Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.

Read more:

Coming Together for Science

The Future of IJERPH

On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.

While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.

Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.

Journal Achievements

In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:

  • Founded by Prof. Dr. Paul B. Tchounwou in 2004
  • Indexed in PubMed in 2008
  • Received its first Impact Factor in 2012
  • Published its 5000th paper in 2017
  • Over 60,000 papers published as at June 30, 2023
  • 131,628,173 paper views in 2018–2022
  • Over 28,000 mentions in prominent news outlets
  • 17,000 papers cited 10 times or more as at June 30, 2023
  • No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
  • Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.

These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.

Closing Thoughts

MDPI’s Impact in Spain

During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.

Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.

The Numbers

Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).

Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.

Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.

Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.

Testimonials

I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:

Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)

Stefan Tochev
Chief Executive Officer
MDPI AG

27 July 2023
Pharmaceutics | Highly Cited Papers in 2021–2022


We are pleased to invite you to read the highly cited papers in 2021 and 2022 in Pharmaceutics (ISSN: 1999-4923). The paper list is as follows:

1. “Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions”
by José H. Correia, José A. Rodrigues, Sara Pimenta, Tao Dong and Zhaochu Yang
Pharmaceutics 2021, 13(9), 1332; https://doi.org/10.3390/pharmaceutics13091332
Available online: https://www.mdpi.com/1999-4923/13/9/1332

2. “Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery”
by Rebekah Omarkhail Elliott and Mei He
Pharmaceutics 2021, 13(1), 122; https://doi.org/10.3390/pharmaceutics13010122
Available online: https://www.mdpi.com/1999-4923/13/1/122

3. “Biodegradable Alginate Films with ZnO Nanoparticles and Citronella Essential Oil—A Novel Antimicrobial Structure”
by Ludmila Motelica, Denisa Ficai, Ovidiu Oprea, Anton Ficai, Roxana-Doina Trusca, Ecaterina Andronescu and Alina Maria Holban
Pharmaceutics 2021, 13(7), 1020; https://doi.org/10.3390/pharmaceutics13071020
Available online: https://www.mdpi.com/1999-4923/13/7/1020

4. “Electrospinning Proteins for Wound Healing Purposes: Opportunities and Challenges”
by Alma Akhmetova and Andrea Heinz
Pharmaceutics 2021, 13(1), 4; https://doi.org/10.3390/pharmaceutics13010004
Available online: https://www.mdpi.com/1999-4923/13/1/4

5. “Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients”
by Wasan Katip, Suriyon Uitrakul and Peninnah Oberdorfer
Pharmaceutics 2022, 14(1), 31; https://doi.org/10.3390/pharmaceutics14010031
Available online: https://www.mdpi.com/1999-4923/14/1/31

6. “Multifunctional Biomimetic Nanofibrous Scaffold Loaded with Asiaticoside for Rapid Diabetic Wound Healing”
by Sneha Anand, Paruvathanahalli Siddalingam Rajinikanth, Dilip Kumar Arya, Prashant Pandey, Ravi K. Gupta, Ruchi Sankhwar and Kumarappan Chidambaram
Pharmaceutics 2022, 14(2), 273; https://doi.org/10.3390/pharmaceutics14020273
Available online: https://www.mdpi.com/1999-4923/14/2/273

7. “EGFR-Targeted Photodynamic Therapy”
by Luca Ulfo, Paolo Emidio Costantini, Matteo Di Giosia, Alberto Danielli and Matteo Calvaresi
Pharmaceutics 2022, 14(2), 241; https://doi.org/10.3390/pharmaceutics14020241
Available online: https://www.mdpi.com/1999-4923/14/2/241

8. “Review on the Scale-Up Methods for the Preparation of Solid Lipid Nanoparticles”
by Sakshi V. Khairnar, Pritha Pagare, Aditya Thakre, Aswathy Rajeevan Nambiar, Vijayabhaskarreddy Junnuthula, Manju Cheripelil Abraham, Praveen Kolimi, Dinesh Nyavanandi and Sathish Dyawanapelly
Pharmaceutics 2022, 14(9), 1886; https://doi.org/10.3390/pharmaceutics14091886
Available online: https://www.mdpi.com/1999-4923/14/9/1886

9. “Recent Developments in Metallic Nanomaterials for Cancer Therapy, Diagnosing and Imaging Applications”
by Dan Nicolae Păduraru, Daniel Ion, Adelina-Gabriela Niculescu, Florentina Mușat, Octavian Andronic, Alexandru Mihai Grumezescu and Alexandra Bolocan
Pharmaceutics 2022, 14(2), 435; https://doi.org/10.3390/pharmaceutics14020435
Available online: https://www.mdpi.com/1999-4923/14/2/435

10. “Imination of Microporous Chitosan Fibers—A Route to Biomaterials with “On Demand” Antimicrobial Activity and Biodegradation for Wound Dressings”
by Alexandru Anisiei, Irina Rosca, Andreea-Isabela Sandu, Adrian Bele, Xinjian Cheng and Luminita Marin
Pharmaceutics 2022, 14(1), 117; https://doi.org/10.3390/pharmaceutics14010117
Available online: https://www.mdpi.com/1999-4923/14/1/117

You can check all highly cited publications at the following link: https://www.mdpi.com/journal/pharmaceutics/most_cited.

21 July 2023
Pharmaceutics | Selected Papers in 2022 in the Section “Nanomedicine and Nanotechnology”


We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Nanomedicine and Nanotechnology”. The paper list is as follows:

1. “Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application”
by Domenico Lombardo and Mikhail A. Kiselev
Pharmaceutics 2022, 14(3), 543; https://doi.org/10.3390/pharmaceutics14030543
Available online: https://www.mdpi.com/1999-4923/14/3/543

2. “An Overview of Nanotechnologies for Drug Delivery to the Brain”
by Ahsan Ayub and Shawn Wettig
Pharmaceutics 2022, 14(2), 224; https://doi.org/10.3390/pharmaceutics14020224
Available online: https://www.mdpi.com/1999-4923/14/2/224

3. “Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma”
by Maria João Ramalho, Joana Angélica Loureiro, Manuel A. N. Coelho and Maria Carmo Pereira
Pharmaceutics 2022, 14(2), 279; https://doi.org/10.3390/pharmaceutics14020279
Available online: https://www.mdpi.com/1999-4923/14/2/279

4. “Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation”
by Hanhee Cho, Seong Ik Jeon, Cheol-Hee Ahn, Man Kyu Shim and Kwangmeyung Kim
Pharmaceutics 2022, 14(4), 728; https://doi.org/10.3390/pharmaceutics14040728
Available online: https://www.mdpi.com/1999-4923/14/4/728

5. “Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release”
by Avelino Corma, Pablo Botella and Eva Rivero-Buceta
Pharmaceutics 2022, 14(1), 110; https://doi.org/10.3390/pharmaceutics14010110
Available online: https://www.mdpi.com/1999-4923/14/1/110

6. “Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment”
by Hyeji Lee, Kanghye Bae, Ah-Rum Baek, Eun-Bin Kwon, Yeoun-Hee Kim, Sung-Wook Nam, Gang Ho Lee and Yongmin Chang
Pharmaceutics 2022, 14(5), 1002; https://doi.org/10.3390/pharmaceutics14051002
Available online: https://www.mdpi.com/1999-4923/14/5/1002

7. “Superparamagnetic Iron Oxide Nanoparticles Decorated Mesoporous Silica Nanosystem for Combined Antibiofilm Therapy”
by Elena Álvarez, Manuel Estévez, Alvaro Gallo-Cordova, Blanca González, Rafael R. Castillo, María del Puerto Morales, Montserrat Colilla, Isabel Izquierdo-Barba and María Vallet-Regí
Pharmaceutics 2022, 14(1), 163; https://doi.org/10.3390/pharmaceutics14010163
Available online: https://www.mdpi.com/1999-4923/14/1/163

8. “mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy”
by Kosuke Sasaki, Yusuke Sato, Kento Okuda, Kazuki Iwakawa and Hideyoshi Harashima
Pharmaceutics 2022, 14(8), 1572; https://doi.org/10.3390/pharmaceutics14081572
Available online: https://www.mdpi.com/1999-4923/14/8/1572

9. “Cu-Doped Hollow Bioactive Glass Nanoparticles for Bone Infection Treatment”
by Javier Jiménez-Holguín, Sandra Sánchez-Salcedo, Mónica Cicuéndez, María Vallet-Regí and Antonio J. Salinas
Pharmaceutics 2022, 14(4), 845; https://doi.org/10.3390/pharmaceutics14040845
Available online: https://www.mdpi.com/1999-4923/14/4/845

10. “A Unique Core—Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects”
by Bei Cheng, Hye-Hyun Ahn, Hwanhee Nam, Zirui Jiang, Feng J. Gao, Il Minn and Martin G. Pomper
Pharmaceutics 2022, 14(2), 373; https://doi.org/10.3390/pharmaceutics14020373
Available online: https://www.mdpi.com/1999-4923/14/2/373

You can check all publications in the Section “Nanomedicine and Nanotechnology” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1027.

21 July 2023
Pharmaceutics | Selected Papers in 2022 in the Section “Gene and Cell Therapy”


We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Gene and Cell Therapy”. The paper list is as follows:

1. “Peptides vs. Polymers: Searching for the Most Efficient Delivery System for Mitochondrial Gene Therapy“
by Rúben Faria, Milan Paul, Swati Biswas, Eric Vivès, Prisca Boisguérin, Ângela Sousa and Diana Costa
Pharmaceutics 2022, 14(4), 757; https://doi.org/10.3390/pharmaceutics14040757
Available online: https://www.mdpi.com/1999-4923/14/4/757

2. “IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte Activation”
by Ahmed E. I. Hamouda, Kai Schulze, Thomas Ebensen, Carlos Alberto Guzmán and Darío Lirussi
Pharmaceutics 2022, 14(12), 2821; https://doi.org/10.3390/pharmaceutics14122821
Available online: https://www.mdpi.com/1999-4923/14/12/2821

3. “Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio”
by Anja Lena Thiebes, Sarah Klein, Jonas Zingsheim, Georg H. Möller, Stefanie Gürzing, Manuel A. Reddemann, Mehdi Behbahani, Stefan Jockenhoevel and Christian G. Cornelissen
Pharmaceutics 2022, 14(11), 2421; https://doi.org/10.3390/pharmaceutics14112421
Available online: https://www.mdpi.com/1999-4923/14/11/2421

4. “Development of a Combined Lipid-Based Nanoparticle Formulation for Enhanced siRNA Delivery to Vascular Endothelial Cells”
by Yutong He, Dongdong Bi, Josée A. Plantinga, Grietje Molema, Jeroen Bussmann and Jan A. A. M. Kamps
Pharmaceutics 2022, 14(10), 2086; https://doi.org/10.3390/pharmaceutics14102086
Available online: https://www.mdpi.com/1999-4923/14/10/2086

5. “Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy“
by Ana Raquel Neves, Tânia Albuquerque, Rúben Faria, Ana M. Gonçalves, Cecília Santos, Eric Vivès, Prisca Boisguérin, Luís A. Passarinha, Ângela Sousa and Diana Costa
Pharmaceutics 2022, 14(10), 2213; https://doi.org/10.3390/pharmaceutics14102213
Available online: https://www.mdpi.com/1999-4923/14/10/2213

6. “Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations”
by Ahmed Salman, Ariel Kantor, Michelle E. McClements, Gemma Marfany, Sonia Trigueros and Robert E. MacLaren
Pharmaceutics 2022, 14(9), 1842; https://doi.org/10.3390/pharmaceutics14091842
Available online: https://www.mdpi.com/1999-4923/14/9/1842

7. “The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA”
by Laura Taina-González and María de la Fuente
Pharmaceutics 2022, 14(2), 460; https://doi.org/10.3390/pharmaceutics14020460
Available online: https://www.mdpi.com/1999-4923/14/2/460

8. “A Narrative Review of Cell-Based Approaches for Cranial Bone Regeneration”
by Maria I. Falguera Uceda, Silvia Sánchez-Casanova, Clara Escudero-Duch and Nuria Vilaboa
Pharmaceutics 2022, 14(1), 132; https://doi.org/10.3390/pharmaceutics14010132
Available online: https://www.mdpi.com/1999-4923/14/1/132

You can check all publications in the Section “Gene and Cell Therapy” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1033.

21 July 2023
Pharmaceutics | Selected Papers in 2022 in the Section “Physical Pharmacy and Formulation”


We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Physical Pharmacy and Formulation”. The paper list is as follows:

1. "Polysaccharide 3D Printing for Drug Delivery Applications"
by Alexandra Zamboulis, Georgia Michailidou, Ioanna Koumentakou and Dimitrios N. Bikiaris
Pharmaceutics 2022, 14(1), 145; https://doi.org/10.3390/pharmaceutics14010145
Available online: https://www.mdpi.com/1999-4923/14/1/145

2. "Engineering the Surface of Ti3C2 MXene Nanosheets for High Stability and Multimodal Anticancer Therapy"
by Chiranjeevi Korupalli, Kai-Long You, Girum Getachew, Akash S. Rasal, Worku Batu Dirersa, Mochamad Zakki Fahmi and Jia-Yaw Chang
Pharmaceutics 202214(2), 304; https://doi.org/10.3390/pharmaceutics14020304
Available online: https://www.mdpi.com/1999-4923/14/2/304

3. "Chemical Composition and Effect against Skin Alterations of Bioactive Extracts Obtained by the Hydrodistillation of Eucalyptus globulus Leaves"
by Patrícia Moreira, Fábio Jesus Sousa, Patrícia Matos, Gonçalo Sousa Brites, Maria José Gonçalves, Carlos Cavaleiro, Artur Figueirinha, Lígia Salgueiro, Maria Teresa Batista, Pedro Costa Branco et al.
Pharmaceutics 202214(3), 561; https://doi.org/10.3390/pharmaceutics14030561
Available online: https://www.mdpi.com/1999-4923/14/3/561

4. "3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review"
by Iris Lafeber, Elisabeth J. Ruijgrok, Henk-Jan Guchelaar and Kirsten J. M. Schimmel
Pharmaceutics 202214(2), 416; https://doi.org/10.3390/pharmaceutics14020416
Available online: https://www.mdpi.com/1999-4923/14/2/416

5. "Polymeric Nanocapsules Containing Fennel Essential Oil: Their Preparation, Physicochemical Characterization, Stability over Time and in Simulated Gastrointestinal Conditions"
by Giuseppe Granata, Carla Riccobene, Edoardo Napoli and Corrada Geraci
Pharmaceutics 202214(4), 873; https://doi.org/10.3390/pharmaceutics14040873
Available online: https://www.mdpi.com/1999-4923/14/4/873

6. "Biodegradable and Bioactive Carriers Based on Poly(betulin disuccinate-co-sebacic Acid) for Rifampicin Delivery"
by Daria Niewolik, Barbara Bednarczyk-Cwynar, Piotr Ruszkowski, Alicja Kazek-Kęsik, Grzegorz Dzido and Katarzyna Jaszcz
Pharmaceutics 202214(3), 579; https://doi.org/10.3390/pharmaceutics14030579
Available online: https://www.mdpi.com/1999-4923/14/3/579

7. "Drug Stability: ICH versus Accelerated Predictive Stability Studies"
by Olga González-González, Irving O. Ramirez, Bianca I. Ramirez, Peter O’Connell, Maria Paloma Ballesteros, Juan José Torrado and Dolores R. Serrano
Pharmaceutics 202214(11), 2324; https://doi.org/10.3390/pharmaceutics14112324
Available online: https://www.mdpi.com/1999-4923/14/11/2324

8. "Moxifloxacin Liposomes: Effect of Liposome Preparation Method on Physicochemical Properties and Antimicrobial Activity against Staphylococcus epidermidis"
by Evangelos Natsaridis, Foteini Gkartziou, Spyridon Mourtas, Marc C. A. Stuart, Fevronia Kolonitsiou, Pavlos Klepetsanis, Iris Spiliopoulou and Sophia G. Antimisiaris
Pharmaceutics 202214(2), 370; https://doi.org/10.3390/pharmaceutics14020370
Available online: https://www.mdpi.com/1999-4923/14/2/370

9. "Skin Regenerative Potential of Cupuaçu Seed Extract (Theobroma grandiflorum), a Native Fruit from the Amazon: Development of a Topical Formulation Based on Chitosan-Coated Nanocapsules"
by Geisa Nascimento Barbalho, Breno Noronha Matos, Gabriel Ferreira da Silva Brito, Thamires da Cunha Miranda, Thuany Alencar-Silva, Fernando Fabriz Sodré, Guilherme Martins Gelfuso, Marcilio Cunha-Filho, Juliana Lott Carvalho, Joyce Kelly do Rosário da Silva et al.
Pharmaceutics 202214(1), 207; https://doi.org/10.3390/pharmaceutics14010207
Available online: https://www.mdpi.com/1999-4923/14/1/207

10. "Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release"
by David Encinas-Basurto, John P. Konhilas, Robin Polt, Meredith Hay and Heidi M. Mansour
Pharmaceutics 202214(3), 587; https://doi.org/10.3390/pharmaceutics14030587
Available online: https://www.mdpi.com/1999-4923/14/3/587

You can check all publications in the Section “Physical Pharmacy and Formulation” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1029.

21 July 2023
Pharmaceutics | Selected Papers in 2022 in the Section “Pharmacokinetics and Pharmacodynamics”


We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Pharmacokinetics and Pharmacodynamics”. The paper list is as follows:

1. “Toxicokinetics of β-Amanitin in Mice and In Vitro Drug–Drug Interaction Potential”
by Young Yoon Bang, Im-Sook Song, Min Seo Lee, Chang Ho Lim, Yong-Yeon Cho, Joo Young Lee, Han Chang Kang and Hye Suk Lee
Pharmaceutics 2022, 14(4), 774; https://doi.org/10.3390/pharmaceutics14040774
Available online: https://www.mdpi.com/1999-4923/14/4/774

2. “Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution”
by Hinojal Zazo, Clara I. Colino, Carmen Gutiérrez-Millán, Andres A. Cordero, Matthias Bartneck and José M. Lanao
Pharmaceutics 2022, 14(2), 406; https://doi.org/10.3390/pharmaceutics14020406
Available online: https://www.mdpi.com/1999-4923/14/2/406

3. “Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations”
by Alexander Janssen, Frank C. Bennis and Ron A. A. Mathôt
Pharmaceutics 2022, 14(9), 1814; https://doi.org/10.3390/pharmaceutics14091814
Available online: https://www.mdpi.com/1999-4923/14/9/1814

4. “Pharmacophore-Based Discovery of Substrates of a Novel Drug/Proton-Antiporter in the Human Brain Endothelial hCMEC/D3 Cell Line”
by Maria Smirnova, Laura Goracci, Gabriele Cruciani, Laetitia Federici, Xavier Declèves, Hélène Chapy and Salvatore Cisternino
Pharmaceutics 2022, 14(2), 255; https://doi.org/10.3390/pharmaceutics14020255
Available online: https://www.mdpi.com/1999-4923/14/2/255

5. “Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis”
by Karine Rodríguez-Fernández, Víctor Mangas-Sanjuán, Matilde Merino-Sanjuán, Antonio Martorell-Calatayud, Almudena Mateu-Puchades, Mónica Climente-Martí and Elena Gras-Colomer
Pharmaceutics 2022, 14(3), 654; https://doi.org/10.3390/pharmaceutics14030654
Available online: https://www.mdpi.com/1999-4923/14/3/654

6. “Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management”
by Rannissa Puspita Jayanti, Nguyen Phuoc Long, Nguyen Ky Phat, Yong-Soon Cho and Jae-Gook Shin
Pharmaceutics 2022, 14(5), 990; https://doi.org/10.3390/pharmaceutics14050990
Available online: https://www.mdpi.com/1999-4923/14/5/990

7. “Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug–Drug–Gene Interaction Predictions”
by Helena Leonie Hanae Loer, Denise Türk, José David Gómez-Mantilla, Dominik Selzer and Thorsten Lehr
Pharmaceutics 2022, 14(5), 915; https://doi.org/10.3390/pharmaceutics14050915
Available online: https://www.mdpi.com/1999-4923/14/5/915

8. “Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination”
by Eric D. Eisenmann, Dominique A. Garrison, Zahra Talebi, Yan Jin, Josie A. Silvaroli, Jin-Gyu Kim, Alex Sparreboom, Michael R. Savona, Alice S. Mims and Sharyn D. Baker
Pharmaceutics 2022, 14(4), 694; https://doi.org/10.3390/pharmaceutics14040694
Available online: https://www.mdpi.com/1999-4923/14/4/694

9. “Integration of a Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Tegoprazan and Its Metabolite: Application for Predicting Food Effect and Intragastric pH Alterations”
by Hyeon-Cheol Jeong, Min-Gul Kim, Zhuodu Wei, Kyeong-Ryoon Lee, Jaehyeok Lee, Im-Sook Song and Kwang-Hee Shin
Pharmaceutics 2022, 14(6), 1298; https://doi.org/10.3390/pharmaceutics14061298
Available online: https://www.mdpi.com/1999-4923/14/6/1298

You can check all publications in the Section “Pharmacokinetics and Pharmacodynamics” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1032.

21 July 2023
Pharmaceutics | Selected Papers in 2022 in the Section “Pharmaceutical Technology, Manufacturing and Devices”


We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Pharmaceutical Technology, Manufacturing and Devices”. The paper list is as follows:

1. “Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs”
by Patrícia C. Pires, Márcio Rodrigue, Gilberto Alves and Adriana O. Santos
Pharmaceutics 2022, 14(3), 588; https://doi.org/10.3390/pharmaceutics14030588
Available online: https://www.mdpi.com/1999-4923/14/3/588

2. “The Evolution of the 3D-Printed Drug Delivery Systems: A Review”
by Ildikó Bácskay, Zoltán Ujhelyi, Pálma Fehér and Petra Arany
Pharmaceutics 2022, 14(7), 1312; https://doi.org/10.3390/pharmaceutics14071312
Available online: https://www.mdpi.com/1999-4923/14/7/1312

3. “Dry Powder Comprised of Isoniazid-Loaded Nanoparticles of Hyaluronic Acid in Conjugation with Mannose-Anchored Chitosan for Macrophage-Targeted Pulmonary Administration in Tuberculosis”
by Mahwash Mukhtar, Noemi Csaba, Sandra Robla, Rubén Varela-Calviño, Attila Nagy, Katalin Burian, Dávid Kókai and Rita Ambrus
Pharmaceutics 2022, 14(8), 1543; https://doi.org/10.3390/pharmaceutics14081543
Available online: https://www.mdpi.com/1999-4923/14/8/1543

4. “Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections”
by Kévin Brunet, Jean-Philippe Martellosio, Frédéric Tewes, Sandrine Marchand and Blandine Rammaert
Pharmaceutics 2022, 14(3), 641; https://doi.org/10.3390/pharmaceutics14030641
Available online: https://www.mdpi.com/1999-4923/14/3/641

5. “Assessment of the Extrusion Process and Printability of Suspension-Type Drug-Loaded AffinisolTM Filaments for 3D Printing”
by Gloria Mora-Castaño, Mónica Millán-Jiménez, Vicente Linares and Isidoro Caraballo
Pharmaceutics 2022, 14(4), 871; https://doi.org/10.3390/pharmaceutics14040871
Available online: https://www.mdpi.com/1999-4923/14/4/871

6. “Emerging Artificial Intelligence (AI) Technologies Used in the Development of Solid Dosage Forms”
by Junhuang Jiang, Xiangyu Ma, Defang Ouyang and Robert O. Williams III
Pharmaceutics 2022, 14(11), 2257; https://doi.org/10.3390/pharmaceutics14112257
Available online: https://www.mdpi.com/1999-4923/14/11/2257

7. “Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People”
by Louise Bracken, Rober Habashy, Emma McDonough, Fiona Wilson, Joanne Shakeshaft, Udeme Ohia, Tamar Garcia-Sorribes, Abdullah Isreb, Mohamed A. Alhnan and Matthew Peak
Pharmaceutics 2022, 14(3), 516; https://doi.org/10.3390/pharmaceutics14030516
Available online: https://www.mdpi.com/1999-4923/14/3/516

8. ”QbD Consideration for Developing a Double-Layered Tablet into a Single-Layered Tablet with Telmisartan and Amlodipine”
by Joo-Eun Kim and Young-Joon Park
Pharmaceutics 2022, 14(2), 377; https://doi.org/10.3390/pharmaceutics14020377
Available online: https://www.mdpi.com/1999-4923/14/2/377

9. “Progress in 3D Bioprinting Technology for Osteochondral Regeneration”
by Markel Lafuente-Merchan, Sandra Ruiz-Alonso, Fátima García-Villén, Idoia Gallego, Patricia Gálvez-Martín, Laura Saenz-del-Burgo and Jose Luis Pedraz
Pharmaceutics 2022, 14(8), 1578; https://doi.org/10.3390/pharmaceutics14081578
Available online: https://www.mdpi.com/1999-4923/14/8/1578

10. “Nanoforming Hyaluronan-Based Thermoresponsive Hydrogels: Optimized and Tunable Functionality in Osteoarthritis Management”
by Alexandre Porcello, Paula Gonzalez-Fernandez, Olivier Jordan and Eric Allémann
Pharmaceutics 2022, 14(3), 659; https://doi.org/10.3390/pharmaceutics14030659
Available online: https://www.mdpi.com/1999-4923/14/3/659

You can check all publications in the Section “Pharmaceutical Technology, Manufacturing and Devices” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1028.

21 July 2023
Pharmaceutics | Selected Papers in 2022 in the Section “Drug Targeting and Design”


We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Drug Targeting and Design”. The paper list is as follows:

1. “Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives”
by Teresa Pardo-Moreno, Anabel González-Acedo, Antonio Rivas-Domínguez, Victoria García-Morales, Francisco Jose García-Cozar, Juan Jose Ramos-Rodríguez and Lucía Melguizo-Rodríguez
Pharmaceutics 2022, 14(6), 1117; https://doi.org/10.3390/pharmaceutics14061117
Available online: https://www.mdpi.com/1999-4923/14/6/1117

2. “Tissue Adhesive, Self-Healing, Biocompatible, Hemostasis, and Antibacterial Properties of Fungal-Derived Carboxymethyl Chitosan-Polydopamine Hydrogels”
by Kummara Madhusudana Rao, Kannan Badri Narayanan, Uluvangada Thammaiah Uthappa, Pil-Hoon Park, Inho Choi and Sung Soo Han
Pharmaceutics 2022, 14(5), 1028; https://doi.org/10.3390/pharmaceutics14051028
Available online: https://www.mdpi.com/1999-4923/14/5/1028

3. “Novel Nanoparticles Based on N,O-Carboxymethyl Chitosan-Dopamine Amide Conjugate for Nose-to-Brain Delivery”
by Adriana Trapani, Stefania Cometa, Elvira De Giglio, Filomena Corbo, Roberta Cassano, Maria Luisa Di Gioia, Sonia Trombino, Md Niamat Hossain, Sante Di Gioia, Giuseppe Trapani et al.
Pharmaceutics 2022, 14(1), 147; https://doi.org/10.3390/pharmaceutics14010147
Available online: https://www.mdpi.com/1999-4923/14/1/147

4. “Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections”
by Aviva Levina, Debbie C. Crans and Peter A. Lay
Pharmaceutics 2022, 14(4), 790; https://doi.org/10.3390/pharmaceutics14040790
Available online: https://www.mdpi.com/1999-4923/14/4/790

5. “Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance”
by Ioana-Andreea Lungu, Octavia-Laura Moldovan, Victoria Biriș and Aura Rusu
Pharmaceutics 2022, 14(8), 1749; https://doi.org/10.3390/pharmaceutics14081749
Available online: https://www.mdpi.com/1999-4923/14/8/1749

6. “Chemically Modified Extracellular Vesicles and Applications in Radiolabeling and Drug Delivery”
by Elisa-Racky N’Diaye, Nicola Salvatore Orefice, Catherine Ghezzi and Ahcène Boumendjel
Pharmaceutics 2022, 14(3), 653; https://doi.org/10.3390/pharmaceutics14030653
Available online: https://www.mdpi.com/1999-4923/14/3/653

7. “Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity”
by Aleen Khoury, Jennette A. Sakoff, Jayne Gilbert, Kieran F. Scott, Shawan Karan, Christopher P. Gordon and Janice R. Aldrich-Wright
Pharmaceutics 2022, 14(4), 787; https://doi.org/10.3390/pharmaceutics14040787
Available online: https://www.mdpi.com/1999-4923/14/4/787

8. “Alternative Antibiotics in Dentistry: Antimicrobial Peptides”
by Alexandra Griffith, Akilah Mateen, Kenneth Markowitz, Steven R. Singer, Carla Cugini, Emi Shimizu, Gregory R. Wiedman and Vivek Kumar
Pharmaceutics 2022, 14(8), 1679; https://doi.org/10.3390/pharmaceutics14081679
Available online: https://www.mdpi.com/1999-4923/14/8/1679

9. “The Importance of Endoplasmic Reticulum Stress as a Novel Antidepressant Drug Target and Its Potential Impact on CNS Disorders”
by Marta Jóźwiak-Bębenista, Paulina Sokołowska, Małgorzata Siatkowska, Cecilia Analia Panek, Piotr Komorowski, Edward Kowalczyk and Anna Wiktorowska-Owczarek
Pharmaceutics 2022, 14(4), 846; https://doi.org/10.3390/pharmaceutics14040846
Available online: https://www.mdpi.com/1999-4923/14/4/846

10. “Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents”
by Paola Oliva, Romeo Romagnoli, Barbara Cacciari, Stefano Manfredini, Chiara Padroni, Andrea Brancale, Salvatore Ferla, Ernest Hamel, Diana Corallo, Sanja Aveic et al.
Pharmaceutics 2022, 14(6), 1191; https://doi.org/10.3390/pharmaceutics14061191
Available online: https://www.mdpi.com/1999-4923/14/6/1191

You can check all publications in the Section “Drug Targeting and Design” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1034.

21 July 2023
Pharmaceutics | Selected Papers in 2022 in the Section “Drug Delivery and Controlled Release”


We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Drug Delivery and Controlled Release”. The paper list is as follows:

1. “Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System”
by Tyler P. Crowe and Walter H. Hsu
Pharmaceutics 2022, 14(3), 629; https://doi.org/10.3390/pharmaceutics14030629
Available online: https://www.mdpi.com/1999-4923/14/3/629

2. “A Historical Review of Brain Drug Delivery”
by William M. Pardridge
Pharmaceutics 2022, 14(6), 1283; https://doi.org/10.3390/pharmaceutics14061283
Available online: https://www.mdpi.com/1999-4923/14/6/1283

3. “EGFR-Targeted Photodynamic Therapy”
by Luca Ulfo, Paolo Emidio Costantini, Matteo Di Giosia, Alberto Danielli and Matteo Calvaresi
Pharmaceutics 2022, 14(2), 241; https://doi.org/10.3390/pharmaceutics14020241
Available online: https://www.mdpi.com/1999-4923/14/2/241

4. “Redesigning of Cell-Penetrating Peptides to Improve Their Efficacy as a Drug Delivery System”
by Ildikó Szabó, Mo’ath Yousef, Dóra Soltész, Csaba Bató, Gábor Mező and Zoltán Bánóczi
Pharmaceutics 2022, 14(5), 907; https://doi.org/10.3390/pharmaceutics14050907
Available online: https://www.mdpi.com/1999-4923/14/5/907

5. “Honey: An Advanced Antimicrobial and Wound Healing Biomaterial for Tissue Engineering Applications”
by Joel Yupanqui Mieles, Cian Vyas, Enes Aslan, Gavin Humphreys, Carl Diver and Paulo Bartolo
Pharmaceutics 2022, 14(8), 1663; https://doi.org/10.3390/pharmaceutics14081663
Available online: https://www.mdpi.com/1999-4923/14/8/1663

6. “Molecular Tuning of IR-786 for Improved Tumor Imaging and Photothermal Therapy”
by Wonbong Lim, Jae Yong Byun, Gayoung Jo, Eun Jeong Kim, Min Ho Park and Hoon Hyun
Pharmaceutics 2022, 14(3), 676; https://doi.org/10.3390/pharmaceutics14030676
Available online: https://www.mdpi.com/1999-4923/14/3/676

7. “Novel Methacrylate-Based Multilayer Nanofilms with Incorporated FePt-Based Nanoparticles and the Anticancer Drug 5-Fluorouracil for Skin Cancer Treatment”
by Kristijan Skok, Tanja Zidarič, Kristjan Orthaber, Matevž Pristovnik, Nina Kostevšek, Kristina Žužek Rožman, Sašo Šturm, Lidija Gradišnik, Uroš Maver and Tina Maver
Pharmaceutics 2022, 14(4), 689; https://doi.org/10.3390/pharmaceutics14040689
Available online: https://www.mdpi.com/1999-4923/14/4/689

8. “Formulation and Biological Evaluation of Mesoporous Silica Nanoparticles Loaded with Combinations of Sortase A Inhibitors and Antimicrobial Peptides”
by Sitah Alharthi, Zyta M. Ziora, Taskeen Janjua, Amirali Popat and Peter M. Moyle
Pharmaceutics 2022, 14(5), 986; https://doi.org/10.3390/pharmaceutics14050986
Available online: https://www.mdpi.com/1999-4923/14/5/986

9. “Design and Validation of Nanofibers Made of Self-Assembled Peptides to Become Multifunctional Stimuli-Sensitive Nanovectors of Anticancer Drug Doxorubicin”
by Valentina Del Genio, Annarita Falanga, Emilie Allard-Vannier, Katel Hervé-Aubert, Marilisa Leone, Rosa Bellavita, Rustem Uzbekov, Igor Chourpa and Stefania Galdie
Pharmaceutics 2022, 14(8), 1544; https://doi.org/10.3390/pharmaceutics14081544
Available online: https://www.mdpi.com/1999-4923/14/8/1544

10. “Evaluation of the Mucoadhesive Properties of Chitosan-Based Microstructured Lipid Carrier (CH-MLC)”
by Marta Guerini, Giorgia Condrò and Paola Perugini
Pharmaceutics 2022, 14(1), 170; https://doi.org/10.3390/pharmaceutics14010170
Available online: https://www.mdpi.com/1999-4923/14/1/170

You can check all publications in the Section “Drug Delivery and Controlled Release” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1031.

21 July 2023
Pharmaceutics | Selected Papers in 2022 in the Section “Biopharmaceutics”


We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Biopharmaceutics”. The paper list is as follows:

1. “Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges”
by Hojun Choi, Kyungsun Choi, Dae-Hwan Kim, Byung-Koo Oh, Hwayoung Yim, Soojin Jo and Chulhee Choi
Pharmaceutics 2022, 14(3) 672; https://doi.org/10.3390/pharmaceutics14030672
Available online: https://www.mdpi.com/1999-4923/14/3/672

2. “The Role of Glucosinolates from Cruciferous Vegetables (Brassicaceae) in Gastrointestinal Cancers: From Prevention to Therapeutics”
by Catarina Melim, Maria R. Lauro, Isabel M. Pires, Paulo J. Oliveira and Célia Cabral
Pharmaceutics 2022, 14(1) 190; https://doi.org/10.3390/pharmaceutics14010190
Available online: https://www.mdpi.com/1999-4923/14/1/190

3. “In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications”
by Mauricio A. García, Felipe Varum, Jozef Al-Gousous, Michael Hofmann, Susanne Page and Peter Langguth
Pharmaceutics 2022, 14(2), 291; https://doi.org/10.3390/pharmaceutics14020291
Available online: https://www.mdpi.com/1999-4923/14/2/291

4. “Hepatoprotective Effect of Carob Pulp Flour (Ceratonia siliqua L.) Extract Obtained by Optimized Microwave-Assisted Extraction”
by Nikola Martić, Jana Zahorec, Nebojša Stilinović, Bojana Andrejić-Višnjić, Branimir Pavlić, Nebojša Kladar, Dragana Šoronja-Simović, Zita Šereš, Miodrag Vujčić, Olga Horvat et al.
Pharmaceutics 2022, 14(3), 657; https://doi.org/10.3390/pharmaceutics14030657
Available online: https://www.mdpi.com/1999-4923/14/3/657

5. “Investigations on Cellular Uptake Mechanisms and Immunogenicity Profile of Novel Bio-Hybrid Nanovesicles”
by Yi-Hsuan Ou, Jeremy Liang, Wei Heng Chng, Ram Pravin Kumar Muthuramalingam, Zi Xiu Ng, Choon Keong Lee, Yub Raj Neupane, Jia Ning Nicolette Yau, Sitong Zhang, Charles Kang Liang Lou et al.
Pharmaceutics 2022, 14(8), 1738; https://doi.org/10.3390/pharmaceutics14081738
Available online: https://www.mdpi.com/1999-4923/14/8/1738

6. “Oral Lactoferrin Supplementation during Induction Chemotherapy Promotes Gut Microbiome Eubiosis in Pediatric Patients with Hematologic Malignancies”
by Federica D’Amico, Nunzia Decembrino, Edoardo Muratore, Silvia Turroni, Paola Muggeo, Rosamaria Mura, Katia Perruccio, Virginia Vitale, Marco Zecca, Arcangelo Prete et al.
Pharmaceutics 2022, 14(8), 1705; https://doi.org/10.3390/pharmaceutics14081705
Available online: https://www.mdpi.com/1999-4923/14/8/1705

7. “Ultrasound Triggers Hypericin Activation Leading to Multifaceted Anticancer Activity”
by Federica Foglietta, Roberto Canaparo, Simone Cossari, Patrizia Panzanelli, Franco Dosio and Loredana Serpe
Pharmaceutics 2022, 14(5), 1102; https://doi.org/10.3390/pharmaceutics14051102
Available online: https://www.mdpi.com/1999-4923/14/5/1102

8. “Gastrointestinal Fluid Volumes in Pediatrics: A Retrospective MRI Study”
by Matthias Van der Veken, Michael Aertsen, Joachim Brouwers, Cordula Stillhart, Neil Parrott and Patrick Augustijns
Pharmaceutics 2022, 14(9), 1935; https://doi.org/10.3390/pharmaceutics14091935
Available online: https://www.mdpi.com/1999-4923/14/9/1935

9. “Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery”
by Adam J. Plaunt, Tam L. Nguyen, Michel R. Corboz, Vladimir S. Malinin and David C. Cipolla
Pharmaceutics 2022, 14(2), 302; https://doi.org/10.3390/pharmaceutics14020302
Available online: https://www.mdpi.com/1999-4923/14/2/302

10. “Employ of Anthocyanins in Nanocarriers for Nano Delivery: In Vitro and In Vivo Experimental Approaches for Chronic Diseases”
by Ana C. Gonçalves, Amílcar Falcão, Gilberto Alves, João A. Lopes and Luís R. Silva
Pharmaceutics 2022, 14(11), 2272; https://doi.org/10.3390/pharmaceutics14112272
Available online: https://www.mdpi.com/1999-4923/14/11/2272

You can check all publications in the Section “Biopharmaceutics” at the following link:
https://www.mdpi.com/search?journal=pharmaceutics&section=1030.

21 July 2023
Pharmaceutics | Selected Papers in 2022 in the Section “Biologics and Biosimilars”


We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Biologics and Biosimilars”. The paper list is as follows:

1. “Plant-Derived Nano and Microvesicles for Human Health and Therapeutic Potential in Nanomedicine”
by Mariaevelina Alfieri, Antonietta Leone and Alfredo Ambrosone
Pharmaceutics 2021, 13(4), 498; https://doi.org/10.3390/pharmaceutics13040498
Available online: https://www.mdpi.com/1999-4923/13/4/498

2. “Cationic Nanoparticle-Based Cancer Vaccines”
by Jeroen Heuts, Wim Jiskoot, Ferry Ossendorp and Koen van der Maaden
Pharmaceutics 2021, 13(5), 596; https://doi.org/10.3390/pharmaceutics13050596
Available online: https://www.mdpi.com/1999-4923/13/5/596

3. “Host Defense Peptide-Mimicking Polymers and Polymeric-Brush-Tethered Host Defense Peptides: Recent Developments, Limitations, and Potential Success”
by Hashem Etayash and Robert E. W. Hancock
Pharmaceutics 2021, 13(11), 1820; https://doi.org/10.3390/pharmaceutics13111820
Available online: https://www.mdpi.com/1999-4923/13/11/1820

4. “Effective Degradation of Gluten and Its Fragments by Gluten-Specific Peptidases: A Review on Application for the Treatment of Patients with Gluten Sensitivity”
by Yakov E. Dunaevsky, Valeriia F. Tereshchenkova, Mikhail A. Belozersky, Irina Y. Filippova, Brenda Oppert and Elena N. Elpidina
Pharmaceutics 2021, 13(10), 1603; https://doi.org/10.3390/pharmaceutics13101603
Available online: https://www.mdpi.com/1999-4923/13/10/1603

5. “Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases”
by Olga Martinez-Arroyo, Ana Ortega, Maria J. Forner and Raquel Cortes
Pharmaceutics 2022, 14(4), 733; https://doi.org/10.3390/pharmaceutics14040733
Available online: https://www.mdpi.com/1999-4923/14/4/733

6. “Coincubation as miR-Loading Strategy to Improve the Anti-Tumor Effect of Stem Cell-Derived EVs”
by Alessia Brossa, Marta Tapparo, Valentina Fonsato, Elli Papadimitriou, Michela Delena, Giovanni Camussi and Benedetta Bussolati
Pharmaceutics 2021, 13(1), 76; https://doi.org/10.3390/pharmaceutics13010076
Available online: https://www.mdpi.com/1999-4923/13/1/76

7. “Intracellular Delivery of Active Proteins by Polyphosphazene Polymers”
by Bareera Qamar, Melani Solomon, Alexander Marin, Thomas R. Fuerst, Alexander K. Andrianov and Silvia Muro
Pharmaceutics 2021, 13(2), 249; https://doi.org/10.3390/pharmaceutics13020249
Available online: https://www.mdpi.com/1999-4923/13/2/249

8. “Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats”
by Nikita Hanning, Michelle De bruyn, Hannah Ceuleers, Tim Boogaerts, Maya Berg, Annemieke Smet, Heiko U. De Schepper, Jurgen Joossens, Alexander L. N. van Nuijs, Joris G. De Man et al.
Pharmaceutics 2021, 13(6), 811; https://doi.org/10.3390/pharmaceutics13060811
Available online: https://www.mdpi.com/1999-4923/13/6/811

9. “Computational Design and Biological Evaluation of Analogs of Lupin Peptide P5 Endowed with Dual PCSK9/HMG-CoAR Inhibiting Activity”
by Carmen Lammi, Enrico M. A. Fassi, Jianqiang Li, Martina Bartolomei, Giulia Benigno, Gabriella Roda, Anna Arnoldi and Giovanni Grazioso
Pharmaceutics 2022, 14(3), 665; https://doi.org/10.3390/pharmaceutics14030665
Available online: https://www.mdpi.com/1999-4923/14/3/665

10. “Effects of Polyphenols on P-Glycoprotein (ABCB1) Activity”
by Kuljeet Singh, Szabolcs Tarapcsák, Zsuzsanna Gyöngy, Zsuzsanna Ritter, Gyula Batta, Rosevalentine Bosire, Judit Remenyik and Katalin Goda
Pharmaceutics 2021, 13(12), 2062; https://doi.org/10.3390/pharmaceutics13122062
Available online: https://www.mdpi.com/1999-4923/13/12/2062

You can check all publications in the Section “Biologics and Biosimilars” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1035.

11 July 2023
MDPI’s Newly Launched Journals in June 2023

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal topics (selected)
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue growth and development;
diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

4 July 2023
Meet Us at the CRS 2023 Annual Meeting, 24–28 July 2023, Las Vegas, USA


The conference is the 50th annual conference of the Controlled Release Society. The annual CRS conference is the most important conference in the pharmaceutics field. The main topics of the conference include drug delivery and controlled release, nanomedicine and nanotechnology, and biopharmaceutics. The conference organizer has a full program for the duration of the conference with highly prominent plenary talks, technical sessions covering a wide scope of topics, industry-led workshops, and technical forums.

Pharmaceutics (ISSN: 1999-4923) is a peer-reviewed, open access journal on the science and technology of pharmaceutics and biopharmaceutics, and is published monthly online by MDPI. Pharmaceutics will participate in this event as an exhibitor together with eleven other MDPI journals.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth #409. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.eventscribe.net/2023/CRSAnnualMeeting or contact the Pharmaceutics Editorial Office at pharmaceutics@mdpi.com.

3 July 2023
MDPI Insights: The CEO’s Letter #1 - Open Access and Impactful Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

The Future is Open, and MDPI is Leading the Way

I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.

1 Million Published Articles

2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.

Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.

Liberating Science

As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.

In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:

"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”

Impactful Research

MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases

MDPI journals are indexed in every single top database in the world.

As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.

Continued Growth of MDPI Journals

The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.

Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.

Read more

Interview with Indexing Manager—Constanze Shelhorn

Inside MDPI

Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science

At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.

Increased Visibility for Preprints

I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.

Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.

Read more

What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?

Coming Together for Science

The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications

In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.

Working Together

Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.

Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.

Managing Events With Sciforum

If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!

Read more

Sciforum: forthcoming events
Spotlight on Antioxidants

Closing Thoughts

Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang

Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team

During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.

I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.

Testimonials

If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:

“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet

Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection

Stefan Tochev
Chief Executive Officer
MDPI AG

28 June 2023
2022 Impact Factors for MDPI Journals

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Journal Impact Factor Rank Quartile Category
Vaccines 7.8 Q1 Immunology
Medicine, Research & Experimental
Antioxidants 7.0 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 6.0 Q2 Cell Biology
Nutrients 5.9 Q1 Nutrition & Dietetics
International Journal of Molecular Sciences 5.6 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Journal of Theoretical and Applied Electronic Commerce Research 5.6 Q2 Business
Biomolecules 5.5 Q1 Biochemistry & Molecular Biology
Biosensors 5.4 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Fractal and Fractional 5.4 Q1 Mathematics, Interdisciplinary Applications
Marine Drugs 5.4 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Pharmaceutics 5.4 Q1 Pharmacology & Pharmacy
Nanomaterials 5.3 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Cancers 5.2 Q2 Oncology
Foods 5.2 Q1 Food Science & Technology
Polymers 5.0 Q1 Polymer Science
Remote Sensing 5.0 Q1 Geosciences, Multidisciplinary
Q2 Remote Sensing
Imaging Science & Photographic Technology
Environmental Sciences
Antibiotics 4.8 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Drones 4.8 Q2 Remote Sensing
Journal of Functional Biomaterials 4.8 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.7 Q1 Pharmacology & Pharmacy
Q2 Biochemistry & Molecular Biology
Medicine, Research & Experimental
Journal of Fungi 4.7 Q2 Mycology
Microbiology
Viruses 4.7 Q2 Virology
Bioengineering 4.6 Q2 Engineering, Biomedical
Gels 4.6 Q1 Polymer Science
Molecules 4.6 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Pharmaceuticals 4.6 Q2 Pharmacology & Pharmacy
Chemistry, Medicinal
Toxics 4.6 Q1 Toxicology
Q2 Environmental Sciences
Biomimetics 4.5 Q1 Engineering, Multidisciplinary
Q2 Materials Science, Biomaterials
Microorganisms 4.5 Q2 Microbiology
Plants 4.5 Q1 Plant Sciences
Biology 4.2 Q2 Biology
Chemosensors 4.2 Q2 Instruments & Instrumentation
Chemistry, Analytical
Electrochemistry
Membranes 4.2 Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Polymer Science
Toxins 4.2 Q1 Toxicology
Q2 Food Science & Technology
Metabolites 4.2 Q2 Biochemistry & Molecular Biology
Batteries 4.0 Q2 Electrochemistry
Materials Science, Multidisciplinary
Q3 Energy & Fuels
Catalysts 3.9 Q2 Chemistry, Physical
Journal of Clinical Medicine 3.9 Q2 Medicine, General & Internal
Land 3.9 Q2 Environmental Studies
Sensors 3.9 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Sustainability 3.9 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Green & Sustainable Science & Technology (SSCI)
Buildings 3.8 Q2 Construction & Building Technology
Engineering, Civil
Agronomy 3.7 Q1 Agronomy
Q2 Plant Sciences
Fermentation 3.7 Q2 Biotechnology & Applied Microbiology
Pathogens 3.7 Q2 Microbiology
Agriculture 3.6 Q1 Agronomy
Diagnostics 3.6 Q2 Medicine, General & Internal
Genes 3.5 Q2 Genetics & Heredity
Journal of Intelligence 3.5 Q2 Psychology, Multidisciplinary
Lubricants 3.5 Q2 Engineering, Mechanical
Processes 3.5 Q2 Engineering, Chemical
Coatings 3.4 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
ISPRS International Journal of Geo-Information 3.4 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Materials 3.4 Q2 Metallurgy & Metallurgical Engineering
Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Micromachines 3.4 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Water 3.4 Q2 Water Resources
Environmental Sciences
Brain Sciences 3.3 Q3 Neurosciences
Energies 3.2 Q3 Energy & Fuels
Fire 3.2 Q1 Forestry
Q2 Ecology
Life 3.2 Q2 Biology
Current Issues in Molecular Biology 3.1 Q3 Biochemistry & Molecular Biology
Horticulturae 3.1 Q1 Horticulture
Animals 3.0 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Insects 3.0 Q1 Entomology
Atmosphere 2.9 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Electronics 2.9 Q2 Engineering, Electrical & Electronic
Physics, Applied
Q3 Computer Science, Information Systems
Forests 2.9 Q1 Forestry
Inorganics 2.9 Q2 Chemistry, Inorganic & Nuclear
Journal of Marine Science and Engineering 2.9 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Metals 2.9 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Tropical Medicine and Infectious Disease 2.9 Q2 Tropical Medicine
Parasitology
Q3 Infectious Diseases
Universe 2.9 Q2 Astronomy & Astrophysics
Physics, Particles & Fields
Healthcare 2.8 Q2 Health Policy & Services (SSCI)
Q3 Health Care Sciences & Services (SCIE)
Applied Sciences 2.7 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Crystals 2.7 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Entropy 2.7 Q2 Physics, Multidisciplinary
Magnetochemistry 2.7 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Symmetry 2.7 Q2 Multidisciplinary Sciences
Actuators 2.6 Q2 Instruments & Instrumentation
Engineering, Mechanical
Aerospace 2.6 Q1 Engineering, Aerospace
Behavioral Sciences 2.6 Q2 Psychology, Multidisciplinary
Current Oncology 2.6 Q3 Oncology
Machines 2.6 Q2 Engineering, Mechanical
Q3 Engineering, Electrical & Electronic
Medicina 2.6 Q3 Medicine, General & Internal
Separations 2.6 Q3 Chemistry, Analytical
Minerals 2.5 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Children 2.4 Q2 Pediatrics
Diversity 2.4 Q2 Biodiversity Conservation
Q3 Ecology
Journal of Cardiovascular Development and Disease 2.4 Q3 Cardiac & Cardiovascular Systems
Mathematics 2.4 Q1 Mathematics
Photonics 2.4 Q3 Optics
Veterinary Sciences 2.4 Q1 Veterinary Sciences
Fishes 2.3 Q2 Marine & Freshwater Biology
Fisheries
Axioms 2.0 Q2 Mathematics, Applied
Systems 1.9 Q2 Social Sciences, Interdisciplinary
Tomography 1.9 Q3 Radiology, Nuclear Medicine & Medical Imaging


Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2023)

 

15 June 2023
Pharmaceutics Receives an Increased CiteScore of 6.9


We are pleased to inform you that Pharmaceutics (ISSN: 1999-4923) has received an updated CiteScore of 6.9. The 2022 CiteScore™ was released recently, making an assessment of the scientific influence of journals in the 2019 to 2022 period. Pharmaceutics’ CiteScore ranks Q1 (41 out of 171) in the "Pharmaceutical Science" category.

For more journal statistics, please visit https://www.mdpi.com/journal/pharmaceutics/stats.

Excellent performance is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We would like to take this opportunity to thank all of you who have contributed to the journal.

25 May 2023
Meet Us at the 7th Scientific Meeting of Ph.D. Students (JPhD2023), 7–9 June 2023, Barcelona, Spain
 


MDPI will be presenting at the 7th Scientific Meeting of Ph.D. Students at the UAB campus (JPhD2023). The event will be held at the Sala d'Actes Institut de Ciència de Materials de Barcelona in Barcelona, Spain, from 7 to 9 June 2023.

JPhD2023 aims to facilitate the exchange of knowledge about scientific research from different fields, sharing of research works and communication among the Ph.D. students of the BNC-b in an academic and scientific environment.

MDPI Speaker

Dr. Gabriel Martínez Edo

Dr. Gabriel Martínez Edo
Presentation theme: MDPI Open Access & Peer Review Process 

Dr. Gabriel Martínez Edo holds a bachelor’s degree in chemistry (2013) and a master’s degree in pharmaceutical chemistry (2015) from the IQS school of Engineering, Universitat Ramon Llull (Barcelona, Spain). He completed his Ph.D. (2020) in chemistry and chemical engineering at the same institution focusing on the use of nanomaterials as drug delivery systems.

He joined MDPI in June 2020 as Assistant Editor and Section Managing Editor for the journal Nanomaterials. In 2021, he was appointed Managing Editor of the journal Nanomanufacturing, a position he held until his recent appointment as Journal Relations Specialist.  

If you are also attending this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://jphd.icmab.es/.

Relevant Journals:

 

15 May 2023
Topics Webinar | Pharmacology and Toxicology of Amphetamine Type Stimulants, Held on 16 June 2023


On 16 June 2023, MDPI and the journal Future Pharmacology (ISSN: 2673-9879) organized a webinar Pharmacology and Toxicology of Amphetamine Type Stimulants.

Message from Prof. Dr. João Paulo Capela, the webinar Chair:

Thank you for participating in this webinar Pharmacology and Toxicology of Amphetamine Type Stimulants, which is associated with the journal Future Pharmacology. I would like to thank the MDPI team that made this webinar possible.

Dr. Marco Niello gave a presentation titled “SERT Releasing Agents: Making Use of Enantioselective Pharmacology”. Prof. Dr. Nicola Simola delivered a presentation titled “Influence of the Administration Setting, Age and Sex on the Neuroinflammatory and Neurotoxic Effects of MDMA”. Finally, Prof. Dr. João Paulo Capela presented “Cell Culture and Animal Studies Regarding “Ecstasy”, Amphetamine, and Methylphenidate Toxicity”.

The story of amphetamine-type stimulants had its vicissitudes, and we do not know how this “love and hate” story will endure. Certainly, the future will bring new answers, and we hope this webinar contributed to the knowledge in this field.

Please note that this webinar is associated with a Topic in the Future Pharmacology journal—“Pharmacology and Toxicology of Amphetamine Type Stimulants”. The deadline for submissions is 31 December 2023.

You can watch the recorder webinar at the following link: https://youtu.be/8zLhvXcjoBo.

Webinar Chair and Keynote Speakers:

  • Dr. João Paulo Capela, Faculty of Health Sciences, University Fernando Pessoa, Porto, Portugal;
  • Dr. Nicola Simola, University of Cagliari, Monserrato, Italy;
  • Marco Niello, Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.

13 March 2023
MDPI’s Newly Launched Journals in December 2022

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

Journal

Founding Editor-in-Chief

Journal Topics (Selected)

Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue

grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article

Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue

pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article

Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue

receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article

Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue

drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article

Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue

higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to newjournal-committee@mdpi.com.

7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

21 February 2023
Meet Us at the 143rd Annual Meeting of the Pharmaceutical Society of Japan, 25–28 March 2023, Sapporo, Japan


Conference: 143rd Annual Meeting of the Pharmaceutical Society of Japan
Date: 25–28 March 2023
Place: Sapporo, Japan

MDPI will be attending the 143rd Annual Meeting of the Pharmaceutical Society of Japan as the exhibitor. This meeting will be held at Hokkaido University, Sapporo, Japan, from 25 to 28 March 2023. The organizing committee comprises the Faculty of Pharmaceutical Sciences, Hokkaido University. The theme of the 143rd annual meeting is "PharmaScience: Integration for Breakthroughs". Through this meeting, we wish to contribute to the progress of research leading to the development of innovative drugs and therapies by bringing together researchers from various research fields.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://confit.atlas.jp/guide/event/pharm143/top.

16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

30 December 2022
Recruiting Editorial Board Members for Pharmaceutics


We are currently recruiting Editorial Board Members (EBMs) for Pharmaceutics (ISSN: 1999-4923). If you are interested in serving on the Editorial Board, or have potential candidates to recommend, please do not hesitate to contact the Editorial Office (pharmaceutics@mdpi.com).

The Editorial Board Members will be responsible for final decisions on manuscripts in their field of expertise, editing Special Issues, and they may be invited to review manuscripts.

The initial term is for 2 years, which entails:

  • Prescreening and making decisions on new submissions related to their research interests;
  • Setting up at least one Special Issue during their term on a topic related to their research interests (or supervising Special Issues related to their field of research);
  • Providing input or feedback regarding journal policies;
  • Helping to promote the journal among their peers or at conferences;
  • Attending board meetings to suggest journal development strategies;
  • Reviewing manuscripts.

Pharmaceutics is a peer-reviewed, open access journal, published monthly online by MDPI, which covers topics such as pharmaceutical formulation, process development, drug delivery, pharmacokinetics, biopharmaceutics, pharmacogenetics, and interdisciplinary research involving, but not limited to, engineering, biomedical sciences, and cell biology. The aims and scope of the journal can be found on the following website: https://www.mdpi.com/journal/pharmaceutics/about. Pharmaceutics is abstracted and indexed by Scopus, SCIE, PubMed, Embase, PMC, NLM, and DOAJ. The impact factor of the journal is 6.525.

We look forward to hearing from you.

22 December 2022
Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

  • Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
  • Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
  • Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
  • Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

1 Million Infographic

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

12 December 2022
Editorial Board Members from Pharmaceutics Featured in the 2022 Highly Cited Researchers List Published by Clarivate

Recently, ClarivateTM revealed its 2022 list of Highly Cited Researchers™—Individuals at universities, research institutes and commercial organizations.

The scientists who were selected into this year’s list of Highly Cited Researchers have published highly cited papers in the 11-year period from January 2011 to December 2021, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. Based on Web of Science Citation data, 6,938 researchers from across the globe who have demonstrated a disproportionate level of significant and broad influence in their chosen field or fields over the last decade have been awarded Highly Cited Researcher 2022 designations. The list is truly global, spanning 69 countries or regions and spread across a diverse range of research sciences and social sciences.

According to statistics, 7 members of the Editorial Board of Pharmaceutics (ISSN: 1999-4923) have been selected into the list of Highly Cited Researchers of Clarivate in 2022. They are being recognized for their high-quality scientific research achievements and outstanding contributions to professional fields. Pharmaceutics journal office sincerely congratulates all elected Editorial Board Members and hopes that they continue to have an academically productive relationship with the journal.

Name

Affiliation

Dr. David Andes

University of Wisconsin Madison, United States

Prof. Dr. Simon Gaisford

University College London, United Kingdom

Dr. Huile Gao

Sichuan University, China

Prof. Dr. Justin Hanes

Johns Hopkins University, United States

Prof. Dr. Fabian Kiessling

RWTH Aachen University, Germany

Prof. Dr. Veronique Preat

Universite Catholique Louvain, Belgium

Prof. Dr. Werner Weitschies

Ernst Moritz Arndt Universitat Greifswald, Germany

8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

2 December 2022
Editorial Board Members from Pharmaceutics Featured among the World’s Top 2% Scientists in 2022

Scientists at Stanford University have recently published an update of the list of the top 2% most widely cited scientists—the World’s Top 2% Scientists.

The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: “Lifetime Scientific Influence Ranking” and “2022 Annual Scientific Influence Ranking”. The “Lifetime Scientific Influence Ranking” counts the comprehensive influence performance of scientists during their careers, and the “2022 Annual Influence Ranking” focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account.

We are pleased to share that 183 Editorial Board Members from Pharmaceutics (ISSN: 1999-4923) were featured in the World’s Top 2% Scientists list in 2022.

Name

Affiliation

Prof. Dr. Alain Hedoux

Université de Lille, France

Dr. Alexandra R. Fernandes

Universidade NOVA de Lisboa, Portugal

Prof. Dr. Alf Lamprecht

University of Bonn, Germany

Prof. Dr. Alicia Rodríguez-Gascón

University of the Basque Country UPV/EHU, Spain

Prof. Dr. Amílcar Falcão

University of Coimbra, Portugal

Dr. Amirali Popat

The University of Queensland, Australia

Prof. Dr. Andrea Cappelli

Università degli Studi di Siena, Italy

Dr. Andrea Erxleben

National University of Ireland, Ireland

Prof. Dr. Andrea Gazzaniga

Pharmaceutical Technology & Regulatory Affairs “M.E.Sangalli” Unit, Italy

Prof. Dr. Anette Müllertz

University of Copenhagen, Denmark

Prof. Dr. Angel Concheiro

Universidade de Santiago de Compostela, Spain

Prof. Dr. Anna Angela Barba

University of Salerno, USA

Prof. Dr. Anna Maria Fadda

University of Cagliari, Italy

Prof. Dr. Anna Rita Bilia

University of Florence, Italy

Prof. Dr. Anne Marie Healy

The University of Dublin, Ireland

Prof. Dr. Antonello A. Barresi

Politecnico di Torino, Italy

Dr. Armin Mooranian

Curtin University, Australia

Prof. Dr. Arto Urtti

University of Helsinki, Finland

Prof. Dr. Barbara R. Conway

University of Huddersfield, UK

Prof. Dr. Ben J. Boyd

Monash University, Australia

Prof. Dr. Bernd Meibohm

University of Tennessee Health Science Center, USA

Dr. Bhagwat Prasad

Washington State University (WSU), USA

Prof. Dr. Blanka Říhová

Institute of Microbiology of the Czech Academy of Sciences, Czech Republic

Prof. Dr. Bruno Sarmento

Universidade do Porto, Portugal

Prof. Dr. Camilla Foged

University of Copenhagen, Denmark

Prof. Dr. Carlotta Marianecci

Sapienza University of Rome, Italy

Prof. Dr. Carmen Remuñán-López

Universidade de Santiago de Compostela-Campus Vida, Spain

Prof. Dr. Carsten Ehrhardt

Trinity College Dublin, Ireland

Prof. Dr. Chantal Pichon

Center for Molecular Biophysics (CBM, UPR 4301), France

Prof. Dr. Chaoliang He

Chinese Academy of Sciences, China

Dr. Christine Dufès

University of Strathclyde, UK

Prof. Dr. Chun Wang

University of Minnesota, USA

Dr. Conroy Sun

Oregon Health & Science University, USA

Prof. Dr. Costas Demetzos

National and Kapodistrian University of Athens, Greece

Prof. Dr. Dan Peer

Tel Aviv University, Israel

Dr. Diganta B. Das

Loughborough University, UK

Prof. Dr. Dimitrios A. Lamprou

Queen's University Belfast, UK

Prof. Dr. Dimitrios G. Fatouros

Aristotle University of Thessaloniki, Greece

Prof. Dr. Donatella Paolino

University Magna Graecia of Catanzaro, Italy

Dr. Donato Cosco

University “Magna Graecia” of Catanzaro, Italy

Prof. Dr. Dong Hee Na

Chung-Ang University, South Korea

Dr. Driton Vllasaliu

King’s College London, UK

Prof. Dr. Ecevit Bilgili

New Jersey Institute of Technology, USA

Dr. Elena V. Batrakova

University of North Carolina at Chapel Hill, USA

Prof. Dr. Elisabetta Gavini

University of Sassari, Italy

Prof. Dr. Elka Touitou

The Hebrew University of Jerusalem, Israel

Prof. Dr. Eun Seong Lee

The Catholic University of Korea, South Korea

Dr. Evelyne Jacqz-Aigrain

Université Paris Cité, France

Prof. Dr. Fabian Kiessling

RWTH Aachen University, Germany

Prof. Dr. Fabiana Quaglia

University of Napoli Federico II, Italy

Prof. Dr. Federico Pea

University of Bologna, Italy

Dr. Francesca Maestrelli

University of Florence, Italy

Prof. Dr. Francesca Ungaro

University of Napoli Federico II, Italy

Prof. Dr. Francesco Botrè

University of Lausanne, Switzerland

Prof. Dr. Francesco Grossi

University of Insubria, Italy

Prof. Dr. Francisco M. Goycoolea

University of Leeds, UK

Prof. Dr. Franco Dosio

University of Torino, Italy

Prof. Dr. Frank Wuest

University of Alberta, Canada

Dr. Gareth R. Williams

University College London, UK

Prof. Dr. Gavin Walker

University of Limerick, Ireland

Prof. Dr. Gayong Shim

Soongsil University, South Korea

Prof. Dr. Gert Fricker

University of Heidelberg, Germany

Prof. Dr. Gianfranco Pasut

University of Padova via F. Marzolo 5, Italy

Dr. Giovanna Rassu

University of Sassari, Italy

Prof. Dr. Giovanni Tosi

University of Modena and Reggio Emilia, Italy

Dr. Giulia Bonacucina

University of Camerino, Italy

Prof. Dr. Glen S. Kwon

University of Wisconsin, USA

Prof. Dr. Göran Alderborn

Uppsala University, Sweden

Prof. Dr. Guy Van den Mooter

University of Leuven, Belgium

Dr. Hani Al-Salami

Curtin University, Australia

Prof. Dr. Hans Lennernäs

Uppsala University, Sweden

Prof. Dr. Heike Bunjes

Technische Universität Braunschweig, Germany

Prof. Dr. Heiko Heerklotz

University of Toronto, Germany

Dr. Helena Tomás

University of Madeira, Portugal

Prof. Dr. Hirofumi Takeuchi

Gifu Pharmaceutical University, Japan

Prof. Dr. Holger Grohganz

University of Copenhagen, Denmark

Dr. Huile Gao

Sichuan University, China

Prof. Dr. Hwankyu Lee

Dankook University, South Korea

Prof. Dr. Hyuk Sang Yoo

Kangwon National University, South Korea

Prof. Dr. Inge S. Zuhorn

University Medical Center Groningen, the Netherlands

Prof. Dr. Isabel Izquierdo-Barba

Universidad Complutense de Madrid, Spain

Prof. Dr. Jae Hyung Park

Sungkyunkwan University, South Korea

Prof. Dr. James J. Moon

University of Michigan, USA

Prof. Dr. Jeff W.M. Bulte

Johns Hopkins University School of Medicine, USA

Prof. Dr. Jianqing Gao

Zhejiang University, China

Prof. Dr. Johanna Weiss

University Hospital Heidelberg, Germany

Dr. José das Neves

University of Porto, Portugal

Prof. Dr. José Luis Pedraz

University of the Basque Country (UPV/EHU), Spain

Prof. Dr. Joseph Kost

Ben-Gurion University of the Negev, Israel

Prof. Dr. Jukka Rantanen

University of Copenhagen, Denmark

Prof. Dr. Jung Hwan Park

Gachon University, South Korea

Prof. Dr. Justin Hanes

Johns Hopkins University School of Medicine, USA

Prof. Dr. Kah Hay Yuen

Universiti Sains Malaysia, Malaysia

Prof. Dr. Karsten Mäder

Martin Luther University Halle-Wittenberg, Germany

Dr. Katerina Gurova

Roswell Park Comprehensive Cancer Center, USA

Prof. Dr. Kathryn J. Steadman

University of Queensland, Australia

Prof. Dr. Kevin Ita

Touro University, USA

Dr. Ki Young Choi

University of Science and Technology (UST), South Korea

Dr. Kohsaku Kawakami

International Center for Materials Nanoarchitectonics, Japan

Prof. Dr. Konstantinos Avgoustakis

University of Patras, Greece

Prof. Dr. Korbinian Löbmann

University of Copenhagen, Denmark

Prof. Dr. Kousei Ito

Chiba University, Japan

Prof. Dr. Kyriakos Kachrimanis

Aristotle University of Thessaloniki, Greece

Prof. Dr. Kyung Taek Oh

Chung-Ang University, South Korea

Dr. Leena Peltonen

University of Helsinki, Finland

Dr. Lucio Barile

Cardiocentro Ticino Foundation, Switzerland

Prof. Dr. Luigi Battaglia

Università degli Studi di Torino, Italy

Prof. Dr. Luisa Coderch

Catalonia Advanced Chemistry Institute (IQAC-CSIC), Spain

Dr. M. Begoña Delgado-Charro

University of Bath, UK

Prof. Dr. Makoto Otsuka

Shizuoka University, Japan

Prof. Dr. Marc Schneider

Universität des Saarlandes, Germany

Prof. Dr. Maria Nowakowska

Jagielllonian University, Poland

Dr. Maria Vertzoni

National and Kapodistrian University of Athens, Greece

Dr. Marie Alexandrine Bolzinger

Université Claude Bernard Lyon 1, France

Prof. Dr. Marilyn E. Morris

The State University of New York, USA

Prof. Dr. Marina Gallarate

University of Torino, Italy

Prof. Dr. Marival Bermejo

Miguel Hernandez University, Spain

Prof. Dr. Mark R. Prausnitz

Georgia Institute of Technology, USA

Prof. Dr. Martin Brandl

University of Southern, Denmark

Dr. Mine Orlu

University College London, UK

Prof. Dr. Neal M. Davies

University of Alberta, USA

Prof. Dr. Nicolas Anton

University of Strasbourg, France

Dr. Nunzio Denora

University of Bari “Aldo Moro”, Italy

Dr. Oliver Langer

Medical University of Vienna, Australia

Prof. Dr. Paola Mura

Florence University, Italy

Prof. Dr. Paolo Blasi

University of Bologna, Italy

Prof. Dr. Paolo Giunchedi

University of Sassari, Italy

Prof. Dr. Paolo Lanzetta

University of Udine, Italy

Prof. Dr. Per Artursson

Uppsala University, Sweden

Dr. Peter Boyd

Queen’s University Belfast, UK

Prof. Dr. Peter Timmins

University of Huddersfield, UK

Prof. Dr. Peter W. Swaan

University of Maryland, USA

Prof. Dr. Pietro Matricardi

“Sapienza” University of Rome, Italy

Prof. Dr. Piroska Szabó-Révész

University of Szeged, Hungary

Dr. Qingcheng Mao

University of Washington, USA

Prof. Dr. Raimar Löbenberg

University of Alberta, Canada

Prof. Dr. Roberta Cavalli

Università di Torino, Italy

Dr. Roberta Censi

University of Camerino, Italy

Prof. Dr. Roger Schibli

ETH Zurich & Paul Scherrer Institute, Switzerland

Prof. Dr. Rongqin Huang

Fudan University, China

Prof. Dr. Rosario Pignatello

Università di Catania, Italy

Prof. Dr. Ruggero Bettini

University of Parma, Italy

Prof. Dr. Sangkyu Lee

Kyungpook National University, South Korea

Prof. Dr. Sanjay Garg

University of South Australia, Australia

Prof. Dr. Shigeru Kawakami

Nagasaki University, Japan

Prof. Dr. Silvia Rossi

University of Pavia, Italy

Prof. Dr. Simon Gaisford

University College London, UK

Prof. Dr. Sophia G. Antimisiaris

University of Patras, Greece

Prof. Dr. Tal Dvir

Tel Aviv University, Israel

Dr. Tatsuaki Tagami

Nagoya City University, Japan

Prof. Dr. Teresa Musumeci

University of Catania, Italy

Prof. Dr. Thomas Rades

University of Copenhagen, Denmark

Prof. Dr. Thorsteinn Loftsson

University of Iceland, Iceland

Dr. Tihomir Tomašič

University of Ljubljana, Slovenia

Prof. Dr. Uday B. Kompella

University of Colorado, USA

Prof. Dr. Vitaliy V. Khutoryanskiy

University of Reading, UK

Prof. Dr. Waldemar Debinski

Wake Forest University School of Medicine, USA

Dr. Waseem Kaialy

University of Wolverhampton, UK

Dr. Wei He

China Pharmaceutical University, China

Prof. Dr. Wei Lu

Fudan University, China

Prof. Dr. Wei Wu

Fudan University, China

Prof. Dr. Wenbing Dai

Peking University, China

Prof. Dr. Werner Weitschies

University of Greifswald, Germany

Prof. Dr. Wojciech Leppert

Poznan University of Medical Sciences, Poland

Prof. Dr. Wolfgang Löscher

University of Veterinary Medicine, Germany

Prof. Dr. Xavier Fernàndez-Busquets

Barcelona Institute for Global Health (ISGlobal) and Institute for Bioengineering of Catalonia (IBEC), Spain

Prof. Dr. Xiangyang Shi

Donghua University, China

Dr. Xiaowei Zeng

Sun Yat-sen University, China

Prof. Dr. Xiaoyan Chen

Chinese Academy of Sciences, China

Prof. Dr. Xiaoyong Wang

Nanjing University, China

Prof. Dr. Yogeshvar N. Kalia

University of Geneva & University of Lausanne, Switzerland

Prof. Dr. Yoshiyuki Hattori

Hoshi University, Japan

Prof. Dr. Young Jik Kwon

University of California, USA

Prof. Dr. Yu Seok Youn

Sungkyunkwan University, South Korea

Prof. Dr. Yuan Huang

Sichuan University, China

Dr. Yuki Takahashi

Kyoto University, Japan

Prof. Dr. Yunjin Jung

Pusan National University, South Korea

Dr. Yunlu Dai

University of Macau, China

Dr. Yusuke Sato

Hokkaido University, Japan

Prof. Dr. Yvonne Perrie

University of Strathclyde, UK

Prof. Dr. Zeeshan Ahmad

De Montfort University, UK

Dr. Zhenjia Wang

Washington State University, USA

Dr. Zhiqing Pang

Fudan University, China

The latest rankings reflect the significant influence and research excellence of the scientists, who are committed to furthering their knowledge for the benefit of the world.

We would like to congratulate our Editorial Board Members on their excellent achievement and thank them for their immense contribution to the scientific progression and development of Pharmaceutics.

20 October 2022
Meet Us at the 20th International Congress for Tropical Medicine and Malaria (ICTMM2020), 24–28 October 2022, Bangkok, Thailand


Conference: The 20th International Congress for Tropical Medicine and Malaria (ICTMM2020)
Date: 24–28 October 2022
Place: Bangkok, Thailand
Booth: B02

MDPI will be attending the 20th International Congress for Tropical Medicine and Malaria (ICTMM2020) from 24 to 28 October 2022 in Bangkok, Thailand.

The ICTMM is one of the largest tropical-medicine conferences in the world, gathering more than 2,000 scientists, researchers, and experts every four years. It offers an excellent opportunity for delegates to exchange knowledge on tropical medicine with people from all over the world who share the same research interests. The congress will cover topics and updates on tropical medicine, malaria, infectious diseases, neglected diseases, drug resistance, parasitology, zoonoses, and travel medicine, to name just a few.

The following MDPI journals will be represented:

Please do not hesitate to reach out (tropicalmed@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://ictmm2020.org/.

28 September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

17 August 2022
Meet Us at the Chinese Chemical Society Chirality China 2021 (2022) Symposium, 26–28 August 2022, Guangzhou, China


A range of MDPI journals will be attending the Chinese Chemical Society Chirality China 2021 (2022) Symposium as exhibitors. This meeting will be held in Guangzhou, China, from 26 to 28 August 2022.

The conference theme: “Chiral Science Makes Life Better”.

The conference focuses on the following areas:

  • New methods, new concepts, and new strategies for chiral synthesis;
  • Mechanisms and laws of chiral amplification;
  • Mechanism of interaction between chiral molecules and biological macromolecules;
  • Structural and functional relationship of chiral substances;
  • Synthetic technology for the production of chiral medicines and pesticides.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the link https://www.chemsoc.org.cn/meeting/CC2021/, or contact the Pharmaceuticals Editorial Office at pharmaceuticals@mdpi.com.

16 August 2022
Pharmaceutics | Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program.

This program intends to provide an opportunity for early career scientists to enhance their editing, networking, and organizational skills and to work closely with our journal to gain more editorial experience. Early career scientists who have novel ideas for new Pharmaceutics Special Issues will act as Guest Editors under the mentorship of an experienced scientist; this mentor could be a member of the Editorial Board of Pharmaceutics (ISSN: 1999-4923), from other well-established research institutes or laboratories, etc.

The mentee’s responsibilities include:

  • Providing a CV, including a list of publications;
  • Proposing a Special Issue title and a short introduction;
  • Writing a brief promotion plan for the Special Issue;
  • Writing an editorial for the online Special Issue;
  • Reviewing and making decisions for submissions under the mentorship of our Editorial Board Members.

Mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Co-editing the Special Issue with younger scholars and performing quality control of the publications in the Special Issue;
  • Providing suggestions to younger scholars if they have doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the office regularly to discuss problems and improvement suggestions for the Special Issue.

Certificates and awards:

When the Special Issue is closed, the Editorial Office will provide official certificates for all the mentors. The younger scholars will be prioritized as candidates for the Pharmaceutics Young Investigator Award in future editions.

If you are interested in this opportunity, please send your Special Issue proposal to the Pharmaceutics Editorial Office (pharmaceutics@mdpi.com), and we will discuss the process (mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.

In addition to the new Special Issue Mentor Program, Pharmaceutics continues to welcome all Special Issue proposals based on hot research topics as usual.

Pharmaceutics Editorial Office

20 July 2022
Meet Us at the 49th World Polymers Congress MACRO 2022, 17–21 July 2022, Winnipeg, Canada


Conference: 49th World Polymers Congress MACRO 2022
Date: 17–21 July 2022
Place: Winnipeg, Canada
Booth: #6

Polymers (ISSN: 2073-4360) and Materials (ISSN: 1996-1944) will be attending the 49th World Polymers Congress MACRO 2022 as exhibitors from 17 to 21 July 2022 in Winnipeg, Canada.

The year 2022 marks the first time that Canada is hosting the World Polymers Congress since it became a biennial event in 1998. The polymer science community of Canada looks forward to connecting at the 49th World Polymers Congress, which is held in the city of Winnipeg from 17 to 21 July 2022. True to its mission, MACRO 2022 will be a forum for international scientists and students who are in various stages of their career development to share knowledge and experiences.

The MACRO 2022 program comprises nine themes that represent the following subjects:

  • Polymers for Biomedical Engineering;
  • Polymers for Energy and Environmental Applications;
  • Polymer Engineering and Rheology;
  • Polymers for Nanotechnology;
  • Polymer Physics and Characterization;
  • Polymers from Renewable Resources and Biodegradable Polymers;
  • Polymer Science Education;
  • Polymer Synthesis and Kinetics;
  • Smart and Functional Polymers.

The following MDPI journals will be represented:

  • Polymers;
  • Materials;
  • Membranes;
  • Pharmaceutics;
  • Sustainability;
  • Bioengineering;
  • Gels;
  • Electrochem;
  • Solar.

Please do not hesitate to reach out if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://www.macro2022.org/.

28 June 2022
2021 Impact Factors - Released

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

Journal Impact Factor Rank Category
Antioxidants 7.675 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 7.666 Q2 Cell Biology
Nutrients 6.706 Q1 Nutrition & Dietetics
Cancers 6.575 Q1 Oncology
Pharmaceutics 6.525 Q1 Pharmacology & Pharmacy
International Journal of Molecular Sciences 6.208 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Marine Drugs 6.085 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Biomolecules 6.064 Q2 Biochemistry & Molecular Biology
Batteries * 5.938 Q2 Electrochemistry
Energy & Fuels
Materials Science, Multidisciplinary
Viruses 5.818 Q2 Virology
Biosensors 5.743 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Journal of Fungi 5.724 Q1 Mycology
Q2 Microbiology
Nanomaterials 5.719 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Metabolites 5.581 Q2 Biochemistry & Molecular Biology
Foods 5.561 Q1 Food Science & Technology
Drones * 5.532 Q2 Remote Sensing
Remote Sensing 5.349 Q1 Geosciences, Multidisciplinary
Imaging Science & Photographic Technology
Q2 Remote Sensing
Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research 5.318 Q2 Business
Antibiotics 5.222 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Pharmaceuticals 5.215 Q1 Pharmacology & Pharmacy
Q2 Chemistry, Medicinal
Biology 5.168 Q1 Biology
Fermentation 5.123 Q2 Biotechnology & Applied Microbiology
Toxins 5.075 Q1 Toxicology
Q2 Food Science & Technology
Bioengineering * 5.046 Q2 Engineering, Biomedical
Polymers 4.967 Q1 Polymer Science
Journal of Clinical Medicine 4.964 Q2 Medicine, General & Internal
Vaccines 4.961 Q2 Immunology
Medicine, Research & Experimental
Molecules 4.927 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Microorganisms 4.926 Q2 Microbiology
Journal of Functional Biomaterials * 4.901 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.757 Q2 Medicine, Research & Experimental
Pharmacology & Pharmacy
Biochemistry & Molecular Biology
Plants 4.658 Q1 Plant Sciences
International Journal of Environmental Research and Public Health 4.614 Q1 Public, Environmental & Occupational Health (SSCI)
Q2 Public, Environmental & Occupational Health (SCIE)
Environmental Sciences (SCIE)
Membranes 4.562 Q1 Polymer Science
Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Pathogens 4.531 Q2 Microbiology
Catalysts 4.501 Q2 Chemistry, Physical
Toxics 4.472 Q2 Toxicology
Environmental Sciences
Gels 4.432 Q1 Polymer Science
Journal of Cardiovascular Development and Disease 4.415 Q2 Cardiac & Cardiovascular Systems
Chemosensors 4.229 Q1 Instruments & Instrumentation
Q2 Chemistry, Analytical
Q3 Electrochemistry
Genes 4.141 Q2 Genetics & Heredity
Diagnostics 3.992 Q2 Medicine, General & Internal
Agronomy 3.949 Q1 Agronomy
Plant Sciences
Land 3.905 Q2 Environmental Studies
Sustainability 3.889 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Q4 Green & Sustainable Science & Technology (SSCI)
Sensors 3.847 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Materials 3.748 Q1 Metallurgy & Metallurgical Engineering
Q2 Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Biomimetics * 3.743 Q2 Engineering, Multidisciplinary
Q3 Materials Science, Biomaterials
Tropical Medicine and Infectious Disease * 3.711 Q1 Tropical Medicine
Q2 Parasitology
Q3 Infectious Diseases
Lubricants * 3.584 Q2 Engineering, Mechanical
Fractal and Fractional 3.577 Q1 Mathematics, Interdisciplinary Applications
Water 3.530 Q2 Water Resources
Q3 Environmental Sciences
Micromachines 3.523 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Journal of Personalized Medicine 3.508 Q2 Medicine, General & Internal
Health Care Sciences & Services
Agriculture 3.408 Q1 Agronomy
Processes 3.352 Q2 Engineering, Chemical
Separations 3.344 Q2 Chemistry, Analytical
Magnetochemistry 3.336 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Brain Sciences 3.333 Q3 Neurosciences
Buildings 3.324 Q2 Construction & Building Technology
Engineering, Civil
Forests 3.282 Q1 Forestry
Energies 3.252 Q3 Energy & Fuels
Life 3.251 Q2 Biology
Coatings 3.236 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
Animals 3.231 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Journal of Intelligence * 3.176 Q2 Psychology, Multidisciplinary
Fishes 3.170 Q1 Marine & Freshwater Biology
Q2 Fisheries
Healthcare 3.160 Q2 Health Policy & Services (SSCI)
Health Care Sciences & Services (SCIE)
Inorganics * 3.149 Q2 Chemistry, Inorganic & Nuclear
Insects 3.139 Q1 Entomology
Atmosphere 3.110 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Current Oncology 3.109 Q3 Oncology
ISPRS International Journal of Geo-Information 3.099 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Diversity 3.029 Q2 Biodiversity Conservation
Ecology
Tomography 3.000 Q3 Radiology, Nuclear Medicine & Medical Imaging
Current Issues in Molecular Biology 2.976 Q3 Biochemistry & Molecular Biology
Medicina 2.948 Q3 Medicine, General & Internal
Symmetry 2.940 Q2 Multidisciplinary Sciences
Horticulturae 2.923 Q1 Horticulture
Machines 2.899 Q2 Engineering, Mechanical
Engineering, Electrical & Electronic
Systems * 2.895 Q2 Social Sciences, Interdisciplinary
Applied Sciences 2.838 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Children 2.835 Q2 Pediatrics
Minerals 2.818 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Universe 2.813 Q2 Astronomy & Astrophysics
Q3 Physics, Particles & Fields
Journal of Marine Science and Engineering 2.744 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Entropy 2.738 Q2 Physics, Multidisciplinary
Fire * 2.726 Q2 Forestry
Q3 Ecology
Metals 2.695 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Electronics 2.690 Q3 Engineering, Electrical & Electronic
Computer Science, Information Systems
Physics, Applied
Crystals 2.670 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Aerospace 2.660 Q1 Engineering, Aerospace
Mathematics 2.592 Q1 Mathematics
Photonics 2.536 Q3 Optics
Actuators 2.523 Q2 Instruments & Instrumentation
Q3 Engineering, Mechanical
Veterinary Sciences 2.518 Q2 Veterinary Sciences
Behavioral Sciences * 2.286 Q3 Psychology, Multidisciplinary
Axioms * 1.824 Q2 Mathematics, Applied

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

 

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2022)

 

20 June 2022
MDPI’s 2021 Young Investigator Awards in “Medicine & Pharmacology”—Winners Announced

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

  • Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
  • Mateusz Maciejczyk, Medical University of Bialystok, Poland

Current Oncology:

  • Matteo Lambertini, University of Genova, Italy

Dentistry Journal:

  • Helen Rogers, Newcastle University, UK

Healthcare:

  • Amir Karami, University of South Carolina, USA

Journal of Clinical Medicine:

  • Andrea Palermo, Campus Bio-Medico University, Italy

Journal of Personalized Medicine:

  • Simone Di Franco, University of Palermo, Italy
  • Catriona Hippman, University of Calgary, Canada

Medicina:

  • Veeru Kasivisvanathan, University College London, UK
  • Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy

Pharmaceutics:

  • Qi Zhou, Purdue University, USA

20 June 2022
MDPI’s 2021 Travel Awards in “Medicine & Pharmacology”—Winners Announced

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Biomedicines:

  • Soheil Saeedi, University of Zurich, Switzerland

Dentistry Journal:

  • Shawn Alexander Hallett, University of Michigan, USA

Medicines:

  • Claire Albert, Yale University, USA

Pharmaceuticals:

  • Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
  • Patrick Jim Küppers, University Hospital Bonn, Germany

20 June 2022
MDPI’s 2021 Outstanding Reviewer Awards in “Medicine & Pharmacology”—Winners Announced

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.

Cancers:

  • Antonio G. Solimando, University of Bari Aldo Moro, Italy
  • Chenghui Li, University of Arkansas for Medical Sciences, USA
  • Joaquim Carreras, Tokai University, Japan
  • Pierfrancesco Franco, University of Turin School of Medicine, Italy
  • Laurentiu Pop, University of Texas Southwestern Medical Center, USA

Current Oncology:

  • Margaret Fitch, University of Toronto, Canada
  • Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada

Healthcare:

  • Naser Alsharairi, Griffith University, Australia
  • Peter W. Choate, Mount Royal University, Canada
  • Qin Xiang Ng, National University of Singapore, Singapore

Journal of Clinical Medicine:

  • Giulio Francesco, Sapienza University of Rome, Italy
  • Sebastian Schnaubelt, Medical University of Vienna, Austria
  • Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA

Journal of Personalized Medicine:

  • Onofrio Laselva, University of Foggia, Italy
  • Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
  • Vladimir Vladimirov, Virginia Commonwealth University, USA
  • Mauro Giuffrè, University of Trieste, Italy

Medical Sciences:

  • Erika Palmieri, National Cancer Institute at Frederick, USA

Tomography:

  • Anjul Khadria, California Institute of Technology, Pasadena, USA

20 June 2022
MDPI’s 2021 Best Paper Awards in “Medicine & Pharmacology”—Winners Announced

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm

Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055

by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado

Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045

Dentistry Journal:

by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky

Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029

by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin

Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115

Healthcare:

by Chantal Huisman and Helianthe Kort

Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031

by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal

Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037

Journal of Clinical Medicine:

by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy

Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135

by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya

Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025

by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal

Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019

Medicina:

by Borros Arneth

Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015

by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián

Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356

Pharmaceutics:

by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.

Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148

by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu

Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140

9 June 2022
2021 CiteScores - Released


The 2021 citation metrics have been officially released in Scopus!

We are pleased to announce that 182 MDPI journals are included, of which:

● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.

The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:

Journal

CiteScore

Quartile

Category

Non-coding RNA

10.1

Q1

Genetics

Journal of Functional Biomaterials

10.0

Q1

Biomedical Engineering

Marine Drugs

8.1

Q1

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Batteries

7.9

Q1

Electrical and Electronic Engineering

Nutrients

7.9

Q1

Nutrition and Dietetics

Remote Sensing

7.4

Q1

General Earth and Planetary Sciences

Drones

7.2

Q1

Computer Science Applications

International Journal of Molecular Sciences

6.9

Q1

Inorganic Chemistry

Journal of Sensor and Actuator Networks

6.9

Q1

Computer Networks and Communications

Cells

6.7

Q1

General Biochemistry, Genetics and Molecular Biology

Nanomaterials

6.6

Q1

General Chemical Engineering

Toxins

6.6

Q1

Health, Toxicology and Mutagenesis

Viruses

6.6

Q1

Infectious Diseases

Antioxidants

6.5

Q1

Food Science

Fibers

6.5

Q1

Civil and Structural Engineering

Resources

6.4

Q1

Nature and Landscape Conservation

Sensors

6.4

Q1

Instrumentation

Big Data and Cognitive Computing

6.1

Q1

Management Information Systems

Molecules

5.9

Q1

Chemistry (miscellaneous)

Polymers

5.7

Q1

Polymers and Plastics

Biosensors

5.6

Q1

Engineering (miscellaneous)

Catalysts

5.5

Q1

General Environmental Science

Smart Cities

5.5

Q1

Urban Studies

Future Internet

5.4

Q2

Computer Networks and Communications

Beverages

5.3

Q1

Food Science

Fermentation

5.3

Q1

Plant Science

Environments

5.2

Q1

Ecology, Evolution, Behavior and Systematics

Inventions

5.2

Q1

General Engineering

Journal of Open Innovation: Technology, Market, and Complexity

5.1

Q1

Development

Colloids and Interfaces

5.0

Q1

Chemistry (miscellaneous)

Energies

5.0

Q1

Control and Optimization

ISPRS International Journal of Geo-Information

5.0

Q1

Geography, Planning and Development

Sustainability

5.0

Q1

Geography, Planning and Development

Fire

4.9

Q1

Forestry

Robotics

4.9

Q1

Control and Optimization

Soil Systems

4.9

Q1

Soil Science

Geosciences

4.8

Q1

General Earth and Planetary Sciences

Journal of Manufacturing and Materials Processing

4.8

Q1

Mechanical Engineering

Tropical Medicine and Infectious Disease

4.8

Q1

Public Health, Environmental and Occupational Health

Water

4.8

Q1

Geography, Planning and Development

International Journal of Environmental Research and Public Health

4.5

Q1

Public Health, Environmental and Occupational Health

Sports

4.5

Q1

Physical Therapy, Sports Therapy and Rehabilitation

Entropy

4.4

Q1

Mathematical Physics

Journal of Clinical Medicine

4.4

Q1

General Medicine

Symmetry

4.3

Q1

General Mathematics

Cosmetics

4.2

Q1

Surgery

Foods

4.1

Q1

Health Professions (miscellaneous)

Journal of Fungi

4.1

Q1

Plant Science

ChemEngineering

4.0

Q1

General Engineering

Forests

4.0

Q1

Forestry

Journal of Intelligence

4.0

Q1

Education

Antibiotics

3.9

Q1

General Pharmacology, Toxicology and Pharmaceutics

Cryptography

3.9

Q1

Applied Mathematics

Behavioral Sciences

3.8

Q1

Development

Buildings

3.8

Q1

Architecture

Metals

3.8

Q1

Metals and Alloys

Publications

3.5

Q1

Communication

Social Sciences

3.4

Q1

General Social Sciences

Mathematics

2.9

Q1

General Mathematics

Fractal and Fractional

2.8

Q1

Analysis

Animals

2.7

Q1

General Veterinary

Axioms

2.6

Q1

Algebra and Number Theory

Heritage

1.8

Q1

Conservation

Religions

1.0

Q1

Religious Studies

Philosophies

0.9

Q1

Philosophy

Source: 2021 CiteScores™ (Elsevier)

1 June 2022
Recruiting Topical Advisory Panel Members for Pharmaceutics


We are currently recruiting Topical Advisory Panel Members for the journal Pharmaceutics (ISSN: 1999-4923). The main responsibility of Topical Advisory Panel Members is to regularly provide support to the Guest Editors and Section Board Members. The responsibilities of Topical Advisory Panel Members can be found on the following website: https://www.mdpi.com/editors

Pharmaceutics is a peer-reviewed, open access journal, published quarterly online by MDPI, which covers topics including pharmaceutical formulation, process development, drug delivery, pharmacokinetics, biopharmaceutics, pharmacogenetics, and interdisciplinary research involving, but not limited to, engineering, biomedical sciences, and cell biology. The aims and scope of the journal can be found on the following website: https://www.mdpi.com/journal/pharmaceutics/about.

To qualify as a Topical Advisory Panel Member, applicants must:

  • Have expertise and experience in a field related to the journal;
  • Have received a Ph.D. in approximately the last 10 years;
  • Have published at least 6 papers in the last 5 years, as a first author or corresponding author;
  • Currently hold an independent research position in academia or a government institute.

If you are interested in this position, please apply via the following link: https://www.mdpi.com/journal/pharmaceutics/topical_advisory_panel_application. Alternatively, please send an email to pharmaceutics@mdpi.com with your academic CV. We look forward to hearing from you.

24 December 2021
Meet Us Virtually at the 7th German Pharm-Tox Summit and the 88th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT)


Date: 7-10 March 2022
Websitehttps://www.gpts-kongress.de

On behalf of the scientific committee, we warmly welcome all participants of the 7th German Pharm-Tox-Summit which will be held online from 7 to 10 March 2022. As in previous years, the Pharm-Tox-Summit is organized as a joint conference of the member societies of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT), and also features an integrated Symposium of the Paul-Martini-Stiftung. 

The well-structured schedule program covers a wide variety of plenary lectures, symposia, short talks, advanced courses on up-to-date topics of basic and clinical pharmacology and toxicology as well as other special events. The central goal is the bridging between the three key topics implemented in the scientific program.

Join us and make the 7th German Pharm-Tox Summit an exciting event to foster existing and build up new scientific interactions, collaborations, and friendships.

22 November 2021
722 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction

It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

Abate, Antonio
Abatzoglou, John T.
Abbaszadeh, Mostafa
Acharya, U. Rajendra
Acharya, Viral V.
Agarwal, Ravi P.
Ahn, Myung-Ju
Airoldi, Laura
Ali, Imran
Allakhverdiev, Suleyman I.
Aluko, Rotimi E.
Anasori, Babak
Andersson, Dan I.
Andes, David
Anker, Stefan D.
Apergis, Nicholas
Ariga, Katsuhiko
Arqub, Omar Abu
Aschner, Michael
Assaraf, Yehuda G.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Atangana, Abdon
Bahram, Mohammad
Bakris, George L.
Balandin, Alexander A.
Baleanu, Dumitru
Balsamo, Gianpaolo
Bando, Yoshio
Banks, William A.
Bansal-Travers, Maansi
Barba, Francisco J.
Barros, Lillian
Basit, Abdul W.
Baskonus, Haci Mehmet
Bassetti, Matteo
Battino, Maurizio
Bell, Jordana T.
Bellomo, Nicola
Benediktsson, Jon Atli
Benelli, Giovanni
Benjakul, Soottawat
Bhatnagar, Amit
Biddle, Stuart J. H.
Biondi, Antonio
Biondi-Zoccai, Giuseppe
Bjarnsholt, Thomas
Blaabjerg, Frede
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boffetta, Paolo
Bogers, Marcel
Bonomo, Robert A.
Bowman, David M.J.S.
Boyer, Cyrille
Brestic, Marian
Brevik, Eric C.
Buhalis, Dimitrios
Burdick, Jason A.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cai, Jianchao
Calhoun, Vince D.
Calin, George
Cao, Jinde
Cao, Guozhong
Carvalho, Andre F.
Castellanos-Gomez, Andres
Cerqueira, Miguel Ângelo Parente Ribeiro
Chang, Jo-Shu
Chang, Chih-Hao
Chastin, Sebastien
Chau, Kwok-wing
Chemat, Farid
Chen, Xiaobo
Chen, YangQuan
Chen, Jianmin
Chen, Chaoji
Chen, Min
Chen, Qi
Chen, Jun
Chen, Xi
Chen, Peng
Chen, Yulin
Chen, Bo
Chen, Chen
Chen, Zhi-Gang
Chen, Wei-Hsin
Chen, Gang
Chen, Yongsheng
Chen, Xiang
Chen, Yimin
Chen, Runsheng
Chen, Lidong
Chen, Shaowei
Chen, Qian
Chen, Yu
Chen, Shuangming
Chiclana, Francisco
Cho, Sun Young
Choi, Wonyong
Chowdhary, Anuradha
Choyke, Peter L.
Cichocki, Andrzej
Corella, Dolores
Corma, Avelino
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Crommie, Michael F.
Cui, Yi
Cui, Haiying
Cui, Qinghua
Cummings, Kenneth Michael
Dai, Shifeng
Dai, Sheng
Daiber, Andreas
Davis, Steven J.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Decker, Eric Andrew
Dekel, Avishai
Demaria, Marco
Deng, Yong
Deng, Xiangzheng
DePinho, Ronald A.
Desneux, Nicolas
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Dionysiou, Dionysios D.
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Fan
Dou, Shi Xue
Dou, Letian
Du, Qian
Du, Bo
Dube, Shanta Rishi
Dufresne, Alain
Dummer, Reinhard
Dupont, Didier
Edwards, David
Elaissari, Abdelhamid
Elhoseny, Mohamed
Ellahi, Rahmat
Ellis, Erle C.
ElMasry, Gamal
Esteller, Manel
Estévez, Mario
Fabbro, Doriano
Facchetti, Antonio
Fan, Zhanxi
Fang, Chuanglin
Fasano, Alessio
Fečkan, Michal
Felser, Claudia
Feng, Liangzhu
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Ferreira, Isabel C. F. R.
Filippi, Massimo
Fisher, Helen
Fortino, Giancarlo
Fosso Wamba, Samuel
Franceschi, Claudio
Fujita, Hamido
Fujita, Masayuki
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gan, Lihua
Gandomi, Amir H.
Gao, Bin
Gao, Feng
Gao, Minrui
Gao, Huijun
Gao, Wei
Gao, Huile
Garbe, Claus
Garcia, Hermenegildo
Gasbarrini, Antonio
Gasco, Laura
Gautret, Philippe
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghadimi, Noradin
Ghaffari, Roozbeh
Ghamisi, Pedram
Giampieri, Francesca
Glick, Bernard R.
Gnant, Michael
Goel, Ajay
Gogotsi, Yury
Goldewijk, Kees Klein
Gong, Jinlong
Gong, Yongji
Govindan, Kannan
Granato, Daniel
Grancini, Giulia
Green, Douglas R.
Grosso, Giuseppe
Gu, Ke
Guan, Cao
Guastella, Adam J.
Guerrero, Josep M.
Gui, Guan
Guizani, Mohsen
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Habibi-Yangjeh, Aziz
Hagemann, Stefan
Hagger, Martin
Hamblin, Michael R.
Hammoudeh, Shawkat
Han, Heesup
Hanes, Justin
Harrison, Roy M.
Hartung, Hans-Peter
Hasanuzzaman, Mirza
He, Jr-Hau
He, Hongwen
He, Jiaqing
He, Debiao
Henseler, Jörg
Herrera, Francisco
Herrera-Viedma, Enrique
Hetz, Claudio
Ho Kim, Jung
Holmes, Elaine
Hossain, Ekram
Hsueh, Po-Ren
Hu, Xiaosong
Hu, Wenbin
Huang, Jianping
Huang, Hongwei
Huang, Yu
Huang, Jianying
Huang, Peng
Huang, Baibiao
Huang, Shaoming
Hubacek, Klaus

Iqbal, Hafiz M. N.
Ismail, Ahmad Fauzi
Izzo, Angelo A.
Jacobson, Kenneth A.
Jain, Atul
Jankovic, Joseph
Jelezko, Fedor
Ji, Xiaobo
Ji, Guangbin
Jiang, Hai-Long
Jiang, Lei
Jiang, Junjun
Jiang, Qing
Jiang, Shibo
Jin, Shi
Jones, Peter A.
Kalantar-zadeh, Kourosh
Kaner, Richard B.
Kannan, Kurunthachalam
Kappos, Ludwig
Karagiannidis, George K.
Karimi, Hamid Reza
Karimi-Maleh, Hassan
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Keesstra, Saskia
Kepp, Oliver
Keyzers, Robert A.
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kim, Ki-Hyun
Kim, Haegyeom
Kim, Jeonghun
Kim, Jong Seung
Kirkwood, John M.
Kisi, Ozgur
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Konopleva, Marina Y.
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kou, Gang
Krausmann, Fridolin
Krebs, Frederik C.
Kroemer, Guido
Kuca, Kamil
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Devendra
Kumar, Alan Prem
Kumar, Sudhir
Kumar Sangaiah, Arun
Kurths, Juergen
Kuznetsov, Nikolay V.
Kuzyakov, Yakov
Kwan, Mei-Po
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lam, James
Lammers, Twan
Lamuela-Raventos, Rosa M.
Lancellotti, Patrizio
Landi, Francesco
Laurent, Sophie
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Sang Soo
Lee, Jin-Wook
Lee, Pooi See
Lehmann, Johannes
Lei, Yaguo
Lei, Ting
Leng, Lijian
Leung, Dennis Y. C.
Leung, Victor C. M.
Levine, Ross
Li, Wei
Li, Jie
Li, Jinghong
Li, Jun
Li, Heng
Li, Gang
Li, Yat
Li, Peng
Li, Hailong
Li, Changpin
Li, Yan
Li, Yurui
Li, Xiaodi
Li, Hong
Li, Shutao
Li, Hongyi
Li, Zhijun
Li, Peiyue
Lin, Yuehe
Lin, Hongjun
Lin, Lin
Lip, Gregory Y. H.
Liu, Jian
Liu, Meng
Liu, Hong
Liu, Tao
Liu, Lei
Liu, Jianxing
Liu, Wei
Liu, Gang
Liu, Yang
Liu, Peide
Lockhart, Shawn R.
Long, Hualou
Löscher, Wolfgang
Lu, Jun
Lu, Jianquan
Lu, Nanshu
Lucey, Brian
Lund, Henrik
Luo, Jun
Luo, Yi
Luo, Jingshan
Luo, Yangchao
Lupton, Deborah
Luque, Rafael
Lv, Wei
Lvov, Yuri M.
Lyons, Timothy W.
Ma, Tianyi
Ma, Jun
Ma, Jiayi
Ma, Wen-Xiu
Ma, Yanming
Maggioni, Aldo Pietro
Mahmood, Nasir
Mahmoudi, Morteza
Mai, Liqiang
Mallavarapu, Megharaj
Mandala, Mario
Mardani, Abbas
Marengo, Jose
Maria Rossolini, Gian
Martinoia, Enrico
Mathiesen, Brian Vad
Mathivanan, Suresh
Mattick, John S.
Matyjaszewski, Krzysztof
McCabe, Matthew E.
McCauley, Darren
McClements, David Julian
Melcher, Karsten
Melenhorst, Jan Joseph
Melero, Ignacio
Mezzetti, Bruno
Mirjalili, Seyedali
Mishchenko, Artem
Mittler, Ron
Moreau, Philippe
Motohashi, Hozumi
Mousavi Khaneghah, Amin
Mu, Shichun
Mueller, Lukas A.
Mueller-Roeber, Bernd
Muenzel, Thomas
Muhammad, Khan
Munger, J. William
Nauen, Ralf
Naushad, Mu.
Negri, Eva
Nemeroff, Charles B.
Newman, David J.
Niaura, Raymond S.
Nie, Feiping
Nieto, Juan J.
Novara, Agata
Nunkoo, Robin
Ogino, Shuji
Olabi, Abdul-Ghani
Ong, Hwai Chyuan
O'Regan, Donal
Orsini, Nicola
Ouyang, Minggao
Ozcan, Aydogan
Pacher, Pal
Pan, Xiaoqing
Pan, Likun
Pan, Quan-Ke
Pang, Huan
Pavela, Roman
Pedrycz, Witold
Pei, Yanzhong
Peng, Shushi
Peng, Qing
Peng, Mugen
Perc, Matjaz
Perez-Alvarez, Jose Angel
Perlin, David S.
Piquero, Alex R.
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Postolache, Mihai
Potenza, Marc N.
Poulter, Benjamin
Preat, Veronique
Prinsep, Michele R.
Pu, Hong-Bin
Putnik, Predrag
Qiu, Jieshan
Qu, Xiaogang
Quiles, José L.
Rabczuk, Timon
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Recio, Isidra
Reiter, Russel J.
Remuzzi, Giuseppe
Ren, Jinsong
Ren, Jun
Riahi, Keywan
Richardson, Paul G.
Rignot, Eric
Rimm, David
Rinn, John L.
Robert, Caroline
Rodriguez, Rosa M.
Rojo, Teofilo
Ros, Emilio
Rosen, Marc A.
Roubaud, David
Russo, Alessandro
Russo, Gian Luigi

Saad, Fred
Saad, Walid
Sadorsky, Perry
Sander, Chris
Santamouris, Mattheos
Santoro, Gabriele
Saraiva, Jorge A.
Sarchiapone, Marco
Scalbert, Augustin
Schloter, Michael
Schneider, Gisbert
Schubert, Ulrich S.
Schulz, Rainer
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scorrano, Luca
Scott, David
Scott, Stuart A.
Scott, Daniel
Serra-Majem, Lluis
Sethi, Gautam
Shabala, Sergey
Shaheen, Sabry M.
Shao, Zongping
Sharma, Gaurav
Shen, Guozhen
Shen, Hao
Sheremet, Mikhail A.
Shi, Peng
Shi, Yumeng
Shoenfeld, Yehuda
Siano, Pierluigi
Sillanpaa, Mika
Simões, Manuel
Simpson, Richard J.
Singh, Bhupinder Pal
Singh, Vijay P.
Smagghe, Guy
Song, Yu
Song, Houbing
Sood, Anil K.
Srivastava, Hari M.
Stadler, Marc
Stadler, Peter F.
Stanley, H. Eugene
Stoumpos, Constantinos C.
Strano, Michael S.
Stunnenberg, Hendrik G.
Su, shiliangsu@whu.edu.cn
Su, Chun-Yi
Subramanian, S. V.
Sun, Zhipei
Sun, Fengchun
Sun, Hongqi
Sunderland, Elsie M.
Suzuki, Nobuhiro
Svenning, Jens-Christian
Szabo, Csaba
Szallasi, Arpad
Szolnoki, Attila
Tacke, Frank
Tan, Weihong
Tan, Chaoliang
Tang, Hua
Tang, Chuyang
Tang, Chuan-He
Tanzi, Rudolph E.
Teichmann, Sarah
Telenti, Amalio
Thakur, Vijay Kumar
Thiele, Holger
Tian, Jie
Tohge, Takayuki
Tran, Lam-Son Phan
Truhlar, Donald G.
Tsao, Rong
Tsuda, Kenichi
Tukker, Arnold
Tung, Chen-Ho
Turskis, Zenonas
Urquhart, Andrew
Valko, Marian
Van Breusegem, Frank
Van de Wiele, Tom
van der Werf, Guido
van Wesemael, Bas
Vangronsveld, Jaco
Varma, Rajender S.
Varsani, Arvind
Varshney, Rajeev K.
Vasilakis, Nikos
Vasilakos, Athanasios V.
Vasquez, Juan C.
Vatanen, Tommi
Ventura, Marco
Vermote, Eric
Veronese, Nicola
Verpoorte, Robert
Vethaak, A. Dick
Vieta, Eduard
Vincent, Jean-Louis
Wagner, Wolfgang
Walton, Vaughn M.
Wan, Jiafu
Wan, Shaohua
Wang, Qi
Wang, Joseph
Wang, Meng
Wang, Tao
Wang, Yuan
Wang, Xin
Wang, Chao
Wang, Yong
Wang, Jun
Wang, Erkang
Wang, Sibo
Wang, Jian
Wang, Ning
Wang, John
Wang, Qin
Wang, Shaojian
Wang, Guoxiu
Wang, Huanting
Wang, Chunsheng
Wang, Gongming
Wang, Zhong Lin
Wang, Lianzhou
Wang, Shaobin
Wang, Yang
Wang, Zifa
Wei, Zhixiang
Wei, Leyi
Weissleder, Ralph
Wen, Guanghui
Wiens, John J.
Wigneron, Jean-Pierre
Willerslev, Eske
Wishart, David S.
Witlox, Frank
Wu, Jun
Wu, Tom
Wu, Hao Bin
Wu, Hui
Wu, Haijun
Wu, Zhongbiao
Wu, Zhong-Shuai
Wu, Zheng-Guang
Xia, Meimei
Xia, Xinhui
Xiang, Quanjun
Xiao, Jianbo
Xiao, Jie
Xie, Jian-Hua
Xin, Sen
Xing, Baoshan
Xiong, Rui
Xu, Bin
Xu, Li Da
Xu, Yi-Jun
Xu, Hui
Xu, Zeshui
Yamauchi, Yusuke
Yan, Huaicheng
Yan, Kai
Yang, Chenguang
Yang, Xiao-Jun
Yang, Bing
Yang, Yun-Gui
Yang, Jie
Yang, Jian
Yang, Xinsong
Yang, Shihe
Yang, Yi
Yang, Yang
Yao, Jen-Chih
Yao, Yonggang
Yazyev, Oleg
Yin, Yulong
Yin, Zongyou
Yin, Shen
Yin, Ya-xia
Yin, Shou-Wei
Ying, Guang-Guo
Young, Allan H.
Yu, Shu-Hong
Yu, Jun
Yu, Guihua
Yu, Wenwu
Yu, Guocan
Yu, Minghao
Zarco-Tejada, Pablo J.
Zavadskas, Edmundas Kazimieras
Zeadally, Sherali
Zhai, Tianyou
Zhang, Wei
Zhang, Binlin
Zhang, Shujun
Zhang, Guoping
Zhang, Zengqiang
Zhang, Yu Shrike
Zhang, Qichun
Zhang, Xian-Ming
Zhang, Guowen
Zhang, Min
Zhang, Yue-Jun
Zhang, Shaoqing
Zhang, Fan
Zhang, Weili
Zhang, Xiaodong
Zhang, Zhien
Zhang, Tierui
Zhang, Hongjie
Zhang, Dengsong
Zhang, Liangpei
Zhang, Dan
Zhang, Yu-Dong
Zhang, Fusuo
Zhao, Yi
Zhao, Guochun
Zhao, Li-Dong
Zheng, Hao
Zheng, Gengfeng
Zhong, Cheng
Zhou, Weiqi
Zhou, Qi
Zhou, Jizhong
Zhu, Hongwei
Zhu, Chengzhou
Zhu, Junfa
Zhu, Zhe
Zhu, Quanxin
Zhuang, Xiaodong
Zhuang, Xiaoying
Zou, Quan

The full list of 2021 Highly Cited Researchers  can be accessed at the following webpage in the Web of ScienceTM https://recognition.webofscience.com/awards/highly-cited/2021/.

--- Highly Cited Researchers (HCR) is a Clarivate product.

16 November 2021
Topical Advisory Panel Established to Support Editorial Board

Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.

The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.

Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.

To qualify as a Topical Advisory Panel Member, applicants must:

  • Have expertise and experience in the field related to the journal;
  • Have received a Ph.D. in the last 10 years, approximately;
  • Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
  • Currently hold an independent research position in academia or a government institute.

If you are interested in this role, please contact the editorial office by email.

We look forward to hearing from you soon.

16 November 2021
Meet Us Virtually at the 1st International Electronic Conference on Processes: Processes System Innovation (ECP2022), 17–31 May 2022


It is our sincere pleasure and great honor to announce the 1st International Electronic Conference on Processes: Processes System Innovation (ECP2022), organized by the MDPI open-access journal Processes (ISSN: 2227-9717). This conference will be hosted online by https://sciforum.net/event/ECP2022 from 17 to 31 May 2022.

This conference will present the latest studies in process/system-related research in chemistry, biology, material, energy, environment, food, pharmaceutical, and allied engineering fields. The goal is to create an advanced forum for new development, challenges, and opportunities in process systems engineering.

All processes/system-related scientists or researchers are welcome to join this event and share their findings around the following general and related themes including, but not limited to:

  • Experimental, theoretical, and computational research on process development and engineering;
  • Process modeling, simulation, optimization, and control;
  • Integrated process design and scaleup;
  • Sustainable and renewable systems engineering;
  • Supply chain management;
  • Circular economies;
  • Eco-friendly processes and methods.

Submitted abstracts will be reviewed by the conference committee. The authors of accepted contributions will be invited to produce an extended abstract for the conference proceedings along with a presentation slide of their work. Following the conference, selected contributions will be invited for submission to the journal Processes (Impact Factor: 2.847).

We look forward to having you join us at this exciting event.

Conference Chair:

Prof. Dr. Giancarlo Cravotto (University of Turin, Italy)

Conference Secretariat:

Ms. Wency Xiang
Ms. Susan Ji
Ms. Elena Shi
Email: ecp2022@mdpi.com

25 October 2021
Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25–31 October

Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.

The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.

For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.

International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.

Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.

Read our anniversary blog post: "Sharing 'Collective Human Knowledge': The Benefits of Open Access Publication"

Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.

The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.

Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.

We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.

  • 25 October 2021
    Energies journal and Institute of Mechanics, Chinese Academy of Sciences
  • 28 October 2021
    Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University
  • 29 October 2021
    Processes journal and Beijing Institute of Technology
  • 29 October 2021
    Coatings journal and Wuhan University of Technology

MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.

23 September 2021
2020 MDPI Top Reviewer Award—Winners Announced


Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:

  • Adriana Burlea-Schiopoiu;
  • Alban Kuriqi;
  • Álvaro González-Vila;
  • Alessandro Alaimo;
  • Alexey Beskopylny;
  • Alexander Yu Churyumov;
  • Alberto Fernández-Isabel;
  • Andrea Mastinu;
  • Antonios N. Papadopoulos;
  • Anton Rassõlkin;
  • Antonio Humberto Hamad Minervino;
  • Arkadiusz Matwijczuk;
  • Artur Słomka;
  • Baojie He;
  • Bartłomiej Potaniec;
  • Bojan Đurin;
  • Camilo Arturo Rodriguez Diaz;
  • Carmelo Maria Musarella;
  • Chiachung Chen;
  • Chiman Kwan;
  • Cristian Busu;
  • Danil Pimenov;
  • Dan-Cristian Dabija;
  • Delfín Ortega-Sánchez;
  • Demetrio Antonio Zema;
  • Denis Butusov;
  • Elena Lucchi;
  • Gaurab Dutta;
  • Livia Anastasiu;
  • M. R. Safaei.

For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.

22 September 2021
MDPI Joins SDG Publishers Compact

UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.

MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.

Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.

The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.

For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
liliane.auwerter@mdpi.com

3 August 2021
Announcement on Japanese Consumption Tax (JCT)

This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.

For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").

Contact: Setsuko Nishihara, MDPI Tokyo

30 June 2021
2020 Impact Factors - Released

The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!

We are pleased to announce that 85 MDPI journals are included, of which:

  • 10 journals received their first impact factor
  • 96% of journals increased their impact factor from 2019
  • 32 journals (38%) ranked among the top 25% of journals, in at least one category
Journal Impact Factor Rank Category
Cancers 6.639 Q1 • Oncology
Cells 6.600 Q2 • Cell Biology
Pharmaceutics 6.321 Q1 • Pharmacology & Pharmacy
Antioxidants 6.313 Q1 • Food Science & Technology 
• Biochemistry & Molecular Biology
• Chemistry, Medicinal
Biomedicines 6.081 Q1 • Medicine, Research & Experimental
• Pharmacology & Pharmacy 
• Biochemistry & Molecular Biology
International Journal of Molecular Sciences 5.924 Q1 • Biochemistry & Molecular Biology
Q2 • Chemistry, Multidisciplinary
Pharmaceuticals 5.863 Q1 • Pharmacology & Pharmacy
• Chemistry, Medicinal
Journal of Fungi 5.816 Q1 • Mycology
• Microbiology
Nutrients 5.719 Q1 • Nutrition & Dietetics
Biosensors 5.519 Q1 • Chemistry, Analytical
• Instruments & Instrumentation
Q2 • Nanoscience & Nanotechnology
Marine Drugs 5.118 Q1 • Chemistry, Medicinal
• Pharmacology & Pharmacy
Biology 5.079 Q1 • Biology
Nanomaterials 5.076 Q1 • Physics, Applied
Q2 • Chemistry, Multidisciplinary
• Materials Science, Multidisciplinary 
• Nanoscience & Nanotechnology
Viruses 5.048 Q2 • Virology
Journal of Personalized Medicine 4.945 Q1 • Medicine, General & Internal
• Health Care Sciences & Services
Metabolites 4.932 Q2 • Biochemistry & Molecular Biology
Biomolecules 4.879 Q2 • Biochemistry & Molecular Biology
Remote Sensing 4.848 Q1 • Geosciences, Multidisciplinary
Q2 • Remote Sensing
• Imaging Science & Photographic Technology 
• Environmental Sciences
Gels * 4.702 Q1 • Polymer Science
Antibiotics 4.639 Q2 • Infectious Diseases
• Pharmacology & Pharmacy
Toxins 4.546 Q1 • Toxicology
• Food Science & Technology
Vaccines 4.422 Q2 • Immunology
• Medicine, Research & Experimental
Molecules 4.412 Q2 • Chemistry, Multidisciplinary
• Biochemistry & Molecular Biology
Foods 4.350 Q2 • Food Science & Technology
Polymers 4.329 Q1 • Polymer Science
Journal of Clinical Medicine 4.242 Q1 • Medicine, General & Internal
Toxics 4.146 Q2 • Toxicology
• Environmental Sciences
Catalysts 4.146 Q2 • Chemistry, Physical
Microorganisms 4.128 Q2 • Microbiology
Membranes 4.106 Q1 • Polymer Science
Q2 • Engineering, Chemical
• Materials Science, Multidisciplinary 
• Chemistry, Physical
Genes 4.096 Q2 • Genetics & Heredity
Fermentation * 3.975 Q2 • Biotechnology & Applied Microbiology
Journal of Cardiovascular Development and Disease * 3.948 Q2 • Cardiac & Cardiovascular Systems
Plants 3.935 Q1 • Plant Sciences
Life 3.817 Q2 • Biology
Diagnostics 3.706 Q2 • Medicine, General & Internal
Current Oncology 3.677 Q3 • Oncology
Materials 3.623 Q1 • Metallurgy & Metallurgical Engineering
Q2 • Materials Science, Multidisciplinary
• Chemistry, Physical 
• Physics, Applied 
• Physics, Condensed Matter
Sensors 3.576 Q1 • Instruments & Instrumentation
Q2 • Chemistry, Analytical
• Engineering, Electrical & Electronic
Pathogens 3.492 Q2 • Microbiology
Agronomy 3.417 Q1 • Agronomy
• Plant Sciences
Chemosensors 3.398 Q2 • Instruments & Instrumentation
• Chemistry, Analytical
Q3 • Electrochemistry
Land 3.398 Q2 • Environmental Studies
Brain Sciences 3.394 Q3 • Neurosciences
International Journal of Environmental Research and Public Health 3.390 Q1 • Public, Environmental & Occupational Health (SSCI)
Q2 • Public, Environmental & Occupational Health (SCIE)
• Environmental Sciences (SCIE)
Tomography 3.358 Q2 • Radiology, Nuclear Medicine & Medical Imaging
Fractal and Fractional * 3.313 Q1 • Mathematics, Interdisciplinary Applications
Sustainability 3.251 Q2 • Environmental Sciences (SCIE)
• Environmental Studies (SSCI)
Q3 • Green & Sustainable Science & Technology (SCIE)
• Green & Sustainable Science & Technology (SSCI)
Water 3.103 Q2 • Water Resources
• Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research 3.049 Q3 • Business
Energies 3.004 Q3 • Energy & Fuels
Agriculture 2.925 Q1 • Agronomy
ISPRS International Journal of Geo-Information 2.899 Q2 • Geography, Physical
• Computer Science, Information Systems
Q3 • Remote Sensing
Micromachines 2.891 Q2 • Instruments & Instrumentation
• Physics, Applied
Q3 • Chemistry, Analytical
• Nanoscience & Nanotechnology
Coatings 2.881 Q2 • Materials Science, Coatings & Films
• Physics, Applied
Q3 • Materials Science, Multidisciplinary
Children 2.863 Q2 • Pediatrics
Processes 2.847 Q3 • Engineering, Chemical
Separations 2.777 Q3 • Chemistry, Analytical
Insects 2.769 Q1 • Entomology
Animals 2.752 Q1 • Agriculture, Dairy & Animal Science
• Veterinary Sciences
Symmetry 2.713 Q2 • Multidisciplinary Sciences
Atmosphere 2.686 Q3 • Meteorology & Atmospheric Sciences
• Environmental Sciences
Applied Sciences 2.679 Q2 • Engineering, Multidisciplinary
• Physics, Applied
Q3 • Chemistry, Multidisciplinary
• Materials Science, Multidisciplinary
Photonics 2.676 Q2 • Optics
Buildings * 2.648 Q2 • Construction & Building Technology
• Engineering, Civil
Healthcare 2.645 Q2 • Health Policy & Services (SSCI)
Q3 • Health Care Sciences & Services (SCIE)
Minerals 2.644 Q2 • Mining & Mineral Processing
• Mineralogy
• Geochemistry & Geophysics
Forests 2.634 Q1 • Forestry
Crystals 2.589 Q2 • Crystallography
Q3 • Materials Science, Multidisciplinary
Entropy 2.524 Q2 • Physics, Multidisciplinary
Diversity 2.465 Q2 • Biodiversity Conservation
Q3 • Ecology
Journal of Marine Science and Engineering 2.458 Q2 • Oceanography
• Engineering, Marine 
• Engineering, Ocean
Medicina 2.430 Q2 • Medicine, General & Internal
Machines * 2.428 Q2 • Engineering, Mechanical
Q3 • Engineering, Electrical & Electronic
Electronics 2.397 Q3 • Engineering, Electrical & Electronic
• Computer Science, Information Systems 
• Physics, Applied
Fishes * 2.385 Q2 • Fisheries
• Marine & Freshwater Biology
Metals 2.351 Q2 • Metallurgy & Metallurgical Engineering
Q3 • Materials Science, Multidisciplinary
Horticulturae * 2.331 Q1 • Horticulture
Veterinary Sciences * 2.304 Q1 • Veterinary Sciences
Universe 2.278 Q3 • Physics, Particles & Fields
• Astronomy & Astrophysics
Mathematics 2.258 Q1 • Mathematics
Magnetochemistry 2.193 Q3 • Chemistry, Inorganic & Nuclear
• Chemistry, Physical 
• Materials Science, Multidisciplinary
Current Issues in Molecular Biology 2.081 Q4 • Biochemistry & Molecular Biology
Actuators 1.994 Q3 • Instruments & Instrumentation
• Engineering, Mechanical
Aerospace * 1.659 Q2 • Engineering, Aerospace

* Journals given their first Impact Factor in 2021

Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)

28 April 2021
Book BuilderCompile a Customized E-Book from Your Favorite MDPI Open Access Content

MDPI Books recently released Book Builder, a new online tool to conveniently arrange, design and produce an eBook from any content published in MDPI journals. Book Builder offers two functions: on the one hand (1) Selections, available to every registered user of MDPI; on the other hand (2) Special Issue Reprints, which can be used exclusively by Guest Editors of Special Issues.

Selections

In just a matter of a few clicks, all users are now able to assemble books from MDPI articles and receive instantaneous feedback in the form of a fully produced and compiled book (PDF), which can be downloaded or ordered as print copy. Selections can include any paper published with MDPI, picking and combining content from different journals and special issues.

This way, the user may for example choose to compile an ebook focusing around a particular topic, or assemble articles from a group of others.

 

We invite you to make yourself familiar with the new tool! The Book Builder can be found here: https://www.mdpi.com/books/book_builder.

Special Issue Reprints

The Book Builder allows Guest Editors of MDPI journals to create a reprint from a successfully completed Special Issue or Topical Collection in book format. If you are a Guest Editor for an MDPI journal, you can use the new tool  to create an PDF document which includes all articles published in the Special Issue as well as a book cover and table of contents.

For Special Issues containing a minimum of 5 articles, the Guest Editor can request its publication on the MDPI Book platform. Published reprints are assigned an ISBN and DOI.

In addition to the PDF copy of the Reprint Book, as a token of our gratitude, MDPI offers every Guest Editor one (1) complimentary print copy (via print-on-demand). All contributors benefit from a discount on orders of any additional print copies, to share with colleagues or libraries or others.

 



Why choose MDPI Books?

In line with our organization's values, MDPI Books publishes all content in open access, promoting the exchange of ideas and knowledge in a globalized world. MDPI Books encompasses all the benefits of open access—high availability and visibility, as well as wide and rapid dissemination. MDPI Books are distributed under the terms and conditions of the Creative Commons Attribution License, meaning as an author you retain the copyright for your work. In addition, with MDPI Books you can complement the digital version of your work with a high-quality printed counterpart.

If you are interested in editing a book volume or series, or have a monograph manuscript to be considered for publication, please submit your proposal online and look at our Information for Authors.

Contact: Laura Wagner, MDPI Books Manager (email)

15 April 2021
MDPI Celebrates Company Milestone With 25th Anniversary Page
"We exist to help scientists achieve their own objectives"


In June of this year, MDPI will celebrate the 25th anniversary of its foundation. To mark this significant milestone, we have created a 25th Anniversary page on our website that evokes the development of our company over the past quarter-century.

MDPI has been a pioneer of Open Access publishing ever since the concept was first created.

In a wide-ranging interview, our CEO Delia Mihaila reflects on the company’s 25th anniversary and its contribution to the world of scientific publishing.

Delia considers how MDPI has evolved since starting life in 1996 as a visionary ‘project’ run out of an apartment in Basel, Switzerland, by Dr. Shu-Kun Lin. A chemist who was passionate about the long-term preservation of rare chemical sample, Dr. Lin was determined to help scholars publish their findings as quickly as possible and make their research results available to as wide a readership as possible worldwide. That determination remains unchanged 25 year